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Abstract 
Leukocyte transmigration through venular walls into the surrounding tissue is a 
crucial event during inflammatory responses. Despite increased understanding of the 
mechanisms associated with leukocyte migration through endothelial cells, little is 
known about the mechanisms mediating the subsequent migration through the 
pericyte layer and the basement membrane. We previously reported that gaps 
between adjacent pericytes are co-localised with matrix protein low expression 
regions in the basement membrane, regions that are preferentially used by leukocytes 
to penetrate venular walls (Wang et al., 2006; Voisin et al., 2009; Voisin et al., 
2010). This study extended these findings to other vascular beds showing that 
pericyte morphology is heterogeneous in different tissues (Voisin et al., 2010). To 
investigate whether pericytes facilitate the transmigration process through direct 
morphological changes at sites of inflammation, neutrophil transmigration and 
pericyte shape change was analysed in whole mounted TNF-α- and IL-1β-stimulated 
murine cremaster muscles by immunofluorescence labelling and confocal 
microscopy. Post-capillary pericytes exhibited shape change resulting in a significant 
increase in mean gap size between adjacent cells. Time-course studies indicated that 
TNF-α-induced shape change preceded neutrophil transmigration. This response was 
PMN-independent as it was also noted in PMN depleted mice. Parallel studies 
investigated the effect of these cytokines on shape change of murine pericyte-like 
C3H/10T1/2 cells in vitro by time lapse microscopy. C3H/10T1/2 cells also 
exhibited significant shape change in response to direct TNF-α- and IL-1β-
stimulation in vitro. Post-capillary venular pericytes in vivo and C3H/10T1/2 cells in 
vitro expressed the respective cytokine receptors, TNFRI, TNFRII and IL-1RI, 
indicating that pericytes can respond directly to pro-inflammatory cytokines. Finally, 
pericyte involvement in neutrophil transmigration in vivo was investigated in real 
time by confocal intra vital microscopy using α-SMA-RFPcherryxLys-EGFP mice. 
Neutrophils preferentially used enlarged gaps to migrate into the surrounding tissue. 
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1.1 Inflammation 
Inflammation is a complex multi-cellular host response to harmful stimuli, such as 
pathogens (e.g. viruses, bacteria, fungi or parasites), damaged cells or irritants. The 
innate immune response is part of an inflammatory response and forms the front line 
of host defence. The innate immune response is based on non-specific pathogen 
recognition systems that identify common surface patterns of pathogenic 
microorganisms (e.g. lipopolysaccharides (LPS) on Gram-negative bacteria) and 
involves key phagocytic leukocytes including neutrophils, monocytes and 
macrophages (Figure 1.1). The two major tasks of the innate immune response are 
resolving or confining the infection via phagocytosis and priming the other branch of 
host immunity, the adaptive immune response. Upon the initial encounter of foreign 
antigens, certain cells of the innate immune response act to induce the adaptive 
branch through the activation of specialised B and T lymphocytes that are highly 
specific for defined pathogens. 
Inflammatory responses involve five characteristic symptoms: Heat, pain, redness, 
swelling and loss of functions. These symptoms are caused by the effects of 
inflammatory mediators on local blood vessels and the resulting recruitment of 
leukocytes to the surrounding tissue. In the early phase of inflammation, tissue 
resident macrophages and dendritic cells phagocytose pathogens and generate 
inflammatory mediators such as cytokines (e.g. tumour necrosis factor α (TNF-α) 
and interleukin-1β (IL-1β)), chemokines (e.g. CCL2/monocyte chemoattractant 
protein-1 (MCP-1) and CXCL8/interleukin 8 (IL-8)) and chemoattractants (e.g. 
leukotriene B4 (LTB4)) indicating the site of infection (Figure 1.1 a). These 
inflammatory stimuli activate endothelial cells of local blood vessels leading to 
vasodilatation, increased permeability and an upregulation of pro-inflammatory 
adhesion molecules on the luminal surface of the endothelium. Vasodilatation and 
increased permeability enhance local blood flow and vascular leakage, accounting 
for the heat, redness, and swelling observed during inflammatory responses. 
Collectively these events promote the recruitment of leukocytes from the vascular 
lumen to the site of infection, to which they are attracted, largely through the actions 
of chemokines (Figure 1.1 b). 
  23 
 
Figure 1.1: Aspects of innate immune responses during acute inflammation. (a) After 
injury, pathogens are detected by tissue-resident macrophages via the recognition of 
common surface patterns such as lipopolysaccharides (LPS). This interaction triggers 
macrophages to release inflammatory mediators such as cytokines and chemokines. (b) 
Inflammatory mediators stimulate local blood vessels, which initiates the recruitment of 
polymorphonuclear leukocytes (PMNs) such as neutrophils. PMNs can also be stimulated 
directly and once in the tissue they help clearing the infection via phagocytosis of pathogens 
as well as secretion of cytotoxic components. In addition, mast cells in the tissue get 
activated to release histamine from intracellular stores which induces vasodilation. (c) In 
most reactions neutrophil transmigration is followed by monocyte infiltration into the tissue, 
where they rapidly differentiate into macrophages. Finally, repair mechanisms are activated 
to initiate wound healing. Adapted from Finlay and Hancock, 2004. 
The migration of cells into the tissue and their local responses such as the release of 
lytic enzymes and cytotoxic components activate sensory nerves causing the pain felt 
during inflammatory conditions. Neutrophils and monocytes are present in high 
numbers in the circulation and are therefore immediately available to react to 
inflammatory signals. Neutrophils are the most abundant subtype of blood leukocytes 
and are the first to be recruited into the infected tissue. Like macrophages, 
neutrophils express surface receptors for common bacterial components and are 
therefore able to engulf and destroy pathogenic microorganisms (Figure 1.1 b). In 
addition, neutrophils have numerous granules containing potent anti-microbial 
substances such as lytic enzymes and are able to generate reactive oxygen species 
that are cytotoxic for both pathogens and host tissue at high concentrations 
(Figure 1.1 b). Hence, neutrophil recruitment and activation has to be a controlled 
event in host defence so that it effectively eliminates pathogens while injury to host 
  24 
cells is kept to a minimum. Neutrophil infiltration is often followed by monocyte 
transmigration into the tissue upon which monocytes rapidly differentiate into 
macrophages (Figure 1.1 c). Following internalisation and degradation of pathogens, 
macrophages become activated and present foreign antigens on their cell surface. 
However, the cells that are more specialised in presenting antigens and initiating 
adaptive immunity are dendritic cells, which reside in the tissue and become 
activated upon antigen encounter. During inflammatory responses the flow of lymph 
increases which promotes the migration of antigen-bearing macrophages and 
dendritic cells into lymphatic vessels and finally lymphoid tissues where they 
activate B and T lymphocytes initiating the slower but highly specific adaptive 
immune response. Activated dendritic cells migrate into lymph vessels to reach 
lymphoid tissues and prime the adaptive immune response by presenting the foreign 
antigens to T lymphocytes, resulting in the development of a highly specific 
population of B and T lymphocytes. Inflammation can be classified into either acute 
or chronic. Acute inflammatory responses are transient episodes, whereas chronic 
inflammation occurs when the infection persists or during autoimmune diseases. 
Collectively, inflammation is a complex response that plays a vital role in host 
defence via a number of means such as regulating the spread of pathogens, delivering 
additional effector molecules and cells to sites of infection, priming the adaptive 
immune response and finally activating repair mechanisms to promote healing of the 
injured tissue. Immunity is a carefully balanced process targeting specifically foreign 
antigens while tolerating host antigens, however, in certain disorders the system is 
inappropriately triggered, excessive or prolonged or self-tolerance is lost leading to 
damage to the host. Therefore, it is important to investigate and understand the 
mechanisms that mediate and regulate leukocyte recruitment to be able to target this 
process when developing treatments for pathological inflammatory conditions. 
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1.2 The leukocyte adhesion cascade 
The recruitment of leukocytes from blood to inflammatory sites is a crucial event 
during inflammatory responses. The mechanisms involved in the transmigration of 
leukocytes from the vascular lumen through venular walls into the surrounding tissue 
are summarised in a paradigm known as the leukocyte adhesion cascade. Initially, 
three steps had been described: Rolling, activation and arrest/firm adhesion of 
leukocytes (Butcher, 1991; Springer, 1994, 1995). These steps have been extended 
and refined, which led to the addition of extra steps such as slow rolling, adhesion 
strengthening, intraluminal crawling and paracellular and transcellular migration 
through the endothelium (Ley et al., 2007) (Figure 1.2). 
 
Figure 1.2: The leukocyte adhesion cascade. Originally known steps are shown in bold 
print compared to recently added ones. Key molecules involved in each step are indicated in 
boxes. Taken from Ley et al., 2007. 
Furthermore, more insight has been gained into the mechanisms that mediate 
leukocyte transmigration through the endothelium (Woodfin et al., 2010) and some 
progress has been made in understanding how leukocytes breach the underlying 
vascular basement membrane and migrate within the extravascular tissue (Ley et al., 
2007; Voisin et al., 2009; Nourshargh et al., 2010). However, the leukocyte adhesion 
cascade as it is recognised at present does not include the role of pericytes. By 
surrounding endothelial cells, they represent the second cellular component of 
venular walls, but very little is known about the role of these cells in inflammatory 
responses. Therefore, this study aims to elucidate the potential role of pericytes in 
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regulating leukocyte transmigration to understand the possible contribution of these 
cells to the overall molecular events during leukocyte extravasation. 
1.2.1 Leukocyte capture and rolling 
The earliest step in the leukocyte adhesion cascade is the capture of leukocytes from 
the circulation (also termed leukocyte tethering), which is followed by leukocyte 
rolling along activated endothelial cells. During inflammatory conditions, the 
endothelium is activated by inflammatory stimuli such as endotoxins, cytokines, 
chemokines and chemoattractants resulting in the expression of selectins (E-selectin 
and P-selectin) and cell adhesion molecules (intercellular adhesion molecule 1 
(ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1)) on the luminal surface. 
Subsequently, leukocytes are captured from the blood stream and start rolling along 
the activated endothelial cells, a process that is mainly mediated by the interaction of 
selectins and their respective ligands (Figure 1.3) (Kansas, 1996; Vestweber and 
Blanks, 1999). 
 
Figure 1.3: Capture of circulating leukocytes and subsequent rolling on activated 
endothelium mediated via interactions between selectins and their ligands. The diagram 
shows leukocytes constitutively expressing PSGL-1 and L-selectin. Upon activation through 
inflammatory stimuli endothelial cells express P-selectin and E-selectin and leukocytes start 
interacting by random contact with the activated endothelium through PSGL-1-P-selectin 
binding. E-Selectin also participates in these interactions by binding to PSGL-1 or other 
ligands on leukocytes. These interactions enable leukocytes to tether to and roll along the 
endothelium. Leukocyte–leukocyte interactions involving L-selectin and PSGL-1 are also 
depicted. Adapted from Varki A, 2009. 
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Selectins are type I transmembrane proteins with long extracellular and short 
cytoplasmic domains. The extracellular domain contains the ligand binding lectin 
domain located at the aminoterminus followed by an epidermal growth factor (EGF)-
like domain and short consensus repeats (Vestweber and Blanks, 1999). At present 
three selectins are known: E-selectin (CD62E) which is expressed on activated 
endothelial cells (Bevilacqua et al., 1987; Pober et al., 1987; Bevilacqua et al., 1989), 
L-selectin (CD62L) which is found on all circulating leukocytes (Gallatin et al., 
1983) and P-selectin (CD62P) which is present on activated endothelial cells and 
platelets (Hsu-Lin et al., 1984; McEver and Martin, 1984; Johnston et al., 1989). All 
selectin ligands are fucosylated carbohydrate structures containing sulfated-sialyl-
Lewisx, which is a tetrasaccharide carbohydrate recognised by the lectin domain of 
selectins. Circulating leukocytes express selectin ligands as shown in Table 1.1. 
Selectin ligand Expressed on 
Binding 
partner 
Corresponding 
references 
E-selectin ligand 1 (ESL-1) Leukocytes E-selectin Levinovitz et al., 1993 
CD44 Leukocytes E-selectin Dimitroff et al., 2001; Katayama et al., 2005 
P-selectin glycoprotein ligand 1 
(PSGL-1) Leukocytes 
All 
selectins 
Bargatze et al., 1994; 
Asa et al., 1995; Moore 
et al., 1995; Jutila and 
Kurk, 1996; Goetz et 
al., 1997 
Table 1.1: Expression of selectin ligands on leukocytes. 
The formed selectin bonds have very high on- and off-rates allowing the captured 
leukocytes to roll along the activated endothelial layer (Figure 1.3) (Lawrence and 
Springer, 1991; Hammer and Apte, 1992; Alon et al., 1995). In fact, the high shear 
rate along the vessel wall is necessary to promote and support P-selectin and L-
selectin mediated leukocyte rolling (Finger et al., 1996; Lawrence et al., 1997). This 
is due to the catch bond character of selectins, meaning that each bond is 
strengthened as shear stress is applied (Marshall et al., 2003). P-selectin is the main 
selectin mediating leukocyte capture and early rolling events, since it is rapidly 
translocated from intracellular granules called Weibel-Palade bodies to the luminal 
surface of endothelial cells upon endothelial activation through inflammatory stimuli 
(Hsu-Lin et al., 1984; McEver and Martin, 1984; Geng et al., 1990). In addition, P-
selectin synthesis can be induced by TNF-α, IL-1β and IL-4 (Pan and McEver, 1995; 
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Yao et al., 1996; Yao et al., 1999; Woltmann et al., 2000). In contrast, there are no 
intracellular stores of E-selectin, hence this molecule is newly synthesized as a result 
of endothelial cell activation by LPS or by inflammatory cytokines such as TNF-α 
and IL-1β (Bevilacqua et al., 1987; Pober et al., 1987). Therefore, E-selectin 
expression peaks at 3-4 h after stimulation (Bevilacqua et al., 1987; Pober et al., 
1987). PSGL-1 seems to be the main selectin ligand involved in mediating leukocyte 
recruitment and rolling in vivo (Norman et al., 1995; Borges et al., 1997a; Borges et 
al., 1997b). The interaction of L-selectin with PSGL-1 initiates leukocyte-leukocyte 
interactions which facilitates the capture of secondary leukocytes (Figure 1.3) 
(Bargatze et al., 1994; Eriksson et al., 2001). 
Apart from mediating rolling, selectin-mediated leukocyte-endothelial interactions 
also trigger signalling events in both cells, inducing the activation of integrins and 
subsequent integrin-mediated firm adhesion (Simon et al., 2000). Integrins are 
heterodimeric cell surface proteins consisting of an α- and a β-subunit and are basally 
expressed on leukocytes but are able to adopt different conformation states that vary 
in affinity for their ligand (low, intermediate and high affinity; Figure 1.4) (Arnaout 
et al., 2005). Leukocyte rolling on E-selectin induces conformational changes in 
integrins from low affinity to intermediate affinity. This is true for integrin αLβ2 (also 
known as lymphocyte-function-associated antigen 1 (LFA-1) or CD11a/CD18) and 
integrin αMβ2 (macrophage receptor 1 (Mac-1) or CD11b/CD18) which are both 
expressed on neutrophils. Their activation leads to the formation of transient bonds 
with their ligand ICAM-1 on activated endothelial cells supporting neutrophil rolling 
(Lo et al., 1991; Salas et al., 2004; Chesnutt et al., 2006). Another ligand for LFA-1 
and Mac-1 is ICAM-2. In contrast to ICAM-1, which is expressed in a continuous 
manner on the luminal surface of the endothelium (Sumagin and Sarelius, 2006), 
ICAM-2 is mostly expressed at endothelial cell junctions (Huang et al., 2006) 
indicating a role for this molecule in leukocyte transmigration rather than rolling and 
adhesion. Indeed, to date ICAM-2 has only been implicated in leukocyte 
transmigration (Issekutz et al., 1999; Huang et al., 2006; Woodfin et al., 2009). T-
cells and monocytes have been shown to express integrin α4β1 (also termed very late 
integrin 4 (VLA-4) or CD49d/CD29) which interacts with VCAM-1 on activated 
endothelium to mediate leukocyte rolling in vitro and in vivo such as in the central 
nervous system (CNS) (Berlin et al., 1995; Grabovsky et al., 2000; Huo et al., 2000; 
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Chan et al., 2001; Singbartl et al., 2001). It has been shown in vivo that leukocyte 
rolling velocity eventually decreases at sites of inflammation, a phenomenon that is 
termed slow rolling and requires not only E-selectin, but also engagement of LFA-1 
and/or Mac-1 with their ligand ICAM-1 (Kunkel and Ley, 1996; Jung et al., 1998; 
Dunne et al., 2002; Zarbock et al., 2008). 
1.2.2 Leukocyte arrest and intravascular crawling to sites of 
transendothelial migration 
Integrin-mediated slow rolling of leukocytes represents the transition from selectin-
mediated rolling to integrin-mediated firm arrest (Simon et al., 2000; Zarbock and 
Ley, 2008). Chemokines and chemoattractants, synthesized by endothelial cells upon 
activation by inflammatory cytokines, are transported to the luminal surface where 
they are presented by being bound to glucosaminoglycans (GAGs) (Spillmann et al., 
1998; Halden et al., 2004; Johnson et al., 2005). In addition, it has been shown that 
activated endothelial cells are able to transport chemokines and chemoattractants, 
which have been generated in the infected tissue such as the chemokine CCL2 and 
the bacteria-derived chemoattractant peptide formylated methionine-leucine-proline 
(fMLP), from their abluminal to their luminal side (Middleton et al., 1997; Rot, 
2005). Leukocyte slow rolling allows for the binding of chemokines and 
chemoattractants on the luminal surface of endothelial cells to G-protein coupled 
receptors (GPCRs) on leukocytes. This interaction induces intracellular signalling 
pathways in leukocytes leading to a further activation of integrins from intermediate 
affinity to high affinity conformation (Figure 1.4), a process termed inside-out 
signalling (Constantin et al., 2000; Laudanna et al., 2002). 
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Figure 1.4: Different integrin conformation states and their associated ligand affinities. 
The diagram shows the three different conformations that integrins can adopt. In the bent 
head-piece conformation integrins exhibit low ligand affinity, whereas extension of the head-
piece leads to conformations with intermediate and high affinity. Adapted from Kinashi, 
2005. 
The intracellular signalling induced in slow rolling leukocytes by the high affinity 
binding of fully activated integrins to their ligands on the endothelium is known as 
outside-in signalling (Arnaout et al., 2005; Shattil, 2005; Giagulli et al., 2006). The 
integrins primarily involved in this process are LFA-1, Mac-1 and VLA-4. The high 
affinity interaction with their endothelial ligands, mainly ICAM-1 and VCAM-1, 
results in adhesion strengthening leading to leukocyte arrest (Campbell et al., 1998; 
Constantin et al., 2000; Kim et al., 2003; Shamri et al., 2005).  
Upon arrest leukocytes undergo changes in cell shape, which results in an elongated 
polarised phenotype and the formation of a leading edge (lammellipod or pseudopod) 
and a trailing edge (uropod) (Rose et al., 2007). This process, termed cell spreading, 
enables subsequent intravascular crawling to sites of transendothelial migration. This 
is important, since leukocyte arrest does not necessarily result in subsequent 
transendothelial migration at the same location. Leukocytes often show intravascular 
crawling from the initial site of arrest to preferred spots of transmigration, an event 
that requires Mac-1 and ICAM-1 interactions (Schenkel et al., 2004; Phillipson et al., 
2006; Ryschich et al., 2006). However, details of the mechanisms involved in 
initiating and mediating intravascular crawling remain to be elucidated. Recently, it 
has been shown in vivo that Vav1, a guanine exchange factor for the Rho family 
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GTPases Rac and Cdc42, is a major regulator of the actin cytoskeleton organization 
during leukocyte polarization and plays an important role in intravascular crawling 
(Mor et al., 2007; Phillipson et al., 2009). Additionally, junctional adhesion molecule 
A (JAM-A), an adhesion molecule expressed on the surface of both leukocytes and 
endothelial cells, has recently been implicated in leukocyte motility (Corada et al., 
2005; Cera et al., 2009). 
Intravascular crawling seems to be important in finding ideal exit points for 
migration through the endothelium such as endothelial junctions since its blockade 
reportedly increases the frequency of transcellular migration (migration through the 
body of an endothelial cell, detailed in section 1.2.3.2) as opposed to paracellular 
migration (migration through endothelial cell junctions, detailed in section 1.2.3.1) 
(Phillipson et al., 2006). 
1.2.3 Leukocyte transmigration through the endothelial layer 
Intravascular crawling is followed by leukocyte adhesion at sites of transendothelial 
migration. Endothelial cells actively support leukocyte adhesion and transendothelial 
migration via the formation of pro-adhesive sites termed endothelial adhesive 
platforms (EAPs) (Barreiro et al., 2008; Ley and Zhang, 2008) and pro-
transmigratory structures termed docking structures or transmigratory cups (Barreiro 
et al., 2002; Carman and Springer, 2004) (Figure 1.5). 
 
Figure 1.5: Formation of endothelial cell adhesion platforms and docking structures. 
After firm arrest, leukocytes crawl on the luminal surface to the point of transendothelial 
migration (TEM). Subsequently, leukocytes adhere to the endothelium via adhesive 
platforms (EAPs) resulting in the formation of docking structures (DSs). These structures 
facilitate transendothelial migration, which may occur via the paracellular or the transcellular 
route. ERM: Ezrin, radixin and moesin. Adapted from Woodfin et al., 2010. 
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EAPs form independently of leukocyte-endothelial cell interactions and are 
determined by pre-existing tetraspanin-enriched microdomains (composed of e.g. 
CD9, CD151 and CD81) on the endothelial cell surface into which ICAM-1 and 
VCAM-1 are incorporated (Barreiro et al., 2008). Subsequently, the interaction of 
leukocyte integrins with their endothelial-cell ligands (ICAM-1 and VCAM-1) 
triggers the formation of docking structures in endothelial cells around leukocytes 
adhering to EAPs. These docking structures are endothelial protrusions that are rich 
in ICAM-1 and VCAM-1, the cytoskeletal protein α-actinin and cytoplasmic adaptor 
molecules such as vinculin, talin-1 and ERM proteins (ezrin, radixin and moesin) 
(Barreiro et al., 2002; Barreiro et al., 2007). Docking structures partially embrace 
adherent leukocytes and initiate leukocyte passage through the endothelium which 
can occur either via the paracellular or the transcellular route. 
1.2.3.1 Paracellular route 
Leukocyte transmigration through post-capillary venules occurs mainly via the 
paracellular route, through endothelial junctions (Figure 1.7 a). Endothelial cell 
junctions contain a number of adhesion molecules many of which interact in a 
homophilic manner to maintain the integrity of the endothelium and regulate its 
barrier function to macromolecules (Figure 1.6) (Dejana, 2004). 
The following junctional adhesion molecules also actively mediate the migration of 
leukocytes through endothelial cell junctions: Platelet endothelial cell adhesion 
molecule 1 (PECAM-1), ICAM-2, CD99, endothelial cell selective adhesion 
molecule (ESAM), JAM-A, JAM-B and JAM-C (Figure 1.7 a) (Thompson et al., 
2001; Muller, 2003; Huang et al., 2006; Bixel et al., 2007; Woodfin et al., 2007). 
Junctional molecules that are not involved in leukocyte transmigration such as VE-
cadherin transiently disappear from the junction (Allport et al., 2000; Shaw et al., 
2001). Recently, our group could show that adhesion molecules located within 
different regions of the endothelial cell junction can act in a sequential manner 
during leukocyte transmigration (Woodfin et al., 2009). By analysing the site of 
arrest of neutrophils in IL-1β-stimulated cremasteric post-capillary venules of 
ICAM-2, JAM-A and PECAM-1 knockout mice we proposed the following 
sequence: ICAM-2, which is expressed on the luminal side of endothelial junctions 
and interacts with Mac-1 and LFA-1 on leukocytes (Staunton et al., 1989; Xie et al., 
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1995), might be involved in guiding leukocytes to endothelial junctions. JAM-A, 
which is located within junctions and binds to LFA-1 and possibly JAM-A on 
leukocytes (Dejana, 2004; Weber et al., 2007), is involved in facilitating leukocyte 
migration through endothelial junctions. Finally, homophilic PECAM-1 interactions 
(Muller, 2003) induce signalling pathways within leukocytes leading to the up-
regulation of the laminin receptor α6β1 integrin, which seems to be necessary to 
breach the vascular basement membrane (Dangerfield et al., 2002). These adhesion 
molecules also exhibit a stimulus-specific role. In contrast to IL-1β, other 
inflammatory mediators such as TNF-α, fMLP or LTB4 induce neutrophil 
transmigration that occurs independently of ICAM-2, JAM-A and PECAM-1 (Huang 
et al., 2006; Nourshargh et al., 2006; Woodfin et al., 2007). 
 
Figure 1.6: Transmembrane adhesion proteins at endothelial cell junctions. At tight 
junctions, cell-cell connection is mediated by claudins, occludin, members of the junctional 
adhesion molecule (JAM) family and endothelial cell selective adhesion molecule (ESAM). 
Junctional integrity at adherens junctions is mostly promoted by vascular endothelial 
cadherin (VE-cadherin). Nectin participates in the organization of both tight junctions and 
adherens junctions. Platelet endothelial cell adhesion molecule (PECAM), which does not 
form a part of tight or adherens junctions, also contributes to endothelial cell-cell adhesion. 
Adapted from Dejana, 2004. 
A second mechanism that keeps the paracellular seal between endothelial cells and 
transmigrating leukocytes intact is shape change (Huang et al., 1988; Huang et al., 
1993). Both leukocytes and endothelial cells undergo shape change to facilitate 
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leukocyte passage. Leukocytes squeeze through endothelial junctions while 
endothelial cells contract resulting in the opening of endothelial junctions. 
Endothelial contraction is mediated by a transient rise in endothelial intracellular 
calcium, leading to the activation of myosin light chain kinase and ultimately to 
actin-induced retraction of endothelial cells (Huang et al., 1993; Hixenbaugh et al., 
1997; Su et al., 2000; Muller, 2003; Ley et al., 2007). 
1.2.3.2 Transcellular route 
Leukocytes have also been reported to migrate through the endothelial cell body via 
the transcellular route (Figure 1.7 b) (Feng et al., 1998; Carman and Springer, 2004). 
At present, the contributions and mechanisms of this pathway are not fully 
understood, but recently some mechanistic insights have been gained. 
Leukocyte transcellular migration seems to be initiated by the formation of leukocyte 
protrusions, termed podosomes, which reach into endothelial invaginations to search 
for permissive sites (Cinamon et al., 2004; Millan et al., 2006; Carman et al., 2007; 
Carman, 2009). Podosomes are actin-rich adhesion structures that are a characteristic 
of invasive cells such as cancer cells (Linder and Aepfelbacher, 2003) and bind to 
endothelial cell ICAM-1 clusters on the endothelium (Millan et al., 2006). Upon 
podosome binding, ICAM-1 is internalized into caveolae that link together forming 
vesicular vacuolar organelles (VVOs) (Millan et al., 2006). VVOs form a 
transcellular pore connected to F-actin stress fibers providing additional membrane 
and structural support during leukocyte passage and finally facilitating the fusion of 
the apical and basal membranes of endothelial cells (Carman et al., 2007; Marmon et 
al., 2009). 
The physiological and pathological role of transendothelial migration via the 
transcellular route is unclear but the response appears to occur when mechanism 
involved in mediating paracellular transmigration are blocked (Phillipson et al., 
2006). 
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Figure 1.7: Leukocyte transmigration through the endothelial layer. Passage of 
leukocytes through the endothelium occurs either via the paracellular (a) or the transcellular 
route (b). (a) Junctional adhesion molecules on endothelial cells such as PECAM-1, 
ICAM-2, ESAM, CD99 JAM-A, JAM-B and JAM-C are involved in mediating leukocyte 
transendothelial migration via the paracellular pathway, through endothelial cell junctions. 
Junctional adhesion molecules not only guide the passage of leukocytes but also induce the 
expression of β1 integrins on leukocytes, which might facilitate the subsequent step of 
leukocyte migration through the underlying basement membrane. (b) Transcellular migration 
is initiated by ICAM-1 ligation, which results in the internalization of ICAM-1 followed by 
it’s translocation to actin- and caveolae-rich regions. ICAM-1 containing caveolae link 
together to form vesiculo-vacuolar organelles (VVOs) leading to the formation of an 
intracellular transmigratory pore supported by F-actin stress fibers. Taken from Ley et al., 
2007. 
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1.3 Pericytes and the venular basement membrane: 
Additional barriers for transmigrating leukocytes 
Despite the improved understanding of the mechanisms involved in leukocyte 
transmigration through endothelial cell junctions, at present little is known about the 
mechanisms by which leukocytes penetrate the remaining components of the vessel 
wall. The endothelial cell layer of collecting venules, post-capillary venules and 
capillaries is surrounded by pericytes, which are embedded in the vascular basement 
membrane (Diaz-Flores et al., 1991; Shimada et al., 1992; Hirschi and D'Amore, 
1996; Voisin et al., 2010). Hence, the basement membrane and pericytes represent 
additional barriers for transmigrating leukocytes (Figure 1.8). Due to the complexity 
of vascular basement membranes and the technical difficulties associated with 
isolating primary pericytes hardly any in vitro models exist that can be used to 
investigate transmigration of leukocytes through these venular components. 
Therefore, only few investigations into the mechanisms that mediate and regulate 
leukocyte transmigration through these barriers exist. 
Recent findings have provided more insight into how leukocytes breach the basement 
membrane (Wang et al., 2006; Rowe and Weiss, 2008; Voisin et al., 2009; 
Nourshargh et al., 2010; Voisin et al., 2010). The venular basement membrane is a 
complex network consisting of collagen type IV, laminin 8 and 10, perlecan and 
nidogen, which are interconnected to form a dense layer of extracellular matrix 
(Figure 1.9) (Hallmann et al., 2005; Rowe and Weiss, 2008). We could demonstrate 
that the venular basement membrane is discontinuous exhibiting numerous regions of 
low matrix protein deposition, which we termed low expression regions or LERs 
(Wang et al., 2006; Voisin et al., 2010). LERs seem to be preferential sites of 
leukocyte transmigration as observed in different inflammatory reactions (Sixt et al., 
2001; Wang et al., 2006; Voisin et al., 2009; Voisin et al., 2010). This might be due 
to LERs being easier to breach by leukocytes since the protein density is significantly 
lower in these regions. LERs might also be more permissive for chemoattractants 
generated in the inflammed tissue leading to leukocyte attraction. 
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Figure 1.8: Pericytes and the venular basement membrane represent additional 
barriers for leukocytes after transendothelial migration. (a) The diagram illustrates the 
leukocyte adhesion cascade including leukocyte migration steps after transendothelial 
migration. After crossing the endothelium, leukocytes have to penetrate the remaining 
components of the venular wall, the venular basement membrane and the pericyte sheath and 
finally reach the site of infection via interstitial motility. (b) Three-dimensional (3D)-
reconstructed confocal images depicting the different components of post-capillary venules 
visualised via triple immunofluorescence staining: Endothelial cells (PECAM-1 labelling, 
blue), pericytes (stained for α-smooth muscle actin (α-SMA), red) and the venular basement 
membrane (laminin staining, green). These structures differ greatly in terms of their 
morphology. Endothelial cells form a confluent monolayer, but the pericyte layer is 
discontinuous and exhibits gaps between adjacent cells. The expression of vascular basement 
membrane components is also heterogeneous exhibiting regions of low protein deposition, 
termed low expression regions or LERs (white circles indicate examples). (c) The cross-
section of the triple stained post-capillary venule shown in (b) illustrates the relative 
localization of the vessel wall components. Endothelial cells line the lumen and are 
surrounded on their abluminal side by pericytes, which are embedded in the basement 
membrane. Taken from Nourshargh et al., 2010. 
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Figure 1.9: Components and structure of basement membranes. Basement membrane 
components are secreted as functional units: Type IV collagen protomers, laminin trimers, 
nidogen (also termed entactin) and perlecan. Laminins are anchored to the cell by receptor 
proteins such as integrins and then associate with the type IV collagen network that has 
formed extracellularly. Nidogen and perlecan crosslink laminins with the type IV collagen 
network. Taken from Kalluri, 2003. 
The mechanisms involved in leukocyte migration through LERs differ among 
leukocyte subtypes. Monocytes have been observed to squeeze through LERs, 
however, the underlying mechanism remains unknown (Voisin et al., 2009). In 
contrary to that, neutrophils seem to be unable to squeeze through LERs and have 
been shown to remodel and enlarge these regions in a neutrophil elastase-dependent 
manner (Wang et al., 2006; Voisin et al., 2009; Voisin et al., 2010). Transendothelial 
migration of neutrophils triggers the release of proteases such as neutrophil elastase 
that are stored in granules (Cepinskas et al., 1999; Wang et al., 2005). In addition to 
protease release, leukocyte-endothelial cell interactions during transmigration also 
induce changes in the expression of β1-integrins (receptors for main basement 
membrane components) on leukocytes aiding the passage of the vascular basement 
membrane (Dangerfield et al., 2002). 
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At present, very little is known about the role of pericytes in leukocyte 
transmigration. One in vivo study exists that has reported transcellular migration of 
leukocytes through pericytes in response to fMLP (Feng et al., 1998) and our group 
could demonstrate by using various other inflammatory conditions in vivo that 
leukocytes preferentially use the paracellular route to cross the pericyte layer (Wang 
et al., 2006), but the associated mechanisms remain to be elucidated. 
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1.4 Pericytes 
1.4.1 Definition and Identification 
Pericytes, also known as adventitial cells, perivascular cells, Rouget cells, mural 
cells, periendothelial cells and pericapillary cells, surround the endothelial cell layer 
of capillaries, post-capillary venules and collecting venules (Diaz-Flores et al., 1991; 
Shimada et al., 1992; Hirschi and D'Amore, 1996) (Figure 1.10). They are embedded 
in the vascular basement membrane and can contribute to the generation of basement 
membrane components (Cohen et al., 1980; Mandarino et al., 1993). 
 
Figure 1.10: Vessel wall components of cremasteric collecting and post-capillary 
venules and capillaries. A representative 3D-reconstructed longitudinal confocal image 
section illustrating venular wall components such as endothelium, pericytes and basement 
membrane is shown. Cremaster muscles were isolated from unstimulated WT C57BL/6 mice 
and immunostained for PECAM-1 (blue, to visualize endothelial cell junctions), α-SMA 
(pink, to visualise pericytes) and collagen IV (green, to visualise this component of the 
vascular basement membrane). C, capillary; CV, collecting venule; PCV, post-capillary 
venule. Bar, 20 μm. The confocal image was kindly provided by Dr. Mathieu-Benoit Voisin. 
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Pericyes are derived from undifferentiated mesenchymal cells, but have also been 
shown to be of mesodermal (Hungerford and Little, 1999), neural crest (Etchevers et 
al., 2001) or bone marrow origin (Rajantie et al., 2004). They are able to differentiate 
into other cell types (Schor et al., 1995) such as fibroblasts (Sundberg et al., 1996), 
chondroblasts (Farrington-Rock et al., 2004), osteoblasts (Brighton et al., 1992; 
Diaz-Flores et al., 1992; Canfield et al., 1996; Doherty et al., 1998) and adipocytes 
(Farrington-Rock et al., 2004). 
Several markers for pericytes have been reported to date, including intracellular 
markers such as smooth muscle α-actin (α-SMA), desmin, and the regulator of G-
protein signalling 5 (RGS5) and extracellular markers like neuron-glia antigen 2 
(NG2), platelet-growth factor receptor β (PDGFR-β), endosialin (CD 248), and the 
unknown antigen of the antibody 3G5 (Gerhardt and Betsholtz, 2003). However, 
unfortunately none of these markers is absolutely specific for pericytes or recognizes 
all pericytes. Their expression varies depending on vessel type (capillaries or 
venules), vascular bed and species (Nehls and Drenckhahn, 1991; Chan-Ling et al., 
2004; Hughes and Chan-Ling, 2004; Murfee et al., 2005). For example, pericytes of 
post-capillary and collecting venules and smooth muscle cells on pre-capillary 
arteriols and arteries express α-SMA, but pericytes of midcapillary pericytes show 
hardly any α-SMA expression (Nehls and Drenckhahn, 1991). Additionally, marker 
expression was also shown to change during pathological conditions such as cancer 
(Morikawa et al., 2002). This has led to misinterpreted findings in previous studies, 
where pericyte loss on angiogenic sprouts and tumour vessels was described due to 
the use of markers, which have later been shown not to be expressed under 
pathological conditions (Morikawa et al., 2002; Baluk et al., 2005). More recently, 
pericytes were reported to be abundant on tumour vessels (Morikawa et al., 2002; 
Baluk et al., 2005). 
1.4.2 Distribution, Morphology and Structure 
Pericytes are the second cellular component of capillaries, post-capillary venules and 
collecting venules (Diaz-Flores et al., 1991; Shimada et al., 1992; Hirschi and 
D'Amore, 1996) (Figure 1.10). They form a discontinuous network with gaps 
between adjacent cells (Shimada et al., 1992; Wang et al., 2006) (Figure 1.11) and 
show close association to the underlying endothelium. Morphological differences 
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exist depending on vessel type (capillaries or venules), vascular bed, developmental 
stage, species and pathological conditions (Diaz-Flores et al., 1991; Morikawa et al., 
2002). Furthermore, pericyte coverage of the abluminal vessel area varies in different 
organs, developmental stages and species (Shepro and Morel, 1993; Egginton et al., 
1996). The ratio of pericytes to endothelial cells varies in different vascular beds 
ranging from 1:1 to 1:100. The retina exhibits one of the highest ratios of 1:3, but the 
highest pericyte abundance (1:1) is found in the CNS (Shepro and Morel, 1993). 
Pericytes can be distinguished from VSMC, which are wrapped tighly aroung 
arteriols, arteries and veins (Figure 1.11) by their location, their morphology and 
their marker expression. However, an absolute distinction between pericytes and 
VSMC is not always possible. There is a continuum of cells from true pericytes 
surrounding post-capillary venules and capillaries to intermediate cells resembling 
both pericytes and smooth muscle cells at the interface between arteriolar capillaries 
and arterioles, to true smooth muscle cells surrounding arterioles, arteries and veins 
(Shimada et al., 1992). 
 
Figure 1.11: Morphology of smooth muscle cells on arterioles and pericytes on 
capillaries and venules. (a) Scanning electron microscopy images depicting smooth muscle 
cells (SM) surrounding an arteriole (A) as well as pericytes (P) on a capillary (C) and a 
venule (V). Taken from Shimada et al., 1992. (b) Schematic drawings illustrating 
morphological differences between smooth muscle cells and pericytes as well as among 
pericytes depending on the vessel type. Taken from Morikawa et al., 2002. (a and b) Smooth 
muscle cells on arterioles are uniformly shaped, circumferentially arranged, closely packed, 
and tightly associated with the endothelium. Pericytes on capillaries have two thin major 
processes that are oriented longitudinally along the vessel from which mutiple minor process 
extend surrounding the capillary. Capillary pericytes cover only a small proportion of the 
endothelial surface. Pericytes on venules exhibit an irregular shape and extend numerous 
major processes covering a great part of the endothelial surface. 
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Pericytes have a large kidney-shaped nucleus and their cytoplasm contains 
multivesicular bodies, osmiophilic bodies and lysosomes (Diaz-Flores et al., 1991). 
They also exhibit structures important for contraction. It has been shown by electron 
microscopy that pericytes contain a pronounced network of filaments (Forbes et al., 
1977), including actin microfilaments of both smooth muscle and nonmuscle 
isoforms (Herman and D'Amore, 1985; Skalli et al., 1989). Pericytes also posses 
significant amounts of other regulator proteins of contractile responses such as GMP-
dependent protein kinase (Joyce et al., 1984), and tropomyosin (Joyce et al., 1985b, 
a). 
1.4.3 Functions 
Pericytes play a critical role in maintaining the integrity of the vessel wall and in 
generating the vascular BM, in which they are embedded (Cohen et al., 1980; 
Mandarino et al., 1993). The close interaction of pericytes with endothelial cells 
provides mechanical support (Lindahl et al., 1997) and mediates endothelial 
metabolism, growth and motility. Pericytes interact with endothelial cells via soluble 
factors as well as cell-cell contacts (Armulik et al., 2005) such as tight junctions, gap 
junctions (Cuevas et al., 1984; Larson et al., 1987; Fujimoto, 1995; Little et al., 
1995), adhesion plaques (Forbes et al., 1977), and peg and socket connections (Diaz-
Flores et al., 1991). These are mediated via adhesion molecules such as CAMs, N-
cadherin (Gilbertson-Beadling and Fisher, 1993; Gerhardt et al., 2000), VCAM-1 
(Verbeek et al., 1995), substrate adherence molecules (SAMs) and integrins (Silva et 
al., 2008). Furthermore, mechanical linkage between pericytes and endothelial cells 
occurs via endothelial fibronectin-rich cytoplasmic fibrils, which are inserted into the 
plasma membrane of pericytes (Courtoy and Boyles, 1983). Pericyte processes in 
contrary do not frequently come into contact (Diaz-Flores et al., 1991) and 
intercellular junctions between pericytes have not been reported. 
On newly formed vessel sprouts pericytes are recruited via soluble growth factors 
such as basic fibroblast growth factor (bFGF), heparin-binding epidermal growth 
factor (HB-EGF) and platelet-derived growth factor (PDGF) (Hirschi and D'Amore, 
1996). After recruitment, pericytes suppress endothelial proliferation via a contact-
dependent activation of TGF-β (Orlidge and D'Amore, 1986, 1987). Endothelial 
movement in vitro has also been shown to be blocked by the activation of latent 
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TGF-β (Sato and Rifkin, 1989). Pericyte proliferation on the other hand is regulated 
by bFGF, HB-EGF, PDGF (D'Amore and Smith, 1993) and endothelin, which have 
been shown to be mitogenic for pericytes in vitro. Endotoxins and platelet-activating 
factor (PAF) show also direct mitogenic activity on pericytes (Khoury and 
Langleben, 1996, 1998). Inhibition of pericyte growth and proliferation is mediated 
by TGF-β (D'Amore and Smith, 1993), heparin (Newcomb and Herman, 1993) and 
vascular endothelial growth factor (VEGF) (Greenberg et al., 2008). 
Apart from providing mechanical support and stability for the vessel wall and 
regulating endothelial proliferation, pericytes have the ability to contract and thereby 
regulate vascular flow and permeability. Pericytes posses a contractile apparatus and 
structural components for contractile mechanisms by expressing numerous proteins, 
which are typical for contractile cells (Joyce et al., 1984; Joyce et al., 1985a, b; Skalli 
et al., 1989). Additionally, they posses high affinity binding sites for endothelin, 
which is a potent vasoconstrictive agent. Hence, pericytes are able to contribute to 
the regulation of capillary and venular blood flow and permeability (Peppiatt et al., 
2006). Pericytes are also considered to posses potential phagocytotic activity 
(Brachvogel et al., 2007) and have been shown to exhibit numerous vesicles and 
lysosomes (Diaz-Flores et al., 1991). Therefore, pericytes might contribute to the 
clearance of pathogens via phagocytosis of pathogens or release of toxic components 
from their vesicles. 
1.4.4 Related diseases 
Many of the crucial functions of pericytes are highlighted by their implication in 
diseases such as diabetic retinopathy, multiple sclerosis, tumour angiogenesis, 
hypertension, central nervous system dementia and calcification of vascular tissues 
(Wallow et al., 1993; Verbeek et al., 1999; Yamagishi et al., 1999; Collett and 
Canfield, 2005). Apoptosis and loss of retinal capillary pericytes and disruption of 
pericyte-endothelial contacts are characteristic features of diabetic retinopathy and 
can also occur in other capillary beds in humans with diabetes (Sima et al., 1985). 
The absence of pericytes results in a loss of capillary tone, leading to dilatation, 
formation of micro-aneurysms and retinal neovascularisation. Pericytes on tumour 
vessels have multiple abnormalities such as variation in marker expression and 
changes in morphology. Here, pericytes are noted to detach from vessels and the 
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processes extend away from the endothelium into the surrounding tissue, resulting in 
a loss of endothelial growth control, which supports tumour angiogenesis (Morikawa 
et al., 2002). In Acute Respiratory Distress Syndrome (ARDS), increased 
permeability (pulmonary oedema) can be diagnosed in early stages of the disease 
(Matthay and Zimmerman, 2005). After direct lung injury pro-inflammatory 
cytokines are released resulting in pulmonary microvasculature injury and an 
increase in permeability (Matthay and Zimmerman, 2005). This might be mediated 
by pericytes, because these cells have been shown to be crucial in the development of 
microvascular permeability and capillary leak (Leveen et al., 1994; Hellstrom et al., 
2001). Interestingly, pericytes have also been implicated in the regulation of 
leukocyte extravasation. During multiple sclerosis T-Lymphocyte adhesion and 
migration into the human brain is mediated via the interaction of very late antigen-4 
(VLA-4) on T-lymphocytes and VCAM-1, which is expressed on endothelial cells 
and pericytes (Verbeek et al., 1995). Therefore, pericytes may also play a role in T-
cell infiltration into the brain via direct adhesive interactions with extravasating T-
cells. 
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1.5 Aim of this study 
At present very little is known about the potential role of pericytes in leukocyte 
transmigration. Therefore, this project aimed to investigate the involvement of 
pericytes in regulating leukocyte transmigration in vivo by addressing the following 
key questions: 
Does pericyte phenotype/morphology differ in different vessel types and 
vascular beds in the mouse? 
To date no study has described and compared morphological characteristics of 
pericytes in different vascular beds in the mouse. Therefore, pericytes were 
characterized in different types of blood vessels in the cremaster muscle as well as in 
post-capillary venules in selected vascular beds in the mouse. 
Does pericyte morphology change under inflammatory conditions? 
To elucidate potential pericyte responsiveness during inflammatory conditions in 
vivo, changes in pericyte morphology upon stimulation with various inflammatory 
mediators were investigated in the murine cremaster muscle. Subsequently, the 
effects of TNF-α and IL-1β were further characterised over time and the involvement 
of neutrophils was examined using neutrophil depleted animals. Furthermore, the 
effects of TNF-α and IL-1β were investigated in an additional vascular bed - the skin 
of the ear - to explore the possibility of tissue-specific mechanisms. 
Is the potential pericyte responsiveness a direct effect of inflammatory stimuli 
on pericytes? 
To complement the in vivo findings and to investigate pericytes and their properties 
isolated from other cell types, murine pericyte-like C3H/10T1/2 cells and their 
responses to TNF-α and IL-1β stimulation were characterized in vitro. To determine 
whether pericytes are able to respond directly to TNF-α- and IL-1β, expression of the 
receptors for these cytokines was examined on C3H/10T1/2 cells in vitro as well as 
on cremasteric post-capillary venular pericytes in vivo. 
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Does pericyte morphology change under inflammatory conditions in a manner 
that would facilitate neutrophil transmigration? 
By using pericyte reporter mice (α-SMA-GFP and α-SMA-RFPcherry mice) and 4D 
confocal Intravital Microscopy TNF-α-induced pericyte shape change and its 
involvement in leukocyte transmigration could be observed and analysed in vivo.
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2.1 Animals 
All animal studies were performed according to the directions of the United 
Kingdom Home Office Animals (Scientific Procedures) Act (1986). 
2.1.1 Strains 
C57BL/6 mice Male wild type (WT) C57BL/6 mice were routinely 
used between the ages of 6-12 weeks (~ 25 g) and were 
purchased from Harlan-Olac (Bicester, UK). 
α-SMA-GFP mice C57BL/6 mice which express Green Fluorescent 
Protein (GFP) under the control of the α-smooth 
muscle actin (α-SMA) promoter (Yokota et al., 2006) 
were obtained as a gift from Prof. Clare Isacke 
(Breakthrough Breast Cancer Research Centre, The 
Institute of Cancer Research, London, UK) with the 
authorisation of Prof. Sanai Sato (Department of 
Medicine, University of Oklahoma Health Science 
Center, Oklahoma City, USA). 
α-SMA-RFPcherry mice C57BL/6 mice which express the cherry variant of Red 
Fluorescent Protein (RFPcherry) under the control of 
the α-SMA promoter were obtained as a gift from Dr. 
David Rowe (Department of Genetics and 
Developmental Biology, University of Connecticut 
Health Center, Farmington, USA). 
Lys-EGFP mice This mouse strain was generated as described by Faust 
et al. in 2000 and contains the mutated murine 
lysozyme M (lys) locus into which coding sequence for 
eGFP has been inserted (Faust et al., 2000). Lys-EGFP 
mice exhibit EGFP labelled myelomonocytic cells and 
especially high fluorescence intensity is observed in 
mature neutrophil granulocytes. Homozygous lys 
knockout mice show normal development and are 
fertile. We noticed no differences in leukocyte 
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transmigration using the homozygous or heterozygous 
mice. This strain was generated in a C57BL/6 
background and was obtained as a gift from Prof. 
Markus Sperandio (Walter Brendel Center of 
Experimental Medicine, Ludwig-Maximillians-
Universität, Munich, Germany). 
Tumour necrosis factor receptor (TNFR) double knockout mice  
These mice are double mutant mice lacking both genes 
Tnfrsf1a (p55) and Tnfrsf1b (p75). They were 
generated by intercrossing the singly deficient mice 
whereupon the Tnfrsf1b mutation was transferred into 
the Tnfrsf1a background (C57BL/6). The mice are 
viable and fertile and animals were purchased from 
The Jackson Laboratory (stock number: 003243). 
2.1.2 Genotyping and Phenotyping 
2.1.2.1 Phenotyping of the α-SMA-GFP mice 
α-SMA-GFP mice were phenotyped by fluorescence microscopy. For this purpose, 
ear notch samples were taken and the skin was separated carefully from the cartilage 
using forceps. The skin was then whole mounted for fluorescence microscopy to look 
for the presence of GFP positive vascular smooth muscle cells and pericytes 
(Figure 2.1 a). 
2.1.2.2 Phenotyping of the α-SMA-RFPcherry mice 
α-SMA-RFPcherry mice were phenotyped by fluorescence microscopy as described 
above for the α-SMA-GFP mice looking for the presence of RFP positive vascular 
smooth muscle cells and pericytes (Figure 2.1 b). 
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Figure 2.1: Phenotyping of α-SMA-GFP mice (a) and α-SMA-RFPcherry mice (b). 3D-
reconstructed confocal images of skin from ear notch samples. A, arteriole; C, capillary; 
PCV, post-capillary venule. Bars, 20 μm. 
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2.1.2.3 Phenotyping of the Lys-EGFP mice 
The phenotype of Lys-EGFP mice was established by flow cytometry analysis of 
blood leukocytes (performed by Dr. Abigail Woodfin). Homozygous samples could 
be distinguished from heterozygous samples by fluorescence intensity. 
2.1.2.4 Genotyping of the TNFR double knockout mice 
TNFR double knockout mice were genotyped by polymerase chain reaction (PCR). 
For this purpose, ear notch samples were taken and digested in 200 μl lysis buffer 
containing 100 μg/ml proteinase K for 3 h at 55 °C. Afterwards, tubes were shaken 
gently and cooled to room temperature (RT) prior to DNA purification using 
isopropanol/ethanol precipitation. The samples were spun down for 10 min at 
20,000 g/RT and the resulting supernatant was transferred into new tubes containing 
250 μl isopropanol and mixed well resulting in the formation of precipitates. The mix 
was centrifuged for 5 min at 20,000 g/RT and the resulting supernatant was 
discarded. The pellet was washed with 150 μl 70 % (v/v) Ethanol followed by 
centrifugation for 5 min at 20,000 g/RT. After removal of ethanol, the pellet was air 
dried for approximately 10 min. The DNA was resuspended in 50 μl molecular 
biology grade water and stored at 4 °C for short-term storage or at 20 °C for longer 
storage. 2 μl purified DNA were used for PCR. TNFRI and TNFRII gene knockouts 
were assessed in separate reactions. 
Detection of TNFRI (tnfrsf1a) knockout 
TNFRI knockout was detected using a slighty modified version of the Jackson 
Laboratory protocol resulting in separate PCRs for amplification of the WT allele 
and the knockout allele. Two primer pairs were used to either amplify the WT or the 
knockout allele (Table 2.1). PCR master mixes were prepared (Table 1.1 and 
Table 2.3) and mixed with 2 μl purified DNA. Subsequently, DNA fragments were 
amplified in a PCR block (DNAEngine® Peltier Thermal Cycler, Bio-Rad, Hemel 
Hempstead, UK) using either the TNFR1AWT program (Table 2.4) or the 
TNFR1AKO program (Table 2.5) to amplify the WT or the knockout allele 
respectively. 
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Primer Primer sequence Melting temperature 
Primer 
type 
oIMRo834 5'-GGA TTG TCA CGG TGC CGT TGA AG-3' 64.2 °C WT 
oIMRo835 5'-TGA CAA GGA CAC GGT GTG TGG C-3' 64.0 °C WT 
oIMRo836 5'-TGC TGA TGG GGA TAC ATC CAT C-3' 60.3 °C Mutant 
oIMRo837 5'-CCG GTG GAT GTG GAA TGT GTG-3' 61.8 °C Mutant 
Table 2.1: Primers used to amplify either the TNFRI WT or mutant (knockout) allele. 
Reagent Stock concentration 
Volume 
per 
sample 
Final 
concentration 
Primer 1: oIMRo834 100 μM 0.12 μl 0.5 μM 
Primer 2: oIMRo835 100 μM 0.12 μl 0.5 μM 
dNTPs 10 mM 0.5 μl 0.2 mM 
MgCl2 50 mM 1 μl 2 mM 
NH4+ buffer 10 x 2.50 μl 1 x 
TAQ polymerase 5 U/μl 0.15 μl 0.03 U/μl 
dH2O (molecular biology grade)  18.61 μl  
Total  23 μl  
Table 2.2: PCR master mix to amplify the TNFRI WT allele. 
Reagent Stock concentration 
Volume 
per 
sample 
Final 
concentration 
Primer 3: oIMRo836 100 μM 0.12 μl 0.5 μM 
Primer 4: oIMRo837 100 μM 0.12 μl 0.5 μM 
dNTPs 10 mM 0.5 μl 0.2 mM 
MgCl2 50 mM 1 μl 2 mM 
NH4+ buffer 10 x 2.50 μl 1 x 
TAQ polymerase 5 U/μl 0.15 μl 0.03 U/μl 
dH2O (molecular biology grade)  18.61 μl  
Total  23 μl  
Table 2.3: PCR master mix to amplify the TNFRI knockout allele. 
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Initial denaturation 94 °C for 3 min x 1 
Denaturation 94 °C for 30 sec 
35 cycles Annealing 68 °C for 1 min 
Elongation 72 °C for 1 min 
Final elongation 72 °C for 2 min x 1 
Table 2.4: PCR program TNFR1AWT. 
Initial denaturation 94 °C for 3 min x 1 
Denaturation 94 °C for 30 sec 
35 cycles Annealing 64 °C for 1 min 
Elongation 72 °C for 1 min 
Final elongation 72 °C for 2 min x 1 
Table 2.5: PCR program TNFR1AKO. 
After amplification, 2 μl of blue agarose gel electrophoresis loading buffer was 
added to the samples and 10 μl were run on a 3 % (w/v) agarose gel (in TAE buffer) 
supplemented with 2 μl GelRed. A 100 – 1,000 bp DNA ladder was used as a 
marker. Gels were left running in an electrophoresis chamber (Mupid®-One 
electrophoresis system, Eurogentec, Southampton, UK) for approximately 45 min at 
90 V. Subsequently, gel pictures were taken under ultraviolet light on a UV White 
Darkroom BioImaging system (UVP, Cambridge, UK). 120 bp PCR products 
represented WT alleles whereas 155 bp PCR products corresponded to knockout 
alleles. 
Detection of TNFRII (tnfrsf1b) knockout 
Knockout of TNFRII was detected according to the Jackson Laboratory protocol. 
Three primers were used to amplify both the WT and the knockout allele (Table 2.6). 
A PCR master mix was prepared (Table 2.7) and mixed with 2 μl purified DNA. 
Subsequently, DNA was amplified in a PCR block (DNAEngine® Peltier Thermal 
Cycler, Bio-Rad, Hemel Hempstead, UK) using the TNFR1BKO programm 
(Table 2.8). 
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Primer Primer sequence Melting temperature 
Primer 
type 
oIMRo837 5'-CCG GTG GAT GTG GAA TGT GTG-3' 61.8 °C Mutant 
oIMRo838 5'-AGA GCT CCA GGC ACA AGG GC-3' 63.5 °C Common 
oIMRo839 5'-AAC GGG CCA GAC CTC GGG T-3' 63.1 °C WT 
Table 2.6: Primers used to amplify both the TNFRII WT and mutant (knockout) allele. 
Reagent Stock concentration 
Volume per 
sample 
Final 
concentration 
Primer 1: oIMRo837 100 μM 0.13 μl 0.5 μM 
Primer 2: oIMRo838 100 μM 0.26 μl 1 μM 
Primer 3: oIMRo839 100 μM 0.13 μl 0.5 μM 
dNTPs 10 mM 0.5 μl 0.2 mM 
MgCl2 50 mM 1 μl 2 mM 
NH4+ buffer 10 x 2.50 μl 1 x 
TAQ polymerase 5 U/μl 0.15 μl 0.03 U/μl 
dH2O (molecular biology grade)  18.33 μl  
Total  23 μl  
Table 2.7: PCR master mix to amplify both the TNFRII WT and knockout allele. 
Initial denaturation 94 °C for 3 min x 1 
Denaturation 94 °C for 30 sec 
35 
cycles Annealing 69 °C for 1 min 
Elongation 72 °C for 1 min 
Final elongation 72 °C for 2 min x 1 
Table 2.8: PCR program TNFR1BKO. 
After amplification, samples were run on a 1 % (w/v) agarose gel as described above. 
257 bp PCR products represented WT alleles whereas 160 bp PCR products 
corresponded to knockout alleles. 
2.2 Cell lines 
C3H/10T1/2 (clone 8) This adherent cell line was purchased from ATCC 
(Manassas, USA). These murine fibroblasts show 
pericyte-like properties and were isolated from a line 
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of C3H mouse embryo as described in Reznikoff et al. 
in 1973 (Reznikoff et al., 1973). 
2.3 Bacterial strains 
Top10F’ Aliquots of this bacterial strain were received as a gift 
from Dr. Fulvio D’Acquisto (purchased from 
Invitrogen, Cat. No. 44-0301, Paisley, UK). 
2.4 Plasmids 
Lifeact-eGFP The Lifeact-eGFP plasmid encodes for a 17amino-acid 
probe against F-actin fused at the C-Terminus to eGFP. 
Therefore, the probe can be used to directly image 
changes in the actin cytoskeleton in real time (Riedl et 
al., 2008). Lifeact-eGFP has been reported not to 
interfere with actin dynamics in vitro and in vivo and 
was received as a gift from Dr. Michael Sixt (Max 
Planck Institute of Biochemistry, Martinsried, 
Germany). 
2.5 Reagents 
2.5.1 Anaesthetics 
Ketamin Ketaset® Injection, c = 100 mg/ml, Cat. No. SH4401C, 
Fort Dodge Animal Health Ltd, Southampton, UK; 
Xylazine Rompun® 2 %, c = 20 mg/ml, Cat. No. 79767161 
Bayer plc., Newbury, UK; 
2.5.2 Antibodies 
Primary antibodies 
α-SMA Purified monoclonal mouse anti-mouse α-SMA-Cy3, 
clone 1A4, c = 1.3 mg/ml, Sigma-Aldrich, Poole, 
Dorset, UK; 
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Collagen IV Purified polyclonal rabbit anti-mouse collagen IV, 
c = 1 mg/ml, abcam, Cambridge, UK; 
GR1 Purified monoclonal rat anti-mouse Ly-6G and Ly-6C 
(GR1), clone RB6-8C5, c = 1 mg/ml, no azide/low 
endotoxin (NA/LE) formulation, BD Pharmingen, 
Oxford, UK; 
Interleukin-1 receptor I (IL-1RI)  
Armenian hamster anti-mouse IL-1RI, clone 
JAMA-147, c = 0.5 mg/ml, BioLegend (via Cambridge 
Bioscience, Cambridge, UK); Used for flow cytometry 
of cultered cells; 
 Goat anti-mouse IL-1RI, c = 0.2 mg/ml, R&D 
Systems, Abingdon, UK; Used for labelling of whole 
mounted tissues for confocal microscopy; 
MRP-14 Rat anti-mouse MRP-14, clone 2B10, c = 1.4 mg/ml, 
received as a gift from Dr. Nancy Hogg (Leukocyte 
Adhesion Laboratory, Cancer Research UK, London 
Research Institute, Lincoln’s Inn Fields Laboratories, 
London, UK), MRP14 is an intracellular marker for 
neutrophils (Hobbs et al., 2003); 
NG2 Purified polyclonal rabbit anti-rat NG2 chondroitin 
sulfate proteoglycan (cross reacts with mouse), c = 
1 mg/ml, Millipore, Watford, UK; 
PECAM-1-647 Functional grade purified rat anti-mouse CD31 
(PECAM-1), clone 390, c = 1 mg/ml, eBioscience, 
Hatfield, UK. This antibody was then directly 
conjugated to Alexa-647 using the APEXTM Alexa 
Fluor® 647 Antibody Labeling Kit (Cat. No. A10475, 
Invitrogen, Paisley, UK) according to the 
manufacturer’s protocol. 
TNFRI Armenian hamster anti-mouse TNFRI, clone 55R-286, 
c = 0.5 mg/ml, BioLegend (via Cambridge Bioscience, 
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Cambridge, UK); Used for flow cytometry of cultered 
cells; 
 Goat anti-mouse TNFRI, c = 0.2 mg/ml, R&D 
Systems, Abingdon, UK; Used for labelling of whole 
mounted tissues for confocal microscopy; 
TNFRII Armenian hamster anti-mouse TNFRII, clone 
TR75-89, c = 0.5 mg/ml, BioLegend (via Cambridge 
Bioscience, Cambridge, UK); Used for flow cytometry 
of cultered cells; 
 Goat anti-mouse TNFRII, c = 0.2 mg/ml, R&D 
Systems, Abingdon, UK; Used for labelling of whole 
mounted tissues for confocal microscopy; 
Isotype controls 
for GR1 Rat IgG2b κ, c = 1mg/ml, Cat. No. MCA1125XZ, 
AbDSerotec, Oxford, UK; 
for NG2 IgGs from rabbit serum, c = 5 mg/ml, Sigma-Aldrich, 
Poole, Dorset, UK; 
for armenian hamster anti IL-1RI, TNFRI and TNFRII  
armenian hamster IgG1, clone G235-2356, c = 
1 mg/ml, BD Pharmingen, Oxford, UK; 
for goat anti IL-1RI, TNFRI and TNFRII  
Normal goat IgGs, c = 1 mg/ml, R&D Systems, 
Abingdon, UK 
Secondary antibodies and streptavidin conjugates 
anti-armenian hamster-biotin  
Purified biotin conjugated goat anti-armenian hamster 
IgGs antibody, c = 1 mg/ml, Invitrogen, Paisley, UK; 
streptavidin-488 Alexa Fluor conjugated streptavidin, c = 2 mg/ml, 
Invitrogen, Paisley, UK; 
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anti-goat-488 Purified Alexa Fluor conjugated rabbit anti-goat IgGs 
antibody, c = 2 mg/ml, Invitrogen, Paisley, UK; 
anti-rabbit-488 or -633 Purified Alexa Fluor conjugated goat anti-rabbit IgGs 
antibody, c = 2 mg/ml, Invitrogen, Paisley, UK; 
anti-rat-488 or -633 Purified Alexa Fluor conjugated goat anti-rat IgGs 
antibody, c = 2 mg/ml, Invitrogen, Paisley, UK; 
2.5.3 Cell culture reagents 
Dulbecco’s Modified Eagles Medium (DMEM)  
high glucose, Cat. No. 11960-044, Gibco, Paisley, UK; 
Ethylenediaminetetraacetic acid (EDTA)   
Cat. No. E5134, Sigma-Aldrich, Poole, Dorset, UK; 
Fetal bovine serum (FBS) Cat. No. 10270-106, Gibco, Paisley, UK; 
Leibovitz Leibovitz’s, Cat. No. 21083027, Gibco, Paisley, UK; 
L-Glutamine c = 200 mM (100 x), Cat. No. 25030, Gibco, Paisley, 
UK; 
Phosphate buffered saline (PBS)  
1 × PBS, pH 7.2, Cat. No. 20012-019, Gibco, Paisley, 
UK; 
Penicillin/Streptomycin 10 000 u/ml Penicillin and 10 000 μg/ml Streptomycin, 
Cat. No. 15140, Gibco, Paisley, UK; 
Trypan blue Cat. No. 15250-061, Gibco, Paisley, UK; 
Trypsin/EDTA 1 × solution (0.025 % Trypsin and 0.01% EDTA), Cat. 
No. R-001-100, Cascade Biologics (Invitrogen), 
Paisley, UK; 
2.5.4 Fluorescent cell markers 
Draq5 Draq5TM nuclear dye, c = 5 mM, Cat. No. DR50051, 
Biostatus limited, Shepshed, UK; 
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Wheat Germ Agglutinin-488 (WGA-488)  
WGA-488 conjugate, c = 1 mg/ml, Cat. No. Invitrogen, 
Paisley, UK, used as a cell surface marker; 
2.5.5 Cytokines/Chemokines/Chemoattractants 
CCL2 (Monocyte chemotactic protein-1 (MCP-1))  
mouse CCL2, Cat. No. DY479, R&D Systems, 
Abingdon, UK; 
Interleukin-1β (IL-1β) mouse IL-1β, Cat. No. 401-ML-005/CF, R&D 
Systems, Abingdon, UK; 
Leukotriene B4 (LTB4) LTB4, Cat. No. 434625, Merck, Hoddesdon Hets, UK; 
Tumor necrosis factor-α (TNF-α)  
mouse TNF-α, Cat. No. 401-ML-010/CF, R&D 
Systems, Abingdon, UK; 
2.5.6 Enzymes 
BamHI Cat. No. R0136S, New England Biolabs, Hitchin, UK; 
DraIII Cat. No. R0510S, New England Biolabs, Hitchin, UK; 
Proteinase K Cat. No. 3115879001, Roche, Burgess Hill, UK; 
2.5.7 Kits 
BD Cytofix/CytopermTM Kit  
Fixation and Permeabilisation Kit, Cat. No. 554714, 
BD Biosciences, Oxford, UK; 
2.5.8 Other reagents, solutions and buffers 
Blue agarose gel electrophoresis loading buffer  
25 mg Bromophenol Blue  
4 g Sucrose 
10 ml molecular biology grade water 
Bovine serum albumin (BSA)  
New England Biolabs, Hitchin, UK; 
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Bromophenol Blue Cat. No. B0126, Sigma-Aldrich, Poole, Dorset, UK; 
DNA ladders SmartLadder SF (100 – 1,000 bp), Cat. No. MW-1800-
04 or SmartLadder (200 – 10,000 bp), Cat. No. MW-, 
Eurogentec, Southampton, UK 
Ethanol Cat. No. 101077Y, VWR, Soulbury, UK; 
GelRed Cat. No. 41003, Biotium, via Cambridge BioScience, 
Cambridge, UK; 
Genticin Cat. No. 10131-019, Gibco, Paisley, UK; 
Goat Serum Normal goat serum 
Isopropanol Cat. No. 20839.322, VWR, Soulbury, UK; 
Lipofectamine Cat. No. 18324-012, Invitrogen, Paisley, UK; 
Lysis buffer 100 mM Tris-HCl, pH 8.5  
5 mM EDTA  
200 mM NaCl  
0.2 % sodium dodecyl sulphate (SDS) 
Methanol Cat. No. 20847.320, VWR, Soulbury, UK; 
Molecular biology grade water  
UltraPureTM DNase/RNase-free distilled water, Cat. 
No. 10977-049, Invitrogen, Paisley, UK; 
NEB buffer 3 New England Biolabs, Hitchin, UK; 
Paraformaldehyde (PFA) Cat. No. 294474L, VWR, Soulbury, UK; 
Plus reagent Cat. No. 11514-015, Invitrogen, Paisley, UK; 
Rabbit serum Normal rabbit serum, Cat. No. C12SAZ, AbD Serotec, 
Kidlington, UK; 
Saline Sodium chloride, 0.9 % w/v, Cat. No. B1323, Baxter 
Healthcare, Northampton, UK; 
Sodium chloride (NaCl) Cat. No. 71376, Fluka BioChemika, Sigma-Aldrich, 
Poole, Dorset, UK; 
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Sodium dodecyl sulfate (SDS)  
10 % SDS solution, Cat No. 20-4000-05, Severn 
Biotech Ltd., Kidderminster, UK; 
Sucrose Cat. No. 102744, BDH AnalaR®, VWR, Soulbury, 
UK; 
TAE buffer UltraPureTM 10x TAE buffer, Cat. No. 15558-026, 
Invitrogen, Paisley, UK; 
Tris-HCL 1 M Tris-HCL solution, pH 8.5, Cat. No. 20-7901-10, 
Severn Biotech Ltd., Kidderminster, UK; 
Triton X-100 Cat. No. X100, Sigma-Aldrich, Poole, Dorset, UK; 
Tyrode’s salt solution Cat. No. 127K8303, Sigma-Aldrich, Poole, Dorset, 
UK; 
2.6 Induction of inflammation in murine tissues and 
analysis by immunofluorescence labeling and confocal 
microscopy 
2.6.1 Induction of inflammatory reactions in the murine cremaster 
muscle 
Neutrophil transmigration through cremasteric post-capillary venules was induced in 
male WT C57BL/6 mice (~ 25 g) either via intrascrotal (i.s.) injection of 
inflammatory stimuli like IL-1β or TNF-α or topical application of inflammatory 
mediators onto the exteriorised cremaster such as LTB4 or CCL2 or through 
Ischemia Reperfusion Injury (I/R). Different concentrations and in vivo test periods 
were investigated as governed by the time course of action of these stimuli. 
For i.s. injection of IL-1β (50 ng/400 μl saline) and TNF-α (300 ng/400 μl saline), 
mice were sedated via intramuscular (i.m.) injection of 1ml/kg anaesthetic (40 mg 
ketamine and 2 mg xylazine in saline). As a vehicle control, mice received 400 μl 
saline i.s. alone. Different in vivo test periods such as 2 h, 4 h, 8 h and 24 h for IL-1β 
and 0.5 h, 1 h, 2 h and 4 h for TNF-α, were employed. 
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For topical application of CCL2 (5 × 10-9 M) and LTB4 (10-7 M), mice were 
anaesthetised via intraperitoneal (i.p.) injection of ketamine (100 mg/kg) and 
xylazine (10 mg/kg). The cremaster muscle was surgically exteriorised onto a 
purpose-built microscope stage and was continuously perfused with warm Tyrode’s 
solution containing the inflammatory stimulus under investigation for 2 h. As 
control, cremaster muscles were superfused with Tyrode’s solution alone. These 
experiments were performed by Dr. Mathieu-Benoit Voisin. 
I/R was performed by inducing ischemia after placing an artery clamp at the base of 
the cremaster muscle (for 30 min), followed by the removal of the clamp to start 
vascular reflow for 2 h. These experiments were carried out by Dr. Abigail Woodfin 
and Dr. Mathieu-Benoit Voisin. 
At the end of the in vivo test periods, mice were sacrificed and cremaster muscles 
were dissected away and fixed in 100 % Methanol or 4 % PFA for 30 min at 4 °C. 
Subsequently, analysis of venules by immunofluorescence labeling and confocal 
microscopy of whole mounted cremasters was performed. 
2.6.2 Induction of dermal inflammation in the mouse ear 
Mice were anesthetized and injected intradermally (i.d.) with TNF-α (150 ng in 30 μl 
PBS) or IL-1β (10 ng in 30 μl PBS) or 30 μl PBS alone (vehicle control) in the ear. 
At the end of the experiments, animals were sacrificed and ears were dissected for 
subsequent analysis of venules by immunofluorescent labeling and confocal 
microscopy. 
2.6.3 Immunofluorescence labelling of murine tissues and 
analysis by confocal microscopy 
To investigate pericyte morphology in murine post-capillary venules, confocal 
microscopy of whole mounted murine tissues such as cremaster muscle, diaphragm, 
mesentery, peritoneal wall and skin of the ear was performed. These tissues 
(unstimulated tissues, respective controls or tissues stimulated with different 
inflammatory mediators, as described above, 2.6.1) were dissected away from WT 
C57BL/6 mice and fixed in 100 % Methanol or 4 % PFA for 30 min to 1 h at 4 °C. 
Subsequently, immunofluorescent staining of whole mounted tissues was performed. 
For this purpose, the tissues were permeabilised after fixation with 0.5 % Triton 
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X-100 and blocked with 25 % serum (12.5 % FBS and 12.5 % goat serum or rabbit 
serum, depending on the species in which the secondary antibody was raised) in PBS 
for 2 h at RT. This was followed by the incubation with the primary antibodies for 
α-SMA, collagen IV, MRP14, IL-1RI (goat anti-IL-1RI), MRP14, NG2, TNFRI 
(goat anti-TNFRI) or TNFRII (goat anti-TNFRII) or appropriate control antibodies in 
PBS/20 % serum (10 % FBS and 10 % goat serum or rabbit serum, depending on the 
species in which the secondary antibody was raised) over night at 4 °C. After a 
washing step (tissues were washed three times for 5 min in PBS on the shaker), 
appropriate secondary antibodies conjugated with Alexa Fluor 488 or 633 were used 
if necessary (at a final concentration of 10 μg/ml in PBS for 3 h at 4 °C) followed by 
a final washing step in PBS. For confocal analysis the tissues were mounted on glass 
slides and scanned using a Zeiss LSM 5 PASCAL confocal laser-scanning 
microscope (Zeiss Ltd, Welwyn Garden City, UK) and a Zeiss 40x water-dipping 
ACHROPLAN objective (NA 0.75 W, Ph2) or a Zeiss 63x oil Plan-APOCHROMAT 
objective (NA 1.4). Z-stack images of post-capillary venules (analysed vessels were 
largely within a diameter of 20-50μm) were captured using the multiple track 
scanning mode at every 1 μm (40x) or 0.4 μm (63x) of tissue depth at a resolution of 
1024 × 1024 pixels in the x × y plane, corresponding to a voxel size of 
approximately 0.26 × 0.26 × 1/0.4 μm in x × y × z, respectively. The resulting 
confocal images were analysed using softwares for 3D-reconstruction such as ImageJ 
(public domain Java-based image analysis and processing software, developed at the 
National Institutes of Health, USA) and IMARIS (Bitplane AG, Zurich, Switzerland) 
to quantify neutrophil transmigration, determine changes in pericyte morphology and 
assess IL-1RI, TNFRI and TNFRII expression on endothelial cells and pericytes of 
post-capillary venules. To quantify neutrophil transmigration, all neutrophils that 
have transmigrated into the tissue 50 μm above and below a post-capillary venule 
over a length of 200 μm were counted (per 0.02 mm2 of tissue) (Figure 2.2). To 
determine changes in pericyte shape, 3D-reconstructed confocal images were split in 
half in silico along the longitudinal vessel axis. The resulting image sections of semi 
vessels were transformed into gray scale intensity projection and all the gaps 
between adjacent pericytes were encircled manually to measure their area (in μm2) 
(Figure 2.3). Subsequently, the mean gap size was determined for each post-capillary 
venule. At least four post-capillary venules were investigated per cremaster and the 
resulting mean gap sizes were then plotted as mean per mouse. In addition, the 
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number of gaps per defined vessel area (per 1 mm2) was determined to give a 
measure of gap density. The mean gap density was also plotted as mean per mouse. 
To assess IL-1RI, TNFRI and TNFRII expression on post-capillary venules, the 
mean fluorescence intensity (MFI) of isotype control (goat IgG), IL-1RI, TNFRI or 
TNFRII staining was determined using IMARIS software with the advice of expert 
IMARIS users in our group. To analyse endothelial cells and pericytes separately, an 
isosurface has to be created representing exclusively the endothelium or the pericyte 
sheath, respectively (Figure 2.4). This parameter depicts the limitation of the volume 
of interest in which IMARIS determines the MFI of other channels (in this case of 
the channel showing isotype control, IL-1RI, TNFRI or TNFRII staining). 
Isosurfaces embodying the endothelial cell or pericyte layer were built by using the 
channel showing immunofluorescence labeling of PECAM-1 or α-SMA as a source, 
respectively (Figure 2.4). 
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Figure 2.2: Quantification of neutrophil transmigration. 3D-reconstructed confocal 
image of a post-capillary venule (red, pericytes, α-SMA staining) from an IL-1β-stimulated 
cremaster muscle. Neutrophils (green, marker: MRP14) that have transmigrated into the 
tissue 50 μm away from the vessel were counted over a length of 200 μm. Bar, 20 μm. 
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Figure 2.3: Quantification of the size of gaps between adjacent pericytes in post-
capillary venules. (a) 3D-reconstructed confocal image section of a semi post-capillary 
venule (split in half in silico along the longitudinal vessel axis). Bar, 20 μm. (b) Gray scale 
intensity projection of the confocal image section. All gaps between adjacent pericytes were 
encircled manually as shown for an example gap (yellow line) to measure their area. Yellow 
boxed region enlarged in (c). 
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Figure 2.4: Creating isosurfaces using IMARIS software. A representative isosurface 
showing the pericyte layer (b) is illustrated, which has been generated using 
immunofluorescence labelling of α-SMA (a) as a source. 
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2.7 Neutrophil depletion 
Neutrophil depletion was induced by i.p. injection of 100 μg of anti-GR1 antibody in 
1 ml saline 24 h before i.s. administration of IL-1β or TNF-α. Control mice received 
the rat IgG2bκ isotype matched control antibody. To determine the level of 
neutrophil depletion, blood neutrophil counts were performed. For this purpose, tail 
vein blood samples were collected before and 24 h after antibody administration 
indicating an 82 % depletion of circulating neutrophils. 
2.8 Confocal Intravital Microscopy 
Confocal intravital microscopy was used to directly observe leukocyte responses and 
changes in pericyte morphology within murine cremasteric post-capillary venules 
upon TNF-α stimulation in real-time in 3D. 
Observation of pericyte shape change 
To observe changes in pericyte morphology in vivo male α-SMA-GFP mice were 
anaesthetised by i.p. injection of ketamine (100 mg/kg) and xylazine (10 mg/kg) and 
maintained at 37 °C on a custom-built heated microscope stage. The cremaster was 
exteriorized, pinned out flat over the optical window of the stage and superfused with 
Tyrode’s solution (2.5.8). During confocal IVM Z-stack images of a post-capillary 
venule (analysed vessels were largely within a diameter of 20 - 50 μm) were captured 
every minute using a Leica SP5 confocal microscope (Leica Microsystems, Milton 
Keynes, UK) incorporating a 20x water-dipping objective (NA 1.0). Images were 
acquired with sequential scanning of different channels at a resolution of 
1024 × 512 pixels in the x × y plane and 0.7 μm steps in z-direction, corresponding 
to a voxel size of ~ 0.23 × 0.23 × 0.7 μm in x × y × z, respectively. Subsequently, 
after 5 min of imaging, pericyte shape change was induced by adding TNF-α to the 
Tyrode’s solution at 30 ng/ml and images were taken every minute for a further 2 h 
and 30 min. As control, cremasters were superfused with Tyrode’s solution alone. 
The resulting 4D image sequences were processed using IMARIS software (Bitplane, 
Switzerland). 
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Investigation of leukocyte responses 
Pericyte gap enlargement was induced in male α-SMA-RFPcherryxLys-eGFP mice 
(details of the crossing are described in Chapter 6) via i.s. injection of TNF-α 
(300 ng/400 μl saline). Additionally, an anti PECAM-1-647 antibody (3 μg in 300 μl 
saline) was injected i.s. to immunolabel endothelial cell junctions and so aid 
visualisation of the endothelial cell layer. As vehicle control, mice were injected with 
400 μl saline containing the anti PECAM-1-647 antibody only. For i.s. 
administrations, mice were sedated via intramuscular (i.m.) injection of 1ml/kg 
anaesthetic (40 mg ketamine and 2 mg xylazine in saline). After 2 h, mice were 
anaesthetised by i.p. injection of ketamine (100 mg/kg) and xylazine (10 mg/kg) and 
maintained at 37 °C on a custom-built heated microscope stage. The cremaster was 
exteriorized, pinned out flat over the optical window of the stage (Figure 2.5) and 
superfused with Tyrode’s solution. Z-stack images of a post-capillary venule were 
captured every 1 min for 2 h using a Leica SP5 confocal microscope (Leica 
Microsystems, Milton Keynes, UK) incorporating a 20x water-dipping objective (NA 
1.0). Z-stacks were captured at every 0.7 μm of tissue depth at a resolution of 
1024 × 512. The resulting 4D confocal image sequences were analyzed using 
IMARIS software by Dr. Mathieu-Benoit Voisin. 
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Figure 2.5: Surgical exteriorisation and preparation of the cremaster muscle for 
confocal intravital microscopy. (a) The cremaster was exteriorized and pinned out flat over 
the optical window of a heated microscope stage. (b) It was then positioned under the 
confocal microscope and constantly superfused with TNF-α (in Tyrode’s solution) or 
Tyrode’s solution alone. 
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2.9 Characterisation and analysis of the murine pericyte-like 
cell line C3H/10T1/2 
2.9.1 Culture of C3H/10T1/2 cells 
C3H/10T1/2 cells were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM), supplemented with 10 % heat-inactivated fetal bovine serum (FBS), 
4.5 g/l Glucose, 2 mM L-Glutamine, 100 U Penicillin and 100 μg/ml Streptomycin. 
Cells were grown at a confluence of 70 % to 80 %, at 37 °C and 5 % CO2 and were 
not used beyond passage 20. 
2.9.1.1 Thawing cells from liquid nitrogen 
C3H/10T1/2 cells were stored in liquid nitrogen in cryovials containing 10 % DMSO 
in FBS. Cells were thawed at 37 °C and added to 9 ml of C3H/10T1/2 growth 
medium (composition described above, 2.9.1) prior to pelleting the cells by 
centrifugation for 10 min at 200 g/RT. The resulting cell pellet was resuspended in 
5 ml medium. The cells were then plated in a 25 cm2 cell culture flask and incubated 
at 37 °C and 5 % CO2 using C3H/10T1/2 growth medium. 
2.9.1.2 Passaging cells 
To passage cells, the medium was removed and the cells were washed once with 
PBS. Subsequently, the cells were detached from the culture flasks using a 
trypsin/EDTA solution. Cell suspensions were diluted in 9 volumes medium and 
transferred into new cell culture flasks (5 × 103 cells/cm2). 
2.9.1.3 Determination of cell numbers 
For determination of the total cell number, the cells were detached from the cell 
culture flasks and transferred into new medium (as described above, 2.9.1.2). 
Subsequently, the number of cells in the resulting cell suspension was determined 
using a Neubauer haematocytometer. For this purpose, 50 μl of the cell suspension 
were mixed with 50 μl of trypan blue stain in order to exclude dead cells. This 
solution was pipetted under the cover slip of the haematocytometer and the cells in 
two opposed squares were counted. This number reflects the amount of cells per 
0.1 μl cell suspension, because the volume above one square is 0.1 μl and the dilution 
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factor resulting from the trypan blue staining was 1:2. To determine the number of 
cells per 1 ml, the number of cells counted was multiplied by 104. 
2.9.1.4 Freezing cells 
For long-term storage cells were stored in liquid nitrogen. For this purpose, the cells 
were detached from the cell culture flasks and were transferred into new medium (as 
described above, 2.9.1.2). Cell numbers were counted as described (2.9.1.4) and the 
cells pelleted by centrifugation for 10 min at 200 g/RT. The resulting cell pellet was 
resuspended in FBS containing 10 % DMSO such that the final concentration was 
1 × 106 cells/ml. Cell suspensions were distributed into cryovials and stored at – 
80 °C over night. After 24 h, the cryovials were transferred into storage under liquid 
nitrogen. 
2.9.2 Flow cytometry 
To examine the expression of pericyte markers (α-SMA and NG2) or cytokine 
receptors (IL-1RI, TNFRI or TNFRII) by the pericyte-like C3H/10T1/2 cells, Flow 
cytometry was used. For this purpose, the cells were harvested using 0.02 % EDTA 
in PBS to avoid shedding of surface molecules by trypsin. Afterwards the cells were 
counted, pelleted and resuspended in PBS/1 % FBS to obtain a concentration of 
2.5 × 106 cells/ml. Per sample 5 × 105 cells were used to perform fluorescence 
immunostaining. Cells were incubated for 30 min on ice with the primary antibodies 
specific to IL-1RI (armenian hamster anti-IL-1RI), NG2, TNFRI (armenian hamster 
anti-TNFRI) or TNFRII (armenian hamster anti-TNFRII) or appropriate control 
antibodies in 200 μl PBS/1 % FBS. Where use of secondary antibodies was 
appropriate, the cells were washed three times with PBS/1 % FBS before incubation 
in the presence of secondary antibody in 200 μl PBS/1 % FBS for 30 min on ice. For 
detection of IL-1RI, TNFRI and TNFRII a third labelling step was necessary. In this 
instance, detection of the biotinylated anti-armenian hamster secondary antibody was 
performed after three washes in PBS/1 % FBS by incubating the cells with 
streptavidin conjugated with Alexa Fluor 488 in 200 μl for 30 min on ice. To 
visualise intracellular α-SMA, the cells were fixed and permeabilised by incubation 
in 100 μl Fixation/Permeabilisation Solution (BD Cytofix/CytopermTM Kit) for 
20 min on ice. Subsequently, after two washes in Permeabilisation/Washing Buffer 
(P/W Buffer) from the same kit the anti-α-SMA antibody was applied in 200 μl P/W 
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Buffer and the cells were incubated for 30 min on ice. In all cases, after the final 
antibody step, samples were washed three times with PBS/1 % FBS and were 
subsequently analysed using a BD FACSCalibur flow cytometer (BD Biosciences, 
Oxford, UK) and the flow cytometry analysis software FlowJo (Tree Star, Inc., 
Ashland, USA). 
2.9.3 Immunofluorescence labelling and analysis of C3H/10T1/2 
cells grown on chambered slides 
For analysis of pericyte marker and cytokine receptor expression profile by the 
pericyte-like C3H/10T1/2 cell line confocal microscopy was used. For this purpose, 
the cells were seeded on 4-well chamber slides for fluorescence immunostaining at a 
density of 9 × 103 cells/well in 900 μl of C3H/10T1/2 growth medium. After 48 h, 
the medium was removed and the cells were washed twice with cold PBS/1 % FBS. 
Subsequently, the cells were fixed by incubating in 300 μl of 4 % PFA per well for 
10 min on ice and washed twice with cold PBS. This was followed by incubation for 
30 min on ice with the primary antibodies for IL-1RI (armenian hamster anti-
IL-1RI), NG2, TNFRI (armenian hamster anti-TNFRI) or TNFRII (armenian hamster 
anti-TNFRII) or appropriate control antibodies in 300 μl PBS. To label the cell 
membrane, cells were incubated with wheat germ agglutinin-488 (WGA-488) in 
300 μl PBS for 20 min on ice. Where incubation with a secondary antibody was 
necessary, the cells were washed three times with PBS before incubating with the 
secondary antibody in 300 μl PBS for 30 min on ice. For detection of IL-1RI, TNFRI 
and TNFRII a third labelling step was necessary. In this instance, detection of the 
biotinylated anti-armenian hamster secondary antibody was performed after three 
washes in PBS by incubating the cells with streptavidin conjugated with Alexa Fluor 
488 in 300 μl PBS for 30 min on ice. To visualise intracellular α-SMA, the cells were 
fixed and permeabilised by incubation in 300 μl Fixation/Permeabilisation Solution 
(BD Cytofix/CytopermTM Kit) for 20 min on ice. Subsequently, after two washes 
with Permeabilisation/Washing Buffer (P/W Buffer) from the same kit the anti-
α-SMA antibody was applied in 300 μl P/W Buffer and the cells were incubated for 
30 min on ice. After the final antibody incubation, samples were washed three times 
with cold PBS. Cell nuclei were labelled using Draq5 in 300 μl PBS for 1 min on ice 
followed by a final washing step. For confocal analysis, the cells were scanned using 
a Zeiss LSM 5 PASCAL confocal laser-scanning microscope (Zeiss Ltd, Welwyn 
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Garden City, UK) and a Zeiss 20x (NA 0.5 W, Ph2) or Zeiss 40x (NA 0.75 W, Ph2) 
water-dipping ACHROPLAN objective. 
2.9.4 Transfection of C3H/10T1/2 cells with Lifeact-eGFP plasmid 
DNA 
To image changes in the actin cytoskeleton and visualise cell shape change in real 
time using fluorescence time lapse microscopy, C3H/10T1/2 cells were transfected to 
express Lifeact-eGFP. 
2.9.4.1 Transformation of Top10F’ bacteria with Lifeact-eGFP plasmid DNA 
To amplify Lifeact-eGFP plasmids, competent Top10 bacteria were transformed. 
Bacteria were defrosted on ice, mixed with 10 ng Lifeact-eGFP plasmid DNA and 
incubated for 15 min on ice. Afterwards, the tube was placed into a 42 °C water bath 
and incubated for 1 min, followed by incubation on ice for 5 min. The bacteria were 
transferred to a 13 ml culture tube containing 500 μl of warm LB medium (without 
antibiotics!) and incubated at 37 °C for 1 h in an orbital shaker set at 225 rpm. Single 
colonies of transformed bacteria were obtained by streaking the cell suspension 
(20 μl and 200 μl) onto LB Agar culture plates containing Kanamycin (50 μg/ml) and 
incubating them over night at 37 °C. Plates were stored at 4 °C for a maximum of 
four weeks and single bacterial colonies were used to inoculate liquid cultures. 
2.9.4.2 DNA isolation 
To isolate plasmid DNA from bacteria QIAGEN Plasmid Purification Kits were used 
according to the manufacturer’s protocol. These kits are based on alkaline lysis of 
bacteria, followed by a selective immobilisation of the plasmid DNA on a carrier 
substrate (anion-exchange resin). After several washing steps the DNA is eluted from 
the resin and stored at 4 °C for short-term storage or at 20 °C for longer storage. 
DNA minipreps were performed on 1 ml aliquots from 5 ml bacterial cultures 
inoculated from single colonies grown overnight at 37 °C in an orbital shaker set at 
225 rpm. Plasmid DNA was analysed by restriction digest using the enzymes BamHI 
and DraIII to verify the correct version of Lifeact-eGFP using standard procedures. 
Correct fragment sizes are 1213 bp and 3548 bp. The remaining 4 ml of liquid 
culture from verified Lifeact-eGFP clones was used as an inoculum for 300 ml 
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cultures grown as described above and upon which larger scale plasmid extraction 
was performed using the QUIAGEN Maxi Prep Kit. 
2.9.4.3 Quantitation of DNA concentration 
To measure the DNA concentration of Lifeact-eGFP Maxi preparations, a NanoDrop 
ND-1000 spectrophotometer (NanoDrop Technologies, Labtech International Ltd, 
Ringmer, UK) was used according to the manufacturer’s protocol. A sample volume 
of 1 μl was sufficient, because the NanoDrop is based on fibre optic technology. Due 
to surface tension this small sample volume was held in place between two optical 
surfaces. Each sample was assessed at two light path length (0.2 mM and 1 mM), 
providing an extensive dynamic range from 2 ng/μl to 3.7 μg/μl. All measurements 
producing a value higher than 3 μg/μl were repeated using appropriate dilutions of 
the sample. As a blank control the QIAGEN Elution Buffer was used. Between each 
sample the absorbance of QIAGEN Elution Buffer alone was measured to avoid 
potential contamination. Plasmid DNA was stored at 4 °C for short-term storage or at 
20 °C for longer storage. 
2.9.4.4 Transfection of C3H/10T1/2 cells 
For fluorescence time lapse microscopy, C3H/10T1/2 cells were transfected in 
suspension with Lifeact-eGFP plasmid DNA according to the protocol from 
Alexopoulou et al., 2008. For this purpose, 0.5 μg pmeGFP-N1-Lifeact plasmid 
DNA and 1 μl Plus reagent were mixed and serum-free C3H/10T1/2 growth medium 
was added to a final volume of 25 μl. Serum-free C3H/10T1/2 growth medium was 
added to 5.5 μl Lipofectamine to a final volume of 25 μl and incubated for 15 min at 
RT. The diluted Lipofectamine was then added dropwise to the DNA and incubated 
for 20 min at RT. The DNA/Lipofectamine complexes were used to resuspend a 
C3H/10T1/2 cell pellet containing 3.5 × 105 cells, which had been washed with 
serum-free C3H/10T1/2 growth medium beforehand. After 10 min of incubation at 
RT, the cell suspension was transferred into a well of a 6-well-plate containing 2 ml 
warm C3H/10T1/2 growth medium. Fresh C3H/10T1/2 growth medium was added 
after 24 h containing 1 mg/ml Geneticin to select for transfected cells. 
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2.9.5 Fluorescence time lapse microscopy 
To investigate the response of the pericyte-like C3H/10T1/2 cells to the 
inflammatory cytokines IL-1β and TNF-α in vitro, time lapse experiments were 
performed. For this purpose, Lifeact-eGFP transfected C3H/10T1/2 cells were 
seeded into 6-well plates at a density of 3.5 × 105 cells/well in normal growth 
medium 48 h prior to the experiment. For imaging, normal C3H/10T1/2 growth 
medium was exchanged for Leibovitz’s medium without Phenol Red. This medium 
was developed for the support of cell growth in non-CO2-equlibrated environments. 
The 6-well-plates were transferred into the heated chamber of an Olympus IX81 
motorised inverted microscope (Olympus Medical, Southend-on-Sea, UK) and 
incubated at 37 °C throughout the whole experiment. Pictures of three different fields 
of view per dish were taken every 10 minutes for 4 h using an Olympus 20x dry long 
working distance LUCPlanFLN objective lens (NA 0.45, Ph2). Subsequently after 
the first picture, the inflammatory cytokines IL-1β (1, 10 or 100 ng/ml) or TNF-α (10 
or 100 ng/ml) or the vehicle control (PBS) were added to the cells. The eccentricity 
of cells, which is the ratio of cell length to cell width, was manually measured at 
different time points using IMARIS software. The mean cell eccentricity (of all three 
fields of view per well and at least 5 randomly selected cells per field of view) was 
determined and the changes in mean cell eccentricity were plotted per stimulus and 
time point as percentage change normalised to the overall mean at time point 0 h 
(time point before addition of the cytokines or the vehicle control). 
2.10 Statistical analysis 
Results were plotted and statistically analysed using GraphPad Prism® 4. Values 
were expressed as means ± standard error of the mean (SEM) and significant 
differences between multiple groups were identified by one-way analysis of variance 
(ANOVA) followed by Newman-Keuls Multiple Comparison Test. Whenever two 
groups were compared a Student’s t test was used. p values < 0.05 were considered 
as significant. 
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3.1 Introduction 
Pericytes are phenotypically heterogeneous (Sims, 2000). They differ in marker 
expression, morphology and frequency depending on vessel type, vascular bed, 
developmental stage and species. Marker expression and morphology have also been 
shown to be altered during pathological conditions (Morikawa et al., 2002). 
Several markers for pericytes have been reported to date. Intracellular markers 
include α-smooth muscle actin (α-SMA) (Nehls and Drenckhahn, 1991), desmin 
(Fujimoto and Singer, 1987; Hughes and Chan-Ling, 2004), aminopeptidase A and N 
(Schlingemann et al., 1996; Alliot et al., 1999) and the regulator of G-protein 
signalling 5 (RGS5) (Cho et al., 2003). Accepted extracellular markers are neuron-
glia antigen 2 (NG2) (Ozerdem et al., 2001; Ozerdem et al., 2002; Murfee et al., 
2005), platelet-growth factor receptor β (PDGFR-β) (Lindahl et al., 1997), the 
unknown antigen of the antibody 3G5 (Nayak et al., 1988), endosialin (CD248) 
(Rupp et al., 2006) and CD146 (Li et al., 2003). However, none of the known 
pericyte markers is absolutely specific for pericytes or recognizes all pericytes. Their 
expression varies depending on vessel type, vascular bed, developmental stage and 
species (Nehls and Drenckhahn, 1991; Chan-Ling et al., 2004; Hughes and Chan-
Ling, 2004; Murfee et al., 2005). Additionally, marker expression was also shown to 
change during pathological conditions such as cancer (Morikawa et al., 2002). This 
has led to misinterpreted findings in previous studies, where pericyte loss on 
angiogenic sprouts and tumour vessels was described due to the use of markers, 
which have later been shown not to be expressed under pathological conditions 
(Morikawa et al., 2002; Baluk et al., 2005). More recently, pericytes were reported to 
be abundant on tumour vessels (Morikawa et al., 2002; Baluk et al., 2005). 
Morphological differences exist, which also depend on vessel type (capillaries or 
venules), vascular bed, developmental stage, species and pathological conditions 
(Diaz-Flores et al., 1991; Morikawa et al., 2002). Furthermore, pericyte coverage of 
the abluminal vessel area varies in different organs, developmental stages and 
species (Shepro and Morel, 1993; Egginton et al., 1996). The ratio of pericytes to 
endothelial cells varies in different vascular beds ranging from 1:1 to 1:100. The 
retina exhibits one of the highest ratios of 1:3, but the highest pericyte abundance 
(1:1) is found in the CNS (Shepro and Morel, 1993). Pericytes can be distinguished 
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from VSMC, which are wrapped tightly around arteriols, arteries and veins by their 
location, their morphology and their marker expression (Armulik et al., 2005). 
However, an absolute distinction between pericytes and VSMC is not always 
possible. There is a continuum of cells from characteristic pericytes surrounding 
post-capillary venules and capillaries to intermediate cells resembling both pericytes 
and smooth muscle cells at the interface between arteriolar capillaries and arterioles, 
to true smooth muscle cells surrounding arterioles, arteries and veins (Shimada et al., 
1992). 
This chapter aims to investigate the expression profile of various known pericyte 
markers in the mouse cremaster muscle with a focus on finding the best possible 
marker for pericytes on post-capillary venules of murine cremaster muscles. 
Additionally, pericyte morphology was compared in different types of blood vessels 
in the cremaster muscle as well as in post-capillary venules in selected vascular beds 
(cremaster muscle, mesentery, skin of the ear, peritoneal wall and diaphragm) as to 
date no study has described morphological characteristics of pericytes in these 
tissues. 
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3.2 Results 
3.2.1 Pericyte marker expression in the murine cremaster muscle 
In initial studies I aimed to investigate the best possible marker for pericytes on post-
capillary venules of murine cremaster muscles, to be used for subsequent analysis of 
pericyte morphology under basal and inflammatory conditions. The cremaster 
muscle was used for investigations because of its thin and transparent nature, which 
enables it to be used whole mounted for immunofluorescence staining and confocal 
microscopy. 
In this tissue I found an α-SMA expression pattern in line with previous reports using 
other tissues (Nehls and Drenckhahn, 1991; Morikawa et al., 2002). High amounts of 
α-SMA were found in pericytes surrounding post-capillary and collecting venules as 
well as in smooth muscle cells, which are wrapped tightly around arterioles, arteries 
and large veins (Figure 3.1). Pericytes in capillaries on the other hand showed low or 
no expression of α-SMA. However, capillary pericytes could be positively stained 
for the chondroitin sulphate proteoglycan NG2, which is a marker for pericytes and 
neural cells (Figure 3.1). This surface marker was also strongly expressed by smooth 
muscle cells and nerves, but was absent on pericytes of post-capillary venules 
(Figure 3.1). 
Figure 3.1 also highlights the gradual transition of pericyte phenotypes, in this case 
relating to marker expression. Capillary pericytes on the venous side of the capillary 
- where the capillary meets the post-capillary venule - could sometimes be detected 
by α-SMA staining. However, the α-SMA expression here was not as strong as that 
detected on post-capillary venules. In the capillary in Figure 3.1 (marked with C), 
some pericytes were α-SMA positive and also showed weak as well as high NG2 
expression representing intermediate pericyte phenotypes between post-capillary 
venular and capillary pericytes. In the same vessel, the adjacent pericytes appeared to 
show more typical capillary pericyte characteristics by expressing NG2 but no 
α-SMA. 
Other surface markers tested include desmin, platelet derived growth factor-β 
(PDGFR-β) and the unknown antigen of the antibody 3G5. Desmin and PDGFR-β 
were found to be expressed at very low levels in post-capillary venular pericytes. No 
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staining could be detected in the cremaster muscle using the 3G5 antibody. 
Functionality of the 3G5 antibody could be verified on rat brain cryosections. 
Based on these findings, for the rest of this study α-SMA was used as a marker to 
visualise pericytes on post-capillary venules in the murine cremaster muscle as well 
as in various other murine tissues. In addition, transgenic mice became available, 
which express either the Green Fluorescent Protein (GFP) (Yokota et al., 2006) or 
the more recently described cherry variant of the Red Fluorescent Protein 
(RFPcherry) under the control of the α-SMA promoter (see 2.1.1). These mice 
provide an excellent tool for direct in vivo real time imaging of post-capillary venular 
pericytes using confocal intravital microscopy (IVM) (results produced using these 
mice are described in Chapter 6). In addition, using the same marker permits direct 
comparison of data obtained by ex vivo immunofluorescence labelling of whole 
mounted cremaster muscles with real time analysis of post-capillary venular 
pericytes using direct 4D confocal IVM. 
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Figure 3.1: Expression of the pericyte markers α-SMA (red) and NG2 (green) by 
pericytes and smooth muscle cells on unstimulated murine cremasteric vessels. 
Representative 3D-reconstructed confocal images are shown. Cremaster muscles from 
unstimulated WT C57BL/6 mice were used. A, arteriole; C, capillary; N, nerve; PCV, post-
capillary venule. Bars, 50 μm. 
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3.2.2 Pericyte morphology in different types of blood vessels in 
the murine cremaster muscle 
Pericyte morphology was characterised in different types of cremasteric blood 
vessels using immunofluorescence staining and confocal microscopy of whole 
mounted cremaster muscles. To visualise pericytes, the intracellular marker α-SMA 
was used, which was found to be highly expressed in most pericytes and all smooth 
muscle cells in the mouse cremaster muscle (3.2.1). Although pericytes on capillaries 
are usually α-SMA negative, some capillary pericytes expressed α-SMA (described 
in more detail in 3.2.1) and could therefore be investigated as well in terms of their 
morphology. 
In general, pericytes are large cells, which exhibit cytoplasmic processes extending 
from the body of the cell embracing the endothelium (Shepro and Morel, 1993). In 
the cremaster muscle, capillary pericytes showed an elongated shape with two major 
processes expanding along the longitudinal axis of the vessel (Figure 3.2). From 
these two major processes emanated numerous small processes, which encircled the 
capillaries. Consequently, pericytes on capillaries cover only a small proportion of 
the endothelial surface. Pericytes in post-capillary venules on the other hand were 
irregular in shape and orientation and exhibited multiple major processes spreading 
in all directions (Figure 3.2). Hence, pericytes on post-capillary venules form a 
discontinuous layer with significant gaps between adjacent cells. As a consequence 
of the difference in morphology, the percentage of coverage of the underlying 
endothelium is higher in post-capillary venules compared to capillaries. Collecting 
venules were almost completely covered by pericytes with very few small gaps 
between adjacent cells. These pericytes exhibited many major processes, which were 
arranged mainly circumferentially. Therefore, these cells resembled smooth muscle 
cells, which are wrapped tightly around arterioles, arteries and large veins leaving no 
gaps between adjacent cells. 
Hence, besides differences in marker expression, there were also great variances in 
pericyte shape between different vessel types in the cremaster muscle. In this case as 
well, there was a continuum of cell morphology existing between all pericyte shapes 
described above. Furthermore, pericytes on collecting venules resembled more like 
smooth muscles cells than pericytes, which indicates that a gradual transition occurs 
between pericyte and smooth muscle cell phenotypes.
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Figure 3.2: Morphological differences among pericytes as well as between pericytes and 
smooth muscle cells on unstimulated murine cremasteric vessels. Representative 3D-
reconstructed longitudinal confocal image sections depicting different cremasteric vessel 
types are shown. Cremaster muscles were isolated from unstimulated WT C57BL/6 mice, 
fixed and immunostained for α-SMA to visualise pericytes and smooth muscle cells. A, 
arteriole; C, capillary; CV, collecting venule; PCV, post-capillary venule. Bars, 20 μm. 
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3.2.3 Pericyte morphology in post-capillary venules in various 
murine vascular beds 
In the cremaster muscle, pericytes in post-capillary venules form a net-like layer with 
significant gaps between adjacent cells (3.2.2) (Morikawa et al., 2002; Wang et al., 
2006; Voisin et al., 2010). The aim of the following experiments was to investigate 
whether the pericyte layer surrounding post-capillary venules in other murine 
vascular beds also exhibited a discontinuous profile. Tissues such as mesentery, skin 
of the ear, peritoneal wall and diaphragm were chosen for investigation because, like 
the cremaster muscle, they are thin and transparent tissues and can therefore be used 
whole mounted for immunofluorescence staining (using α-SMA to visualise 
pericytes) and confocal microscopy. Confocal images of post-capillary venules 
(analysed vessels were largely within a diameter of 20 - 50 μm) in different vascular 
beds from unstimulated WT C57BL/6 mice were captured and analysed. 
In all tissues analysed, pericytes were present in post-capillary venules and 3D 
reconstructed confocal images consistently indicated a discontinuous nature of the 
pericyte sheath (Figure 3.3) (Voisin et al., 2010). However, a significant diversity 
existed in terms of pericyte shape and distribution, especially regarding size of gaps 
between adjacent cells. Confocal images were then analysed to quantify and compare 
the size of gaps between adjacent pericytes (as described in 2.6.3). The average gap 
size varied among these tissues ranging from 7.1 ± 0.6 μm2 in the cremaster to 
17.2 ± 2.5 μm2 in the mesentery (Figure 3.4 a). Skin (ear) (8.1 ± 1.2 μm2) and 
peritoneal wall (8.2 ± 2.3 μm2) exhibited mean gap sizes similar to the cremaster, 
whereas mean gap sizes were significantly higher in the diaphragm (16.4 ± 2.8 μm2) 
and the mesentery compared to the other three vascular beds (Figure 3.4 a). 
Furthermore, the density of gaps was determined, which is the average number of 
gaps per defined vessel area (per 1 mm2). The investigated vascular beds exhibited 
differences in gap density ranging from 11,007 ± 964 gaps/mm2 in the mesentery to 
27,936 ± 3,191 gaps/mm2 in the skin of the ear (Figure 3.4 b). Interestingly, 
cremaster muscle (14,076 ± 1063 gaps/mm2), mesentery, peritoneal wall 
(13,032 ± 1,803 gaps/mm2) and diaphragm (13749 ± 3,491 gaps/mm2) all revealed 
gap densities around 13,000 gaps/mm2, whereas the gap density was significantly 
higher in the skin of the ear. The percentage of venular surface not covered by 
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pericytes (α-SMA negative area) also varied among all the vascular beds investigated 
and was calculated as follows: 
mean gap size [mm2] ×  2mm1
gapsofnumber  ×  100 = α-SMA negative venular area [%] 
This calculation revealed that the percentage of α-SMA negative venular area varied 
in the multiple vascular beds ranging from 9.58 ± 0.75 % in the cremaster muscle to 
18.19 ± 2.25 % in the mesentery. Therefore, post-capillary venules either exhibited 
vascular pericyte coverage around 90 % as in cremaster muscle and peritoneal wall 
(α-SMA negative venular area: 9.58 ± 0.75 % and 10.15 ± 1.63 %, respectively) or 
around 82 % as seen for mesentery, skin (ear) and diaphragm (α-SMA negative 
venular area: 18.19 ± 2.25 %, 17.82 ± 2.40 % and 17.87 ± 1.92 %, respectively). This 
suggests the existence of a wide range of vascular pericyte coverage, as previously 
detailed in other species (Diaz-Flores et al., 1991; Shepro and Morel, 1993; Egginton 
et al., 1996). Of interest, the low percentage of vascular pericyte coverage in the skin 
(ear) resulted from a significantly higher gap density compared to the other tissues, 
whereas the low values observed for mesentery and diaphragm were due to a 
significantly higher mean gap size in these tissues as compared to the other vascular 
beds. 
All the tissues investigated were also stained for type IV collagen to visualise the 
vascular basement membrane. Our group previously reported that the localization of 
gaps between adjacent pericytes in cremasteric post-capillary venules is directly in 
line with regions of low matrix protein deposition within the basement membrane 
(termed low expression regions, LE regions or LERs) (Wang et al., 2006). The 
findings of the present study demonstrate that the average size and density of type IV 
collagen LERs was directly in line with the average size and density of gaps in the 
pericyte layer in all the vascular beds examined (Figure 3.5 and Figure 3.6) (Voisin 
et al., 2010). 
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Figure 3.3: Differences in pericyte shape and coverage in various vascular beds in the 
mouse. Tissues were isolated from unstimulated WT C57BL/6 mice, fixed and 
immunostained for α-SMA to visualise pericytes. Representative 3D-reconstructed 
longitudinal confocal image sections of post-capillary venules from the indicated vascular 
beds are shown. Bars, 20 μm. 
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Figure 3.4: Mean size and density of gaps between adjacent pericytes in post-capillary 
venules in different murine vascular beds. Indicated tissues were isolated from 
unstimulated WT C57BL/6 mice, fixed and immunostained for α-SMA to visualize 
pericytes. Confocal images of post-capillary venules were acquired and subsequently 3D-
reconstructed longitudinal image sections were analysed to determine the mean gap size and 
gap density per vessel (quantified as described in 2.6.3). (a) Mean gap size between adjacent 
pericytes. (b) Gap density represents the number of gaps per defined vessel area (per mm2). 
In both graphs, for each bar a minimum of three up to nine mice were used. Overall, per 
vascular bed at least eight vessels were analysed. Significant differences between vascular 
beds were determined using one way Anova and are indicated by ## (p < 0.01) and ### 
(p < 0.001). 
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Figure 3.5: Association of pericyte gaps and collagen type IV low expression regions in 
the cremaster muscle and the skin (ear). Tissues were isolated from unstimulated WT 
C57BL/6 mice, fixed and immunostained for α-SMA and collagen type IV to visualise 
pericytes and the vascular basement membrane, respectively. Representative 3D-
reconstructed longitudinal confocal image sections of post-capillary venules are shown. 
Bars, 20 μm. 
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Figure 3.6: Association of the mean size of pericyte gaps and the mean size of collagen 
type IV LERs in post-capillary venules from different murine vascular beds. Indicated 
tissues were isolated from unstimulated WT C57BL/6 mice, fixed and immunostained for 
α-SMA and collagen type IV to visualise pericytes and the vascular basement membrane, 
respectively. Confocal images of post-capillary venules were acquired and subsequently 3D-
reconstructed longitudinal image sections were analysed to determine the mean gap size and 
the mean size of collagen type IV LERs (quantified as described in 2.6.3). (a) Mean gap size 
between adjacent pericytes as shown in Figure 3.4a. (b) Mean size of collagen type IV LERs. 
In both graphs, for each bar a minimum of three up to nine mice were used. Overall, per 
vascular bed at least eight vessels were analysed. Significant differences between vascular 
beds were determined using one way Anova and are indicated by # (p < 0.05), ## (p < 0.01) 
and ### (p < 0.001). 
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3.3 Discussion 
In this chapter, pericyte phenotypes such as marker expression and morphology were 
investigated in different types of blood vessels in the cremaster muscle. Additionally, 
pericyte morphology was compared in post-capillary venules of various vascular 
beds. 
To find a highly expressed pericyte marker for analysis of pericyte morphology in 
the mouse cremaster muscle, the labelling of pericytes as achieved by antibodies 
directed against α-SMA and NG2 was investigated. These are two commonly used 
pericyte markers. α-SMA was found to be highly expressed by pericytes surrounding 
post-capillary and collecting venules as well as by smooth muscle cells tightly 
covering the endothelium of arterioles, arteries and veins confirming previous studies 
using rat mesentery, bovine retina and mouse pancreas (Nehls and Drenckhahn, 
1991; Morikawa et al., 2002). Capillary pericytes showed weak or no expression of 
α-SMA. The pericyte/neural cell surface marker NG2 was strongly expressed on 
capillary pericytes, smooth muscle cells and nerves, but not on pericytes of post-
capillary venules. These differences in NG2 expression had also been observed in a 
previous study using various rat tissues (Murfee et al., 2005). 
Other known pericyte markers include desmin, PDGFR-β, antigen of the antibody 
3G5, endosialin (CD248) and CD146. Desmin and PDGFR-β were expressed at very 
low levels in cremasteric post-capillary venular pericytes and no staining could be 
detected using the 3G5 antibody. The inability of the 3G5 antibody to detect 
pericytes in the mouse cremaster muscle could be caused by either the absence of 
this antigen in the mouse or a lack of cross-reactivity with the murine antigen. 
Unfortunately, murine as well as human endosialin is only expressed in embryonic 
and tumour-associated pericytes (Rupp et al., 2006; Bagley et al., 2008; 
Simonavicius et al., 2008) and CD146 is expressed in numerous cell types in mice 
and humans including endothelial cells (Bardin et al., 2001; Elshal et al., 2005; 
Despoix et al., 2008; Schrage et al., 2008). Due to these findings and because we 
found α-SMA to be highly expressed in cremasteric post-capillary venules, α-SMA 
was used for the rest of this study as a marker to visualise pericytes on post-capillary 
venules in the murine cremaster muscle as well as in various other murine tissues. 
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As a result of the lack of highly specific pericyte markers different pericyte reporter 
mice have been generated including promoter-trap transgene XlacZ4 mice (Tidhar et 
al., 2001), Anxa5-lacZ mice (Brachvogel et al., 2005; Brachvogel et al., 2007), 
RGS5-GFP mice (Nisancioglu et al., 2008), α-SMA-GFP mice (Yokota et al., 2006) 
and α-SMA-RFPcherry mice (see 2.1.1). α-SMA-GFP mice and α-SMA-RFPcherry 
mice are transgenic mice, which express the Green Fluorescent Protein (GFP) or the 
more recently described cherry variant of the Red Fluorescent Protein (RFPcherry) 
under the control of the α-SMA promoter, respectively. α-SMA-GFP and 
α-SMA-RFPcherry mice were used for direct in vivo real time imaging of post-
capillary pericytes, because we found α-SMA to be highly expressed in cremasteric 
post-capillary venular pericytes and by using a fluorescent protein as reporter no 
additional staining step with fluorescent X-gal is required (results produced using 
these mice are described in Chapters 6). 
In common with pericyte marker expression, differences were also evident in 
pericyte shape on the different vessel types in the cremaster muscle. Capillary 
pericytes showed an elongated cell body consisting of two major processes from 
which numerous small processes originated. This has also been reported in an 
electron microscopic study looking at rat submandibular glands, which named the 
two types of processes primary/longitudinal and secondary/circumferential processes 
(Shimada et al., 1992). Pericytes in post-capillary venules were irregular in shape and 
orientation and exhibited multiple major processes forming a discontinuous layer 
with gaps between adjacent cells, confirming observations that had previously been 
made using the mouse cremaster muscle (Wang et al., 2006) and pancreas 
(Morikawa et al., 2002). Pericytes on collecting venules exhibited many major 
processes, however, mainly arranged circumferentially. Due to this difference in 
morphology, the pericyte coverage of the underlying endothelium also varied 
between the different vessel types. 
By investigating pericyte phenotypes in the mouse cremaster muscle, I discovered 
that the transition between different pericyte phenotypes happens gradually. 
Characteristic capillary pericytes express no α-SMA, but show high NG2 expression 
whereas post-capillary pericytes contain high amounts of α-SMA, but are NG2 
negative. However, pericytes on the venous side of the capillary occasionally 
exhibited weak α-SMA staining. Both α-SMA negative capillary pericytes and 
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capillary pericytes expressing α-SMA weakly showed low to high NG2 expression 
representing various intermediate pericyte phenotypes between post-capillary and 
capillary pericytes. Additionally, a continuum of cell shapes existed between 
“classic” pericyte shapes characteristic for a certain vessel type as well as among 
pericytes and smooth muscle cells. Gradual pericyte phenotype transition has to date 
only been observed with regard to pericyte shape (Shimada et al., 1992). A gradual 
transition of pericytes to smooth muscle cells has been reported on the arterial side of 
capillaries, where capillary pericytes exhibit large, band-like, circumferential 
processes completely encircling the vessel (Shimada et al., 1992). This study, 
investigating thyroid glands and cardiac muscles of Japanese monkeys, even 
distinguishes three types of capillary pericytes based on their shape: Mid-capillary 
pericytes with two major longitudinal processes (Type I), pericytes on the arterial 
side of the capillary with large, band-like, circumferential processes (Type II) and 
pericytes on the venous side of the capillary with short irregular processes (Type III). 
Pericyte morphology was also compared among post-capillary venules of different 
vascular beds, such as the cremaster muscle, the mesentery, the skin of the ear, the 
peritoneal wall and the diaphragm using immunofluorescence staining and confocal 
microscopy of whole mounted tissues. This study demonstrated in all vascular beds 
investigated, that the pericyte layer surrounding post-capillary venules is 
discontinuous with significant gaps between adjacent cells (Voisin et al., 2010). 
However, a significant diversity in pericyte shape and coverage was noted among 
these tissues, resulting in different mean size and density of gaps between pericytes. 
This highlights the existence of a wide range of vascular pericyte coverage, which 
has been reported previously to differ among organs (Diaz-Flores et al., 1991; 
Shepro and Morel, 1993; Egginton et al., 1996). Additionally, the ratio of pericytes 
to endothelial cells varies in different vascular beds ranging from 1:1 to 1:100. The 
retina exhibits one of the highest ratios of 1:3, but the highest pericyte abundance is 
found in the CNS (Shepro and Morel, 1993; Armulik et al., 2005). 
Post-capillary venules of the mesentery for example showed the highest mean gap 
size but revealed the lowest gap density. Therefore, this tissue had the highest 
percentage of α-SMA negative vascular area meaning it exhibited the lowest 
percentage of vascular pericyte coverage. Skin (ear) and diaphragm showed similar 
percentages of vascular pericyte coverage. The low pericyte coverage in the 
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diaphragm was also a result of the significantly higher mean gap size, whereas in the 
skin of the ear it resulted from a gap density, which was significantly higher than in 
all other tissues investigated. Low percentage of α-SMA negative vascular area 
resulting in a higher percentage of venular pericyte coverage was seen in the 
cremaster and the peritoneal wall and these tissues exhibited low values for both 
mean gap size and pericyte density. This diversity could lead to differences in 
pericyte function and vascular permeability as well as contribute to tissue-specific 
mechanisms of leukocyte transmigration, which has been discussed in relation to the 
functional needs of different organs (Butcher and Picker, 1996; Petri et al., 2008). 
Therefore, the existence of pronounced gaps between adjacent pericytes within the 
mesentery may support the highly pathogenic environment of the intestine by 
reducing barrier function to emigrating leukocytes to control the dissemination of 
invasive pathogens as compared with an inflammatory response in an organ less 
prone to infection such as the cremaster muscle. 
Co-staining all the tissues investigated for the vascular basement membrane 
component type IV collagen revealed that pericyte gaps corresponded to LERs. 
Hence, pericyte coverage is likely to be the determinant in collagen type IV 
deposition around these vessels. We obtained similar results by investigating 
laminin-511, which is another key basement membrane protein (Voisin et al., 2010). 
In this study, the expression profile of laminin-511 and collagen IV in cremasteric 
post-capillary venules was also compared with other components of the vascular 
basement membrane such as laminin-411, nidogen, and perlecan. Interestingly, all 
basement membrane proteins investigated are also expressed in a heterogeneous 
manner exhibiting LERs and are directly aligned with gaps between adjacent 
pericytes except for perlecan LERs, which could be observed at pericyte positive 
regions. These findings suggest that pericytes are an important source for most of the 
vascular basement membrane components in vivo and that their venular coverage 
determines the properties of the venular basement membrane. Several in vitro studies 
have shown that pericytes can generate key basement membrane constituents such as 
collagen IV, laminin and fibronectin (Cohen et al., 1980; Mandarino et al., 1993; 
Stratman et al., 2009). Therefore, the two main cell types linked to the generation of 
the venular basement membrane are endothelial cells and pericytes, however, 
differences may exist between the relative contributions of these two cell types to the 
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different basement membrane components. Perlecan LERs were mainly located at 
venular regions covered by pericytes indicating that pericytes are not involved in the 
generation of this basement membrane component despite its heterogenous 
expression profile forming LERs. 
Of importance, previous findings from our group have shown that in response to 
IL-1β, transmigrating neutrophils preferentially use the permissive sites formed by 
pericyte gaps and aligned LERs illustrating a functional implication of pericyte 
coverage (Wang et al., 2006). Hence, pericytes represent an additional barrier for 
emigrating leukocytes and therefore play an important role during inflammatory 
conditions. The potential role of pericytes in inflammatory conditions was 
investigated further and the results are detailed in the following Chapters. 
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4.1 Introduction 
Despite the improved understanding of the mechanisms involved in leukocyte 
transmigration through the endothelium in inflammatory conditions, at present very 
little is known about the mechanisms by which leukocytes penetrate the residual 
components of the vessel wall, the pericyte sheath and the vascular basement 
membrane. Our group has previously shown that transmigrating leukocytes 
preferentially use permissive sites formed by gaps in the pericyte layer combined 
with aligned regions of low matrix protein deposition in the vascular basement 
membrane (termed low expression regions, LE regions or LERs) to migrate through 
venular walls (Wang et al., 2006; Voisin et al., 2009; Voisin et al., 2010). However, 
the role of pericytes during inflammatory conditions remains unknown. 
The aim of this chapter was to elucidate potential pericyte responsiveness to pro-
inflammatory stimuli. The murine cremaster muscle was chosen to extend 
investigations of pericyte morphology to inflammatory scenarios, because it 
permitted direct comparison of data obtained by ex vivo immunofluorescence 
staining and confocal analysis with real-time analysis of leukocyte transmigration as 
observed by intravital microscopy. Pericyte response - shape change - was 
investigated using inflammatory mediators such as the pro-inflammatory cytokines 
TNF-α and IL-1β, the chemokine CCL2, the chemoattractant LTB4 and the disease 
model Ischemia Reperfusion (I/R) Injury. Furthermore, the effects of TNF-α and 
IL-1β were examined in an additional vascular bed - the skin of the ear - to explore 
the possibility of tissue-specific mechanisms. Subsequently, the effects of TNF-α and 
IL-1β were further characterised over time in the cremaster muscle and changes in 
pericyte shape were associated with neutrophil transmigration in the same tissues. In 
addition, the involvement of neutrophils in TNF-α- and IL-1β-induced pericyte shape 
change was examined using neutrophil depleted animals. To elucidate whether 
pericytes are able to respond directly to TNF-α- and IL-1β, the expression profile of 
IL-1RI, TNFRI and TNFRII on post-capillary venules in unstimulated cremaster 
muscles was analysed by immunofluorescence staining and confocal microscopy. 
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4.2 Results 
4.2.1 Pericyte shape change in different inflammatory scenarios 
in the murine cremaster muscle 
To study the response of pericytes in murine cremasteric post-capillary venules to 
different inflammatory mediators, cremaster muscles were stimulated either via 
topical application of the chemokine CCL2 or the chemoattractant LTB4 or local 
injection of the inflammatory cytokines TNF-α or IL-1β or by induction of I/R 
injury. Dose and in vivo test periods employed were those known to elicit significant 
leukocyte transmigration in this model based on previous findings from our group. 
Subsequently, the cremaster muscles were dissected away from the mice, fixed and 
used whole mounted for immunofluorescence labelling and confocal analysis. 
Local injection of TNF-α or IL-1β (300 ng or 50 ng in 400 μl saline, respectively) 
induced pericyte shape change resulting in an enhancement of gaps between adjacent 
cells (Figure 4.1 a). Confocal images were then analysed to determine the mean size 
of gaps between adjacent pericytes (as described in section 2.6.3). Saline injection 
(vehicle control) resulted in a mean gap size of 8.3 ± 0.4 μm2 and no significant 
changes were observed (unstimulated cremasters: 7.2 ± 0.4 μm2) (Figure 4.1 b). 
TNF-α and IL-1β stimulation led to a significant increase in mean gap size between 
adjacent pericytes compared to unstimulated and saline-injected controls. In 
comparison to saline injection alone, TNF-α stimulation for 2 h provoked a 
significant 65 % increase in mean gap size to 13.8 ± 0.9 μm2 and after 4 h 
stimulation with IL-1β a significant 63 % increase to 13.6 ± 0.7 μm2 could be seen 
(p < 0.001 for both). 
Superfusion of exteriorised cremaster muscles with the chemokine CCL2 or the 
chemoattractant LTB4 (10-7 M or 5 × 10-9 M in Tyrode’s salt solution, respectively) 
for 2 h elicited no change in pericyte shape (Figure 4.2 a). Image analysis confirmed 
that topical application of CCL2 and LTB4 induced no significant change in mean 
gap size between adjacent pericytes (8.1 ± 0.8 μm2 and 8.9 ± 1.0 μm2, respectively) 
(Figure 4.2 b). Superfusion with Tyrode’s salt solution alone (vehicle control) also 
evoked no significant change in mean gap size (9.0 ± 1.2 μm2). 
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After I/R injury (30 min Ischemia followed by 2 h reperfusion under constant 
superfusion with Tyrode’s salt solution) cremasteric post-capillary venules exhibited 
the most striking change in pericyte shape with large gaps between adjacent pericytes 
(Figure 4.3 a). Gap size quantifications revealed that I/R injury resulted in a 119 % 
enlargement of pericyte gaps (19.7 μm2 ± 4.8 μm2) compared to sham operated 
cremasters (9.0 ± 1.2 μm2) and a significant 175 % increase in mean gap size 
compared to unstimulated cremasters (Figure 4.3 b). The I/R tissues were prepared 
by Dr. Abigail Woodfin and Dr. Mathieu-Benoit Voisin. 
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Figure 4.1: Shape change of pericytes in cremasteric post-capillary venules after TNF-α 
and IL-1β stimulation. Inflammatory conditions were induced in WT C57BL/6 mice via i.s. 
injection of TNF-α or IL-1β (300 ng or 50 ng in 400 μl saline, respectively). As controls, 
unstimulated and saline injected cremasters were used. After the in vivo test periods 
indicated cremasters were dissected, fixed and immunostained (α-SMA) for confocal 
analysis. (a) The panels show representative 3D-reconstructed longitudinal confocal image 
sections of post-capillary venules. Bars, 20 μm. (b) The graph shows the mean gap size 
between adjacent pericytes in μm2 (quantified as described in 2.6.3). Per cremaster at least 
three vessels were analysed and the mean gap size was determined per vessel. Afterwards, 
the mean gap size per mouse was plotted. Each bar represents results from at least three 
mice. White bars represent control samples and grey bars correspond to stimulated 
cremasters. Significant differences between groups were determined using one way Anova. 
Compared to unstimulated controls significant differences are indicated by ### (p < 0.001). 
Significant differences from cremasters injected with vehicle control (saline) are indicated by 
*** (p < 0.001). 
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Figure 4.2: Morphology of pericytes on cremasteric post-capillary venules after CCL2 
and LTB4 stimulation. Inflammatory conditions were induced in WT C57BL/6 mice via 
topical application of LTB4 or CCL2 (10-7 M or 5 × 10-9 M in Tyrode’s solution, 
respectively) onto the exteriorised cremaster muscle. As controls, unstimulated cremasters 
and cremasters superfused with Tyrode’s solution alone were used. After the in vivo test 
periods indicated cremasters were dissected from the mice, fixed and immunostained 
(α-SMA) for confocal analysis. (a) The panels show representative 3D-reconstructed 
longitudinal confocal image sections of unstimulated, CCL2- and LTB4-stimulated post-
capillary venules. Bars, 20 μm. (b) The graph shows the mean gap size between adjacent 
pericytes in μm2 (quantified as described in 2.6.3). Per cremaster at least three vessels were 
analysed and the mean gap size was determined per vessel. Afterwards, the mean gap size 
per mouse was plotted. Each bar represents results from at least three mice. White bars 
represent control samples and grey bars correspond to stimulated cremasters. Significant 
differences between groups were investigated using one way Anova. 
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Figure 4.3: Response of pericytes on cremasteric post-capillary venules to I/R injury. 
Ischemia was induced in WT C57BL/6 mice by placing an artery clamp at the base of the 
cremaster (for 30 min). This was followed by 2 h of reperfusion under constant superfusion 
with Tyrode’s salt solution. As control, unstimulated cremaster muscles and sham operated 
cremasters were used. After a 2 h reperfusion period, cremaster muscles were dissected from 
the mice, fixed and immunostained (α-SMA) for confocal analysis. (a) The panels show 
representative 3D-reconstructed longitudinal confocal image sections of post-capillary 
venules. Bars, 20 μm. (b) The graph shows the mean gap size between adjacent pericytes 
in μm2 (quantified as described in 2.6.3). Per cremaster at least three vessels were analysed. 
Afterwards, the mean gap size per mouse was determined and plotted. Each bar represents 
data from at least four mice. White bars represent control samples and grey bars correspond 
to stimulated cremasters. Significant differences between groups were determined using one 
way Anova. Compared to unstimulated controls significant differences are indicated by # 
(p < 0.05) and significant differences from sham operated cremasters are indicated by * 
(p < 0.05). 
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4.2.2 Effects of TNF-α and IL-1β on pericyte morphology in the 
dorsal skin of the ear 
Based on the findings described in 4.2.1, which showed a significant enhancement of 
gaps between adjacent pericytes in cremasteric post-capillary venules, the responses 
induced by TNF-α and IL-1β were investigated in more detail. Initially, to investigate 
whether there is evidence for tissue-specific mechanisms, the effects of TNF-α and 
IL-1β on pericyte shape change were analysed in the skin of the ear. The skin of the 
ear was chosen for this purpose because, like the cremaster muscle, it is a thin and 
transparent tissue and can therefore be used whole mounted for confocal microscopy. 
In addition, the pericyte sheath in this tissue exhibited the same mean gap size as in 
the cremaster but showed a significantly higher density of gaps, which resulted in an 
almost 2-fold higher percentage of pericyte gap coverage (see Chapter 3). Therefore, 
it is interesting to investigate whether this difference has an effect on pericyte shape 
change during inflammatory scenarios. 
The dose and in vivo test periods that were used with TNF-α and IL-1β in the ear 
skin where those that had led to significant leukocyte transmigration in preliminary 
experiments. Hence 150 ng TNF-α or 10 ng IL-1β (both in 30 μl PBS) were injected 
intradermally and ears were dissected away from the mice after 2 h or 4 h, 
respectively. Subsequently, the skin was separated from the cartilage, fixed and used 
whole mounted for immunofluorescence labelling and confocal microscopy. 
Intradermal injection of TNF-α or IL-1β induced pericyte shape change as seen in the 
cremaster muscle leading to an enhancement of gaps between adjacent cells 
(Figure 4.4 a). Confocal images were then analysed to determine the mean size of 
gaps between adjacent pericytes. PBS injection (vehicle control) resulted in a mean 
gap size of 8.1 ± 0.5 μm2 causing no significant change in mean gap size compared 
to unstimulated skins (8.1 ± 2.4 μm2) (Figure 4.4 b). TNF-α and IL-1β stimulation 
led to a significant increase in mean gap size between adjacent pericytes in 
comparison to PBS injection alone. After 2 h stimulation with TNF-α a significant 
69 % increase in mean gap size to 13.8 ± 2.0 μm2 could be observed and 4 h IL-1β 
stimulation induced a significant 94 % increase to 15.7 ± 2.1 μm2 (p < 0.05 for both). 
Overall the results indicate that as found in the cremaster muscle, TNF-α and IL-1β 
can stimulate pericyte shape change in the mouse ear skin. 
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Figure 4.4: Shape change of pericytes in post-capillary venules in the skin of the ear 
after TNF-α and IL-1β stimulation. Inflammatory conditions were induced in the skin 
(ear) of WT C57BL/6 mice via i.d. injection of TNF-α or IL-1β (150 ng or 10 ng in 30 μl 
PBS, respectively). As controls, unstimulated ears and ears injected with PBS alone were 
used. After the in vivo test periods indicated ears were dissected and the skin was separated 
from the cartilage, fixed and immunostained (α-SMA) for confocal analysis. (a) The panels 
show representative 3D-reconstructed longitudinal confocal image sections of unstimulated, 
TNF-α- and IL-1β-stimulated post-capillary venules. Bars, 20 μm. (b) The graph shows the 
mean gap size between adjacent pericytes in μm2 (quantified as described in 2.6.3). Each bar 
represents at least nine vessels. White bars represent control samples and grey bars 
correspond to stimulated cremaster muscles. Significant differences between groups were 
determined using one way Anova. Significant differences compared to vehicle controls 
(PBS) are indicated by * (p < 0.05). 
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4.2.3 Time-course of TNF-α- and IL-1β-induced pericyte shape 
change in post-capillary venules in the murine cremaster 
muscle 
To further characterise the effects of TNF-α and IL-1β in the cremaster muscle in 
terms of pericyte shape change, the time-course of response elicited by these 
cytokines was investigated. For this purpose, TNF-α or IL-1β were injected as 
describe above and cremaster muscles were dissected from the mice after different in 
vivo test periods, fixed and used whole mounted for immunofluorescence staining 
and confocal analysis. 
The significant change in mean size of gaps between adjacent pericytes upon local 
injection of both TNF-α and IL-1β occurred in a time-dependent manner 
(Figure 4.5). Specifically, in TNF-α-stimulated cremaster muscles a change in 
pericyte shape was already noted at 0.5 h, resulting in a 24 % increase in mean gap 
size (10.4 ± 1.1 μm2) compared to saline injected tissues (8.3 ± 0.4 μm2) 
(Figure 4.5 a). As described above, after 2 h of TNF-α stimulation a significant 65 % 
increase in mean gap size could be seen. The observed gap enlargement was a 
transient response and returned to basal level by 4 h after injection of TNF-α 
(8.2 ± 0.4 μm2). IL-1β induced increase in mean gap size was slower in on-set and 
peaked at 4 h resulting in a significant 63 % gap enlargement (Figure 4.5 b). Time 
points beyond 4 h indicated a gradual decrease in mean pericyte gap size to 
10.6 ± 0.5 μm2 24 h after IL-1β injection. 
The effects of the cytokines on the density of gaps between adjacent pericytes was 
also determined. This parameter is the average number of gaps per defined vessel 
area (per 1 mm2) as detailed in Chapter 3 (3.2.3). In the same Chapter, the gap 
density for unstimulated cremaster muscles was established at 
14,076 ± 1,063 gaps/mm2. Intrascrotal saline injection led to a gap density of 
11,640 ± 2,844 gaps/mm2 and hence induced no significant change (Figure 4.6). In 
comparison to saline controls, upon local injection of TNF-α or IL-1β the gap density 
was slightly reduced but not significantly altered at all the time points investigated. 
The gap densities were in the order of 10,000 gaps/mm2 for TNF-α injection 
(Figure 4.6 a) and 10,500 gaps/mm2 for IL-1β stimulation (Figure 4.6 b). These data 
suggest that during inflammatory reactions in the cremaster muscle overall neither a 
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loss nor a generation of new gaps occurred between adjacent pericytes. The existing 
gaps mainly increased in size, indicating that pericytes have the ability to change 
their shape in response to these cytokines. 
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Figure 4.5: Time course of (a) TNF- α- and (b) IL-1β-induced pericyte shape change in 
the cremaster muscle. TNF-α and IL-1β (300 ng and 50 ng in 400 μl saline, respectively) 
were injected i.s. into WT C57BL/6 mice. Cremaster muscles were dissected away from the 
mice after the in vivo test periods indicated, fixed and immunostained (α-SMA staining) for 
confocal analysis. White bars represent unstimulated control samples and blue or pink bars 
correspond to stimulated cremasters (TNF-α or IL-1β, respectively). Per cremaster at least 
three vessels were analysed and the mean gap size was determined per vessel. Afterwards, 
the mean gap size per mouse was plotted. Each bar represents results from at least four mice. 
Significant differences between groups were determined using one way Anova. Significant 
differences compared to saline injected controls are indicated by * (p < 0.05), ** (p < 0.01) 
and *** (p < 0.001). Significant differences between different time periods of stimulation 
are indicated by # (p < 0.05)  ## (p < 0.01) and ### (p < 0.001). 
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Figure 4.6: Time course of gap density after (a) TNF- α and (b) IL-1β stimulation in the 
cremaster muscle. Gap density represents the number of gaps per defined vessel area 
(per mm2). The confocal images used for analysis were the same as those analysed for 
Figure 4.5. Significant differences between groups were assessed using one way Anova. 
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4.2.4 Profile of neutrophil transmigration in TNF-α- and IL-1β-
stimulated murine cremaster muscles 
All TNF-α- or IL-1β-stimulated cremaster muscles investigated were also stained to 
visualise neutrophils (MRP-14) to associate the time-dependent enlargement of 
pericyte gaps in post-capillary venules with the profile of neutrophil transmigration. 
Local injection of both TNF-α (300 ng) and IL-1β (50 ng) elicited neutrophil 
transmigration into the tissue, which also occurred in a time-dependent manner 
(Figure 4.7, left). TNF-α induced neutrophil transmigration could be detected after 
2 h of stimulation and was further increased at the 4 h time point (Figure 4.7 a, left). 
In this reaction, neutrophil transmigration seemed to be preceded by the 
enhancement of gaps between adjacent pericytes (Figure 4.7 a, right). As described 
in section 4.2.3, in TNF-α-stimulated cremasters a change in pericyte shape was 
noted at 0.5 h, resulting in a 24 % increase in mean gap size compared to saline 
injected control tissues and after 2 h a significant increase in mean gap size of 72 % 
could be seen. Within the time-periods investigated, maximum neutrophil 
transmigration was noted at 4 h post injection of TNF-α, a time-point at which the 
change in mean pericyte gap size had returned to basal level. 
IL-1β induced transmigration peaked at 4 h of stimulation (Figure 4.7 b, left). At this 
in vivo test period the enhancement of gaps between adjacent pericytes was also at its 
maximum showing a significant 63 % increase in mean gap size compared to saline 
injected controls (Figure 4.7 b, right). Hence, in this reaction neutrophil 
transmigration into the tissue was not preceded by pericyte gap enlargement. Time 
points beyond 4 h appeared to indicate a gradual decrease in mean pericyte gap size 
and also in the neutrophil transmigration response. 
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Figure 4.7: Time course of (a) TNF-α- and (b) IL-1β-induced neutrophil transmigration 
and pericyte shape change in the cremaster muscle. The confocal images used for 
analysis were the same as those analysed for Figure 4.5. White bars represent unstimulated 
control samples and blue or pink bars correspond to stimulated cremasters (TNF-α or IL-1β, 
respectively). Significant differences between groups were determined using one way 
Anova. Significant differences compared to unstimulated controls are indicated by * 
(p < 0.05), ** (p < 0.01) and *** (p < 0.001). Significant differences between different time 
periods of stimulation are indicated by ## (p < 0.01) and ### (p < 0.001). Left: Number of 
transmigrated neutrophils per 0.02 mm2. Transmigrated neutrophils were counted in 3D-
reconstructed confocal images and depicted as number of cells per 0.02 mm2. Per cremaster 
at least four vessels were analysed. Subsequently, the mean number of transmigrated 
neutrophils was determined per mouse and plotted. Each bar represents data from at least 
four mice. Right: Mean gap size graphs, Figure 4.5 re-produced to directly compare changes 
in mean gap size to the neutrophil transmigration response. 
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4.2.5 The role of neutrophils in TNF-α- and IL-1β-induced pericyte 
shape change in the cremaster muscle 
As a next step, the involvement of neutrophils in cytokine-induced pericyte shape 
change was investigated. For this purpose, mice were depleted of their circulating 
neutrophils using the anti-GR1 antibody RB6-8C5, injected i.p. 24 h prior to local 
injection of TNF-α and IL-1β and the optimal time points for enhanced pericyte gap 
sizes were investigated for the two cytokines (i.e. 2 h for TNF-α and 4 h for IL-1β). 
Neutrophil depletion experiments using IL-1β as a stimulus were performed by Dr. 
Mathieu-Benoit Voisin. 
In neutrophil-depleted mice (but not in control mice, which received an isotype 
matched control antibody) there was no detectable neutrophil transmigration 2 h after 
administration of TNF-α. Compared to control mice, neutrophil depleted mice 
showed a significant increase in mean gap size in the same range at 2 h post 
administration of TNF-α (control mice: 15.4 μm2 ± 1.1 μm2, 84 % increase compared 
to saline injected mice; depleted mice: 13.5 μm2 ± 0.8 μm2, 62 % enlargement) 
(Figure 4.8). Hence, the results indicate that the increase in mean gap size between 
adjacent pericytes after TNF-α stimulation (2 h) occurs independently of the 
presence of neutrophils. Similar results were obtained by Dr. Mathieu-Benoit Voisin, 
who found that IL-1β induced change in pericyte shape (4 h) occurs independently of 
neutrophils (data not shown). 
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Figure 4.8: TNFα-induced pericyte shape change in the cremaster muscle of neutrophil 
depleted mice. WT C57BL/6 mice were depleted of their circulating neutrophils via i.p. 
application of the anti-GR1 antibody RB6-8C5 24 h before i.s. injection of TNF-α (300 ng in 
400 μl saline). Control mice were injected i.p. with an isotype matched control antibody 
(both antibodies were administered at 100 mg/ml). After 2 h of TNF-α stimulation, cremaster 
muscles were dissected away from the mice, fixed and immunostained for confocal analysis 
(MRP-14 and α-SMA staining to visualise neutrophils and pericytes, respectively). White 
bars represent saline-injected controls, blue bars correspond to TNF-α stimulated mice, 
which received the isotype control antibody, and striped bars depict neutrophil depleted 
mice, which were stimulated with TNF-α. (a) Number of transmigrated neutrophils per 
0.02 mm2. (b) Mean gap size between adjacent pericytes. Preparation of tissues, image 
collection and analysis as well as statistical analysis was performed as described for 
Figure 4.7. At least four vessels were analysed in each cremaster muscle. Afterwards, the 
mean gap size per mouse was determined and plotted. Each bar represents at least three 
mice. ** indicate significance levels of p < 0.01 compared to saline-treated control mice. 
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4.2.6 IL-1RI, TNFRI and TNFRII expression on post-capillary 
venular pericytes and endothelial cells in the murine 
cremaster muscle 
After discovering that the significant increase in mean pericyte gap size upon TNF-α 
and IL-1β stimulation occurred independently of the presence of neutrophils, I 
wanted to elucidate whether cremasteric post-capillary pericytes express the 
receptors for TNF-α and IL-1β in vivo and are therefore able to respond directly to 
these inflammatory cytokines. 
Markers for both endothelial cells and pericytes were used in this experiment in order 
to distinguish receptor expression by the two cellular components of post-capillary 
venules. Unstimulated male WT C57BL/6 mice were injected i.s. with 2 μg rat anti-
mouse PECAM-1 antibody (clone C390, conjugated to Alexa-647) in 400 μl saline to 
label the endothelium. This protocol for labelling PECAM-1 in vivo was employed 
based on extensive optimisation experiments conducted within our group. After 2 h 
incubation, mice were sacrificed and the vasculature was washed using 10 ml saline 
(containing 10 % heparin) to remove all leukocytes from the vascular lumen, which 
would stain positive for TNFRI and TNFRII. Afterwards, the cremaster muscles 
were dissected from the mice, fixed in 4 % PFA and whole mounted tissues were 
subjected to immunofluorescence labelling to visualise the pericyte layer (α-SMA) 
and IL-1RI, TNFRI or TNFRII. 
Expression of IL-1RI, TNFRI and TNFRII could be detected on cremasteric post-
capillary venules compared to stainings using isotype matched control IgGs (goat 
IgG) (Figure 4.9). Cross sections of 3D-reconstructed confocal images indicated that 
both post-capillary pericytes and endothelial cells expressed all three receptors 
(Figure 4.10). In cross sections showing the pericyte layer (α-SMA, red channel) and 
staining for IL-1RI, TNFRI or TNFRII (green channel) receptor immunoreactivity 
could be seen as a distinct line on the luminal side of the pericytes. This line co-
localized with the endothelium (PECAM-1, blue channel). In cross sections depicting 
endothelial cells and receptor staining, a discrete line of receptor immunoreactivity 
was observed on the abluminal side of the endothelial layer representing receptors 
expressed on pericytes. 
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To completely distinguish IL-1RI, TNFRI and TNFRII expression on pericytes from 
those on endothelial cells and to quantify the different expression levels, 
fluorescence intensity analysis using the image analysis software IMARIS was 
performed as advised by expert users of IMARIS in our group (detailed in 2.6.3). 
Briefly, to assess the mean fluorescence intensity (MFI) of a particular channel, in 
this case the green channel (isotype control (goat IgG), IL-1RI, TNFRI or TNFRII 
staining), on one cell type only, an isosurface has to be created representing 
exclusively the endothelium or the pericyte sheath. This parameter depicts the 
limitation of the volume of interest in which IMARIS determines the MFI of other 
channels. Isosurfaces embodying the endothelial cell or pericyte layer were built by 
using the channel showing immunofluorescence labeling of PECAM-1 or α-SMA as 
a source, respectively. 
This was achieved easily for the pericyte layer because α-SMA intensity is evenly 
distributed throughout the pericyte sheath (Figure 4.11 a, top). However, there is an 
immense difference between PECAM-1 intensity of endothelial junctions and non-
junctional areas (endothelial cell bodies). Therefore, to build an isosurface 
representing the entire endothelial cells, the threshold value has to be decreased 
severely to also include regions of very low fluorescence intensity (cell bodies). 
However, when using these settings, regions of high PECAM-1 intensity (endothelial 
junctions) started reaching into the pericyte isosurface. Consequently, it was 
technically not possible to build an isosurface representing the complete endothelial 
layer where regions of high intensity are reaching into the pericyte isosurface. To 
avoid overlap of the two isosurfaces, I generated three individual PECAM-1 
isosurfaces per vessel on endothelial cell body regions avoiding the junctions 
(Figure 4.11 a, bottom). Using this approach, overlap of PECAM-1 isosurfaces with 
the pericyte isosurface could be eliminated and PECAM-1 isosurfaces were located 
on the luminal side of the pericyte isosurface (Figure 4.11 b). Thereby, MFIs could 
be detected individually for both cell types, however, one has to keep in mind that 
this technique determines MFIs on endothelial cell bodies only. 
The above IMARIS analysis confirmed that both post-capillary pericytes and 
endothelial cells expressed all three receptors (Figure 4.12). Compared to an isotype 
control, MFIs of IL-1RI, TNFRI and TNFRII were significantly higher for both the 
pericyte layer (Figure 4.12 left) and the endothelium (Figure 4.12 right) and 
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expression levels for each of the receptors (represented as MFIs) were in the same 
range on the two vascular cell types (Pericytes: TNFRI: 14.6 ± 5.6, TNFRII: 
34.9 ± 20.6 and IL-1RI: 10.0 ± 6.8; Endothelial cells: TNFRI: 12.0 ± 4.4, TNFRII: 
45.0 ± 20.9 and IL-1RI: 15.5 ± 7.7;). Specificity of the TNFRI and TNFRII 
antibodies could be verified on cremaster muscles from TNFR double knockout mice 
(data not shown). By including IL-1 receptor antagonist (IL-1ra) in the staining 
procedure, staining for IL-1RI could almost be abolished showing the specificity of 
the anti-IL-1RI antibody (data not shown). 
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Figure 4.9: IL-1RI, TNFRI and TNFRII expression on post-capillary venules in the 
cremaster muscle. Unstimulated WT C57BL/6 mice were injected i.s. with 2 μg anti-
PECAM-1-Alexa647 antibody in 400 μl saline to label the endothelium (PECAM-1, blue). 
After 2 h incubation, mice were sacrificed, the vasculature was washed using 10 ml saline 
(containing 10 % heparin) and cremaster muscles were dissected from the mice. 
Subsequently, cremasters were fixed in 4 % PFA and whole mount immunofluorescently 
labelled to visualise the pericyte layer (α-SMA, red) and TNFRI, TNFRII or IL-1RI (green). 
Representative 3D-reconstructed longitudinal confocal image sections of post-capillary 
venules are shown. Bars, 20 μm. 
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Figure 4.10: Both post-capillary pericytes and endothelial cells express IL-1RI, TNFRI 
and TNFRII in the cremaster muscle. Preparation of cremaster muscles was performed as 
describe for Figure 4.9. Confocal images shown in Figure 4.9 are depicted as cross sections. 
Bars, 20 μm. Yellow boxed region are shown enlarged underneath the appropriate image. 
Bars, 10 μm. 
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Figure 4.11: Quantification of mean fluorescence intensity (MFI) of isotype control 
(goat IgG), IL-RI, TNFRI or TNFRII staining on post-capillary venular pericytes and 
endothelial cells in the cremaster muscle using IMARIS. (a) Isosurfaces were built 
representing the pericyte layer (α-SMA, red) or non-junctional regions of endothelial cells 
(PECAM-1, blue) to be able to determine the MFI of the green channel (goat IgG, IL-1RI, 
TNFRI or TNFRII) separately on pericytes and endothelial cells. The panel labelled 
“PECAM-1 staining” shows a representative image of immunofluorescence staining using 
standard confocal imaging and IMARIS analysis settings for visualisation of PECAM-1. The 
panel underneath named “PECAM-1 isosurfaces” depicts settings for confocal imaging and 
IMARIS analysis used to also visualise PECAM-1 expression on non-junctional regions. 
Three representative PECAM-1 isosurfaces are shown. Bars, 20 μm. (b) Merge of the 
α-SMA isosurface and the PECAM-1 isosurfaces, abluminal and luminal view showing close 
association but no overlap of the two isosurfaces. Bars, 20 μm. 
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Figure 4.12: Mean fluorescence intensity (MFI) of isotype control (goat IgG), IL-RI, 
TNFRI or TNFRII staining on post-capillary venular pericytes and endothelial cells in 
the cremaster muscle. Isosurfaces were built on the pericyte layer and the endothelium as 
shown in Figure 4.11 and the MFI for goat IgG (white bars), IL-1RI (pink bars), TNFRI 
(light blue bars) or TNFRII (blue bars) was determined separately for each isosurface. Per 
vessel three PECAM-1 isosurfaces were analysed to obtain an overall MFI for the 
endothelium. Per cremaster muscle three vessels were analysed and the resulting MFIs for 
the pericyte layer and the endothelium were plotted per mouse. Each bar represents data 
from four mice. Significant differences compared to the isotype control were determined 
using Student’s t test and are indicated by *** (p < 0.001). 
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4.3 Discussion 
Leukocyte transmigration through venular walls into the surrounding tissue is a 
crucial event during inflammatory responses. At present very little is known about 
the mechanisms mediating leukocyte migration through the pericyte sheath and the 
vascular basement membrane. We previously reported that gaps between adjacent 
pericytes are co-localised with matrix protein low expression regions in the basement 
membrane, regions that are preferentially used by leukocytes to penetrate venular 
walls (Wang et al., 2006; Voisin et al., 2009; Voisin et al., 2010). 
To elucidate the role of pericytes in inflammatory conditions, pericyte responses to 
different inflammatory mediators were investigated in post-capillary venules. 
Cremaster muscles stimulated via topical application of the chemoattractant LTB4 or 
the chemokine CCL2 exhibited no change in pericyte morphology. Intrascrotal 
injection of TNF-α or IL-1β and I/R injury on the other hand induced pericyte shape 
change compared to respective controls, which resulted in a significant enhancement 
of gaps between adjacent cells. Intra dermal injection of TNF-α or IL-1β into the skin 
of the ear induced pericyte shape change as seen in the cremaster muscle leading to a 
significant increase in the mean pericyte gap size, showing no evidence for a tissue-
specific phenomenon. This part of the study extended previous work from our group 
and showed for the first time pericyte responsiveness to inflammatory mediators in 
vivo indicating that pericytes might play an important role in leukocyte 
transmigration during inflammatory conditions. 
Other studies indicate that pericytes also play an important role in regulating 
microvascular permeability. The pro-inflammatory cytokines TNF-α and IL-1β, 
which induced pericyte responses in the cremaster muscle and the skin of the ear, 
have been reported to be released in the lung during Acute Respiratory Distress 
Syndrome (ARDS) leading to an increase in permeability in the microvasculature 
(Matthay and Zimmerman, 2005). The data shown in this Chapter suggest that the 
increased permeability might be due to the enhancement of gaps between adjacent 
pericytes. In agreement to this, pericytes have already been implicated in 
microvascular permeability and capillary leak (Leveen et al., 1994; Hellstrom et al., 
2001). In addition, it has been shown, that histamine and IL-2 stimulation of the rat 
cremaster muscle leads to an increase in albumin permeability (Sims et al., 1990; 
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Sims et al., 1994). Interestingly, IL-2 treatment of the rat cremaster muscle was 
found to alter the distribution of pericytes from a random distribution to localisation 
around endothelial junctions (Sims et al., 1994). 
TNF-α- and IL-1β-induced reactions were selected for more detailed investigations 
and the responses were characterised regarding the time-course of neutrophil 
transmigration and pericyte shape change in the cremaster muscle. Local injection of 
both TNF-α and IL-1β elicited neutrophil transmigration and changes in pericyte 
shape, which resulted in a significant enhancement of gaps between adjacent 
pericytes, in a time-dependent manner. Interestingly, with regards to TNF-α, both the 
on-set and termination of the induced pericyte shape change response was faster than 
that observed for IL-1β. Additionally, in the TNF-α-induced reaction neutrophil 
transmigration seemed to be preceded by the pericyte gap enhancement highlighting 
the existence of different mechanisms of action for these two pro-inflammatory 
stimuli. IL-1β induced pericyte shape change might involve de novo synthesis of 
secondary mediators such as inflammatory mediators or mediators of intracellular 
signalling involved in regulating shape change. Differences in the mechanisms of 
action of TNF-α and IL-1β have also been observed in a previous study 
demonstrating in vivo that intradermal injection of IL-1β induces a slow 
accumulation of neutrophils in rabbit skin (within 3 to 4 h), which is protein 
synthesis dependent (Rampart et al., 1989). In the same study neutrophil 
accumulation induced by TNF-α was rapid (within 30 min) and protein synthesis 
independent. IL-1β-induced release of secondary inflammatory mediators such as 
chemokines or chemoattractants could occur either in pericytes themselves or in 
other cell types such as neutrophils or endothelial cells. IL-1β is known to stimulate 
intracellular signalling pathways leading to de novo protein synthesis of pro-
inflammatory cytokines such as IFNα, IFNβ, IL-6 and TNF-α via activation of the 
transcription factors NFκB and c-JUN (Dinarello, 1996; Muzio et al., 1997; 
Medzhitov et al., 1998; Kopp et al., 1999). IL-1β and TNF-α has also been shown to 
stimulate the release of chemokines (e.g. IL-8) and chemoattractants (e.g. LTB4) in 
neutrophils and endothelial cells (Strieter et al., 1989; Brain and Williams, 1990; 
Huber et al., 1991; Barnes et al., 1998). Neutrophils are not likely to be the source of 
secondary inflammatory mediators in IL-1β-induced pericyte shape change since 
neutrophil depletion had no effect on the significant increase in mean gap size 
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observed after IL-1β stimulation. Similar results were obtained for TNF-α induced 
change in pericyte shape. Hence, in both reactions pericyte gap enhancement did not 
involve neutrophilic mediators or the presence of neutrophils. However, it remains to 
be investigated whether IL-1β-induced pericyte shape change is transcriptionally 
regulated and which mediators and effectors are involved. 
In both the TNF-α- and the IL-1β-induced reaction the density of gaps was not 
altered, suggesting that overall neither a loss nor a generation of new gaps occurred. 
Existing gaps just increased in size, which might be due to pericyte contractility in 
response to these inflammatory cytokines. Pericyte contractility upon TNF-α and 
IL-1β has already been reported for rat lung pericytes in vitro (Kerkar et al., 2006). 
In addition, TNF-α and IL-1β are known to activate small GTPases such as RhoA, 
Rac 1 and cdc42, which are well known for their ability to regulate the actin 
cytoskeleton (Puls et al., 1999). Most understood are cdc42 that promotes filopodial 
extension and may be vital for cell polarity, Rac 1 that promotes an actin-dependent 
protrusive activity characterized by lamellipodia formation, and RhoA that promotes 
focal adhesion and microfilament bundle assembly (Jaffe and Hall, 2005). In vitro 
studies using bovine retinal pericytes demonstrated that pericyte contractility is 
mediated via a RhoA-dependent disassembly of α-SMA stress fibers resulting in a 
dramatic reduction in cell size (Kolyada et al., 2003). Other Rho GTPases such as the 
Ras-related small GTPases Rac 1 and cdc42 were shown not to be involved in 
pericyte shape change (Kolyada et al., 2003; Kutcher et al., 2007; Kutcher and 
Herman, 2009). Pericyte contraction might facilitate leukocyte transmigration 
through enhanced permissiveness to migrating cells, contribute to the establishment 
of chemoattractant gradients or regulate leukocyte transmigration through venular 
contraction. 
To elucidate whether TNF-α or IL-1β could act directly on pericytes, unstimulated 
cremaster muscles were used for whole mount immunofluorescence labelling and 
confocal microscopy to visualize and analyse the expression profile of receptors for 
TNF-α and IL-1β. These receptors have been reported to be present on endothelial 
cells (Orlinick and Chao, 1998; Eissner et al., 2004; Hehlgans and Pfeffer, 2005; 
Boraschi and Tagliabue, 2006), but this study demonstrated for the first time IL-1RI, 
TNFRI and TNFRII expression on the second cellular layer of cremasteric post-
capillary venules, the pericyte sheath. Therefore, TNF-α- and IL-1β-induced pericyte 
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shape change leading to gap enlargement might be a direct effect of these cytokines 
on pericytes. To further dissect whether TNF-α- and IL-1β-induced reactions could 
be due to direct stimulation of pericytes or might depend on cross talk with other cell 
types such as endothelial cells, pericyte responsiveness to these cytokines was 
investigated in vitro using the pericyte-like cell line C3H/10T1/2 (Chapter 5). 
Collectively, these findings highlight the possibility that pericytes might play a 
critical role in facilitating leukocyte transmigration via active shape change during 
inflammatory conditions. Pericytes might also be involved in T-cell infiltration into 
the brain during multiple sclerosis. Verbeek et al. have shown that T-Lymphocyte 
adhesion and migration into the human brain is mediated via the interaction of very 
late antigen-4 (VLA-4) on T-lymphocytes and VCAM-1, which is expressed on 
endothelial cells and pericytes (Verbeek et al., 1995). 
Pericyte involvement in leukocyte transmigration was further investigated in more 
detail in vivo using 4D real time confocal intravital microscopy (Chapter 6). 
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5.1 Introduction 
The in vivo findings described in Chapter 4 showed a pronounced change in shape of 
pericytes in cremasteric post-capillary venules in response to TNF-α and IL-1β 
stimulation resulting in a significant increase in mean gap size between adjacent 
cells. Furthermore, this response appeared to occur independently of the presence of 
neutrophils. To complement these findings and to further dissect whether these 
reactions could be due to a direct stimulation of pericytes or depend on cross talk 
with other cell types such as endothelial cells, pericyte responsiveness to these 
cytokines was investigated in vitro. 
Isolation of primary pericytes from murine tissues presents technical difficulties due 
to the lack of specific markers for pericytes. Most methods for isolation and 
cultivation of pericytes to date are based on the selective culture of cell populations 
derived from tissues bearing high numbers of pericytes. Hence, mainly rat lung 
tissues or bovine retinas are used for pericyte isolation, which is followed by a series 
of phenotypic characterizations (Schor and Schor, 1986; Schor et al., 1995; Khoury 
and Langleben, 1996). In order to use cells derived from the same species for 
investigation of pericyte properties in vitro, the murine pericyte-like cell line 
C3H/10T1/2 was used. 
The cell line C3H/10T1/2 was established in 1973 from 14- to 17-day-old C3H 
mouse embryos (Reznikoff et al., 1973). C3H/10T1/2 cells are of mesenchymal 
origin and display fibroblastic morphology in culture. Being isolated from embryonic 
mesenchym these cells rather represent mesenchymal stem cells than fibroblasts, 
smooth muscle cells or pericytes. To date most studies involving C3H/10T1/2 cells 
have used these cells as fibroblasts (Thorsen et al., 2003; Clemens et al., 2005; Yauk 
et al., 2008). However, C3H/10T1/2 cells also express vascular smooth muscle 
cell/pericyte markers and show similar properties to primary murine meningeal 
perivascular cells (Brachvogel et al., 2007). Hence, C3H/10T1/2 cells are also 
considered to be smooth muscle cells-/pericyte-like cells and have been used as 
cultured pericytes in co-culture studies with endothelial cells (Darland and D'Amore, 
2001). Clearly results obtained from such studies need to be extrapolated to potential 
responses exhibited by primary pericytes with caution. 
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The aim of this Chapter was to characterize the murine pericyte-like cell line 
C3H/10T1/2 and analyse its properties in vitro. To confirm that these cells are an 
useful tool for analysis of pericyte responses in vitro, pericyte-like characteristics 
such as cell shape and pericyte marker expression were investigated. Subsequently, 
to complement the in vivo findings of TNF-α- and IL-1β-induced pericyte shape 
change described in the previous Chapter, the responsiveness of C3H/10T1/2 cells to 
these inflammatory cytokines was investigated in vitro in real time using 
fluorescence time lapse microscopy. Finally, expression of IL-1RI, TNFRI and 
TNFRII by C3H/10T1/2 cells was explored by flow cytometry. 
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5.2 Results 
5.2.1 Cell morphology and expression of pericyte markers 
As a first step, C3H/10T1/2 cells were tested for their pericyte-like characteristics. 
Cultured C3H/10T1/2 cells showed stellate pericyte-like cell shape with several 
processes protruding from the body of the cell (Figure 5.1 a and b). Expression of 
pericyte markers was investigated on these cells by confocal microscopy and flow 
cytometry. For confocal analysis, C3H/10T1/2 cells were grown on 4-well chamber 
slides, fixed and immunofluorescently labelled. To examine the expression of 
pericyte markers by flow cytometry, cells were harvested from culture flasks for 
subsequent immunofluorescence staining using EDTA only instead of 
Trypsin/EDTA to avoid shedding of surface molecules. 
Confocal analysis showed that C3H/10T1/2 cells strongly expressed the key pericyte 
marker α-SMA, indicating a pericyte-like phenotype (Figure 5.2 a and b). Co-
staining with Wheat Germ Agglutinin, a cell membrane marker, demonstrated 
α-SMA expression throughout the whole cell body localised along actin fibres 
(Figure 5.2 a), highlighting the fact that α-SMA staining is an accurate indication of 
pericyte shape. In addition, the pericyte marker NG2 could be found highly 
expressed on C3H/10T1/2 cells covering the entire cell surface (Figure 5.2 b). 
Flow cytometry analysis confirmed strong expression of α-SMA and NG2 by 
C3H/10T1/2 cells (Figure 5.2 c). Both pericyte markers showed high relative 
fluorescence intensity (RFI), which is the x-fold higher mean fluorescence intensity 
of the sample stained with the specific antibody compared to the respective isotype 
control sample (mean RFIs from three experiments: α-SMA: 28.1 ± 0.3, NG2: 
112.4 ± 21.3). 
These data confirm that C3H/10T1/2 cells possess pericyte-like properties and are 
therefore a useful tool for analysis of pericyte responses in vitro. 
  131 
 
Figure 5.1: Morphology of the murine pericyte-like C3H/10T1/2 cells. Representative 
phase contrast images of C3H/10T1/2 cells in culture are shown. Several processes were 
extending from the cell bodies highlighting the stellate cell shape of C3H/10T1/2 cells. (a) 
20x phase contrast image. Bar, 50 μm. (b) Enlarged 40x phase contrast images depicting a 
single cell. Bars, 20 μm. 
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Figure 5.2: Expression of pericyte markers by the pericyte-like C3H/10T1/2 cells. (a and 
b) Representative confocal images of cells grown on 4-well chamber slides are shown. The 
cells were fixed and stained with either (a) Wheat Germ Agglutinin (green) or (b) an anti 
NG2 antibody (green). All cells were also stained to visualise α-SMA (red) and the nucleus 
using the nuclear dye Draq5 (blue). These images are representative of four experiments. 
Bars, 20 μm. (c) Expression of NG2 and α-SMA as shown by flow cytometry histograms 
representative of three experiments. The histograms illustrate the number of events over a 
spectrum of increasing fluorescence intensities. Histograms resulting from analysis of cells 
stained with NG2 or α-SMA antibodies are depicted as overlays over histograms of the 
respective isotype control sample. Black peaks represent labelling using the isotype control 
antibodies and the green or the red peak shows staining with the specific antibodies against 
NG2 or α-SMA, respectively. 
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5.2.2 Effects of TNF-α and IL-1β on cell shape in real time 
To extend the findings of TNF-α- and IL-1β-induced pericyte shape change in vivo 
(Chapter 4), responses of C3H/10T1/2 cells to these cytokines were investigated in 
vitro using fluorescence time lapse microscopy. 
For real time analysis of C3H/10T1/2 responsiveness to TNF-α and IL-1β, cells were 
transfected with Lifeact-eGFP and changes in the actin cytoskeleton as well as 
changes in cell shape were imaged. Cells were seeded into 6-well plates and pictures 
of three different fields of view per dish were taken every 10 minutes using a 
motorised fluorescence time lapse microscope. Different doses of TNF-α (10 ng/ml 
and 100 ng/ml in PBS) and IL-1β (1 ng/ml, 10 ng/ml and 100 ng/ml in PBS) were 
used for an imaging period of 4 h. After applying the vehicle control (PBS), 
C3H/10T1/2 cells showed no change in cell shape over time (Figure 5.3, Movie 5.1). 
However, both TNF-α and IL-1β stimulation led to a striking change in cell shape in 
a time-dependent manner leading to cell elongation (Figure 5.3, Movie 5.2 and 5.3). 
In collaboration with my colleague Dr. Mathieu-Benoit Voisin the image processing 
software IMARIS was used to quantify cell elongation by manually measuring cell 
eccentricity, which is the ratio of cell length to cell width (exemplified in Figure 5.4). 
For all three fields of views cell eccentricity was measured for at least five cells and 
the mean cell eccentricity was determined for each field of view. The mean cell 
eccentricity was then plotted per dish (relates to one experiment), normalised to the 
overall mean at time point 0 h (time point before the addition of cytokines or vehicle 
control). 
Eccentricity measurements confirmed that PBS alone induced no change in cell 
shape over time (7.8 ± 15.1 % elongation after 4 h) (Figure 5.5). In contrast, TNF-α 
at all concentrations elicited cell elongation throughout the experiment resulting in a 
significant change in eccentricity compared to PBS (72.4 ± 22.0 % and 
103.4 ± 22.7 % elongation after 4 h of stimulation with 10 ng/ml and 100 ng/ml, 
respectively). IL-1β at 10 ng/ml and 100 ng/ml also induced a significant change in 
eccentricity over time (71.5 ± 13.7 % and 100.8 ± 28.9 % elongation after 4 h of 
stimulation with 10 ng/ml and 100 ng/ml, respectively). Interestingly, as seen in the 
in vivo time course studies of pericyte shape change (Chapter 4), the use of this in 
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vitro model also showed that IL-1β-induced shape change occurs more slowly than 
the TNF-α-induced response. 
Overall these data support the in vivo findings of pericyte shape change during 
inflammatory conditions and confirms the ability of pericytes to change their shape 
in response to direct stimulation with the inflammatory cytokines TNF-α and IL-1β. 
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Figure 5.3: Time course of TNF-α- and IL-1β-induced shape change of C3H/10T1/2 
cells. Respective fluorescence time lapse microscopy images of Lifeact-eGFP transfected 
cells are shown for certain time points (0 h (time point before the addition of cytokines or 
vehicle control (PBS)), 2 h and 4 h after cytokine or PBS application). Bars, 50 μm. 
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Figure 5.4: Measurement of cell eccentricity using IMARIS to quantify the change in 
cell shape (elongation). Fluorescence time lapse microscopy images of Lifeact-eGFP 
transfected cells are shown for start and endpoint of the time course shown in Figure 5.4 
using 100 ng/ml TNF-α. White arrows depict measurements to determine cell eccentricity, 
which is the ratio of cell length to cell width. Cell length is represented by the longest side in 
directionality of cell elongation. Cell width was measured perpendicularly from the centre 
point of the cell length measurement. 
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Figure 5.5: Time course of percentage change in C3H/10T1/2 cell eccentricity in 
response to TNF-α and IL-1β compared to vehicle control (PBS). Pictures of three 
different fields of view were taken per culture dish every 10 minutes for 4 h. After the first 
picture, TNF-α (10 or 100 ng/ml), IL-1β (1, 10 or 100 ng/ml) or the vehicle control (PBS) 
were added to the cells. For all three fields of views cell eccentricity was measured for at 
least five cells as described in Figure 5.4. Mean cell eccentricity was determined for each 
field of view and the mean cell eccentricity was then plotted per dish (relates to one 
experiment) normalised to the overall mean at time point 0 h (time point before addition of 
the cytokines or the vehicle control (PBS)). Each point represents results from at least seven 
experiments. Significant differences between groups were determined using one way Anova. 
Significant differences compared to time point 0 h are indicated by * (p < 0.05), ** 
(p < 0.01) and *** (p < 0.001). Significant differences at time point 4 h compared to 
treatment with the vehicle control are indicated by # (p < 0.05) and ## (p < 0.01). 
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5.2.3 Expression profile of TNFRI, TNFRII and IL-1RI 
To investigate if the observed cytokine-induced shape change of C3H/10T1/2 cells 
was a result of direct effects of TNF-α and IL-1β on these cells, the expression of the 
respective receptors for these cytokines was determined. Presence of IL-1RI, TNFRI 
and TNFRII on C3H/10T1/2 cells was investigated using flow cytometry. Cells were 
harvested from culture flasks for subsequent immunofluorescence staining. 
Flow cytometry analysis demonstrated IL-1RI, TNFRI and TNFRII expression on 
C3H/10T1/2 cells (Figure 5.6 a). Mean RFIs were low for all three receptors (IL-1RI: 
1.9 ± 0.2, TNFRI: 4.2 ± 0.3 and TNFRII: 2.6 ± 0.2), however, statistical significance 
was noted when compared to the isotype control (armenian hamster IgG1) 
(Figure 5.6 b). By including IL-1 receptor antagonist (IL-1ra) in the staining solution, 
staining for IL-1RI could be abolished showing the specificity of the anti IL-1RI 
antibody (Figure 5.7). Specificity of the TNFRI and TNFRII antibodies could be 
verified on blood leukocytes isolated from TNFR double knockout mice (Figure 5.8). 
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Figure 5.6: C3H/10T1/2 cells expressed IL-1RI, TNFRI and TNFRII as shown by flow 
cytometry. (a) Representative histograms are depicted illustrating the presence of all three 
receptors on the cell surface. The histograms illustrate the number of events over a spectrum 
of increasing fluorescence intensities. Histograms resulting from analysis of cells stained 
with antibodies for IL-1R, TNFRI and TNFRII are depicted as overlays over the histogram 
of the isotype control sample (armenian hamster IgG1). Black peaks represent labelling using 
the isotype control antibody and blue peaks show staining with the respective specific 
antibody. (b) The graph shows mean RFIs for IL-1R, TNFRI and TNFRII staining. Each bar 
represents results from six experiments. The dotted line indicates the isotype control, with an 
RFI of 1 by definition. Significant differences compared to the isotype control were 
determined using student’s t test and are indicated by ** (p < 0.01) and *** (p < 0.001). 
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Figure 5.7: Specificity of the armenian hamster anti-mouse IL-1RI antibody. 
C3H/10T1/2 cells were immunofluorescently labelled for flow cytometry analysis using the 
armenian hamster anti-mouse IL-1RI antibody or armenian hamster IgG (isotype control, 
dotted line). Double the amount of antibody solution was prepared, divided in half and either 
used neat (filled bar) or including IL-1 receptor antagonist (IL-1ra) at 10 μg/ml (striped 
bars). The graph shows mean RFIs representing results from three experiments. The dotted 
line indicates the isotype control, with an RFI of 1 by definition. Significant difference of 
IL-1RI staining compared to staining using armenian hamster IgG (isotype control, dotted 
line) was determined using student’s t test and is indicated by ** (p < 0.01). Significant 
differences between groups shown in the graph were determined using one way Anova and 
are indicated by ### (p < 0.001). 
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Figure 5.8: Specificity of the armenian hamster anti-mouse TNFRI and anti-mouse 
TNFRII antibodies. Double the amount of antibody solution was prepared and divided in 
half and to stain blood leukocytes isolated either from (a) WT C57BL/6 mice or (b) TNFR 
double knockout mice. The graphs show mean RFIs for TNFRI (light blue bars) and TNFRII 
(blue bars) staining. Using the flow cytometry analysis software FlowJo expression levels 
were determined for all live cells (Leukocytes) and additionally for different leukocyte 
subtypes (Neutrophils, Monocytes and Lymphocytes), which were identified according to 
cell size and granularity (position in the forward scatter/side scatter profile). Each bar 
represents results from two experiments. The dotted line indicates staining using armenian 
hamster IgG (isotype control), with an RFI of 1 by definition. Statistical significance has not 
been examined since n-numbers were too low. 
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5.3 Discussion 
As described in Chapter 4, in vivo studies showed the ability of TNF-α and IL-1β to 
induce pericyte shape change in a neutrophil-independent manner. In this Chapter, 
these findings were complemented with in vitro analysis of pericyte responsiveness 
to these cytokines. 
Characterisation of C3H/10T1/2 cells demonstrated stellate cell shape with several 
processes protruding from the body of the cell and expression of key pericyte 
markers such as the surface marker NG2 and the intracellular marker α-SMA, 
indicating pericyte-like properties. This confirms what has been shown in a previous 
study, in which C3H/10T1/2 cells were used as an object of comparison to assess 
pericyte properties of primary murine meningeal perivascular cells (Brachvogel et 
al., 2007). Stellate cell shape is expected and has been reported for pericyte-like cells 
in culture (Canfield et al., 1990). Simultaneous staining with the cell membrane dye 
Wheat Germ Agglutinin confirmed the value of α-SMA staining as an accurate 
indication of pericyte shape. 
One could argue that the expression of NG2 and α-SMA by C3H/10T1/2 cells seem 
to indicate that they rather represent vascular smooth muscle cells than pericytes. In 
Chapter 3, fluorescence immunostaining of whole mounted cremaster muscles ex 
vivo showed that α-SMA is expressed in pericytes surrounding post-capillary and 
collecting venules as well as in vascular smooth muscles cells of arterioles, arteries 
and veins. Pericytes on capillaries on the other hand exhibited almost no expression 
of α-SMA, but were NG2 positive. NG2 was also expressed by vascular smooth 
muscle cells and nerves. Hence, in vivo only vascular smooth muscle cells express 
both α-SMA and NG2. However, pericytes and vascular smooth muscle cells share 
numerous characteristics and are of phenotypic complexity (Chapter 3). These 
phenotypically different subtypes might have lost their specific marker expression 
during immortalisation of these cells. In addition, 2D culture may induce expression 
of pericyte markers in these cells in a way not seen in 3D or in vivo. Apart from that, 
C3H/10T1/2 cells are a cell line and hence these cells cannot be considered 
“authentic” pericytes but have to be considered as pericyte/vascular smooth muscle 
cell-like cells. Furthermore, in vitro experiments can never perfectly mimic complex 
in vivo situation, but they have many important implications and are useful for 
addressing key questions such as dissecting signalling pathways or, as done in this 
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study, supplementing in vivo findings by looking at a cell type singled out from its 
environment to investigate whether observed reactions are dependent on cross talks 
with other cell types. However, to avoid using pericyte-like cells, in future major in 
vitro experiments could be performed using primary murine pericytes freshly 
isolated from retinas or brain tissues from α-SMA-GFP mice or α-SMA-RFPcherry 
mice (details about these mice are described in Chapter 2 and 6). Using NG2 staining 
and fluorescence-activated cell sorting (FACS), different perivascular cell subsets 
could be selectively collected. Post-capillary pericytes would be represented by 
α-SMA positive cells, which are at the same time negative for NG2. 
In fluorescence time lapse microscopy experiments both TNF-α and IL-1β 
stimulation led to a respective change in cell shape in a time-dependent manner 
resulting in a significant cell elongation quantified by measuring cell eccentricity. In 
addition, TNFRI and TNFRII and IL-1RI were expressed on C3H/10T1/2 cells 
showing that these pro-inflammatory cytokines can act directly on the cells. This 
supports the in vivo findings of pericyte shape change during inflammatory 
conditions and provides further evidence to suggest that post-capillary venular 
pericytes are able to change their shape in direct response to TNF-α and IL-1β. In 
vivo, this active shape change, which led to an increase in mean gap size between 
adjacent cells, might facilitate neutrophil transmigration via enhanced permissiveness 
to migrating cells and/or through contributing to the establishment of 
chemoattractant gradients. 
Interestingly, TNF-α-induced cell elongation occurred more rapidly than it did upon 
IL-1β stimulation. This highlights again the existence of different mechanisms of 
action for these two pro-inflammatory stimuli and supports the hypothesis that IL-1β 
induced pericyte shape change might involve de novo synthesis of secondary 
mediators as discussed in Chapter 4. 
Stimulation of shape change has previously been demonstrated for pericytes in vitro. 
Primary rat lung pericytes contract in response to the addition of TNF-α and IL-1β 
(Kerkar et al., 2006). Rat lung pericytes have also been shown to contract after 
addition of VEGF (Donoghue et al., 2006) or vasoactive agents such as histamine 
(Kelley et al., 1987), serotonin (Kelley et al., 1987; Speyer et al., 1999) and 
bradykinin (Speyer et al., 1999) and inflammatory mediators like lipopolysaccharide 
(LPS) (Khoury and Langleben, 1998; Speyer et al., 2000) and platelet-activating 
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factor (PAF) (Khoury and Langleben, 1996). Co-cultures of rat lung pericytes and rat 
pulmonary microvascular endothelial cells exposed to TNF-α, IL-1β and LPS exhibit 
increased permeability (Edelman et al., 2006; Kerkar et al., 2006). These studies 
support the possibility that pericyte shape change, which led to an increase in mean 
gap size between adjacent cells, might not only facilitate neutrophil transmigration 
but also regulate microvascular permeability. Ultimately, pericyte shape change and 
its involvement in leukocyte transmigration was investigated in vivo in real time 
using 4D confocal intra vital microscopy (IVM) and the results are detailed in the 
following Chapter. 
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6.1 Introduction 
To extend the findings described in Chapters 4 and 5, pericyte shape change and its 
involvement in leukocyte transmigration was observed and studied in vivo in real 
time. Intravital microscopy (IVM) is a powerful technique for real time in vivo 
investigation of leukocyte/vessel wall interactions in inflammatory reactions and our 
group recently developed immunofluorescence in vivo labelling to be able to visualise 
different components of the vessel wall for confocal IVM. Pericyte surface markers 
are not expressed in sufficient abundance on pericytes surrounding cremasteric post-
capillary venules in the mouse to enable visualisation by confocal IVM using 
antibody based approaches (Chapter 3, section 3.2.1). An alternative is to generate 
mice expressing reporter genes such as Green Fluorescent Protein (GFP)) under the 
control of cell type specific markers (Maggi and Ciana, 2005). This is achieved either 
via gene fusion, gene knock in technology or a transgenic approach. Reporter fusion 
proteins are created through joining the reporter gene to the gene coding for the 
protein of interest (Maggi and Ciana, 2005). Reporter gene knock-in involves the 
insertion of the reporter gene into the gene encoding the protein of interest and is 
therefore a "targeted" gene insertion whereby the endogenous gene is partially deleted 
(gene knockout) (Koller and Smithies, 1992; Galli-Taliadoros et al., 1995). 
Transgenic reporter animals are generated by introducing the marker gene into their 
genome at random sites using the promoter of a gene of interest (Palmiter and 
Brinster, 1985; Cui et al., 1994). Typically, these technologies of genetic engineering 
are used to generate genetically modified mice since the technology is more advanced 
in this species. 
To date several different pericyte reporter mice have been generated including 
promoter-trap transgene XlacZ4 mice (Tidhar et al., 2001), Anxa5-lacZ mice 
(Brachvogel et al., 2005; Brachvogel et al., 2007), RGS5-GFP mice (Nisancioglu et 
al., 2008), α-SMA-GFP mice (Yokota et al., 2006) and α-SMA-RFPcherry mice (see 
2.1.1). α-SMA-GFP mice and α-SMA-RFPcherry mice are transgenic mice, which 
express GFP or RFPcherry under the control of the α-SMA promoter, respectively. 
These two mouse strains could be used for direct in vivo imaging of post-capillary 
venular pericytes using confocal IVM because deployment of fluorescent proteins as 
pericyte reporter allowed real time imaging since additional staining steps (e.g. using 
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fluorescent X-gal) were not required. Since α-SMA was used as a marker for 
pericytes surrounding post-capillary venules throughout this study, this method was 
advantageous because it permitted direct comparison of data obtained by ex vivo 
immunofluorescence labelling of whole mounted cremaster muscles (Chapters 3 and 
4) with real time analysis of post-capillary venular pericytes using direct 4D confocal 
IVM. 
Using these mice, this Chapter aims to investigate pericyte shape change and its 
involvement in leukocyte transmigration in vivo in real time using 4D confocal IVM. 
Pericyte shape change was imaged using α-SMA-GFP mice and as a start the profile 
of GFP expression in these mice was assessed in cremasteric blood vessels and 
compared in cremasteric post-capillary venules with immunofluorescence labelling 
using the anti-α-SMA antibody that was used throughout this study to visualize 
pericytes and vascular smooth muscle cells. Expression analysis experiments were 
also performed using α-SMA-RFPcherry mice expressing the cherry variant of the 
Red Fluorescent Protein under the control of the α-SMA promoter. The present study 
is the first to show pericyte shape change resulting in an enlargement of gaps between 
adjacent cells in vivo in real time upon topical application of TNF-α. To examine 
pericyte involvement in leukocyte transmigration α-SMA-RFPcherryxLys-EGFP 
mice were used which were generated by crossing α-SMA-RFPcherry mice, with 
mice that have EGFP knocked into the lysozyme gene (Lys-EGFP mice). Using these 
mice, we were able to visualise and study for the first time the transmigration of 
leukocytes (GFP labelled) through gaps between pericytes (RFPcherry labelled) in 
cremasteric post-capillary venules in real time. Ultimately, using the image analysis 
software IMARIS we quantified the association of gap size changes with leukocyte 
transmigration to elucidate whether the transmigrating leukocytes preferentially use 
enlarged pericyte gaps to migrate into the surrounding tissue. 
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6.2 Results 
6.2.1 Phenotype of α-SMA-GFP and α-SMA-RFPcherry mice 
In initial studies, the phenotype of α-SMA-GFP and α-SMA-RFPcherry transgenic 
mice was assessed by investigating the expression profile of GFP or RFPcherry, as 
driven by the α-SMA promoter, in cremasteric blood vessels. In order to visualize all 
types of blood vessels for assessment of their GFP or RFPcherry expression the 
endothelial marker PECAM-1 was used. Unstimulated male α-SMA-GFP or 
α-SMA-RFPcherry mice were injected i.s. with 2 μg rat anti-mouse PECAM-1 
antibody (clone C390, conjugated to Alexa-647) in 400 μl saline to label the 
endothelium (as detailed in 4.2.6). After 2 h incubation, cremaster muscles were 
dissected, fixed and used whole mounted for confocal analysis. 
In the cremaster muscle, the expression of GFP or RFPcherry under the control of the 
α-SMA promoter corresponded to the expression pattern of α-SMA seen by 
immunofluorescence labelling (as described in 3.2.1). GFP or RFPcherry was strongly 
expressed in pericytes surrounding post-capillary and collecting venules as well as in 
smooth muscles cells, which are wrapped tightly around arterioles, arteries and large 
veins (Figure 6.1 and Figure 6.3, respectively). Pericytes in capillaries on the other 
hand showed low or no GFP or RFPcherry expression (Figure 6.1 and Figure 6.3, 
respectively). Interestingly, cell nuclei of smooth muscle cells and all pericyte 
subtypes were GFP or RFPcherry positive, which is highlighted on capillaries in 
Figure 6.1 and Figure 6.3, respectively and post-capillary venules shown in Figure 6.2 
and Figure 6.4, respectively. 
In cremasteric post-capillary venules GFP expression was compared to 
immunofluorescence labelling using the anti-mouse α-SMA-Cy3 antibody (clone 
1A4), which was used throughout this study to visualize pericytes and vascular 
smooth muscle cells. A similar experiment was performed using α-SMA-RFPcherry 
mice and the same clone of the anti-mouse α-SMA antibody but conjugated to Alexa-
488. Cremaster muscles were isolated from unstimulated α-SMA-GFP or 
α-SMA-RFPcherry mice, fixed and used whole mounted for immunofluorescence 
staining and confocal microscopy. The discontinuous nature of the pericyte layer of 
cremasteric post-capillary venules could also be seen in α-SMA-GFP and 
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α-SMA-RFPcherry mice and showed comparable localisation with α-SMA expression 
as visualized by immunofluorescence labelling (Figure 6.2 and Figure 6.4, 
respectively). Of importance, there is an exact colocalisation of gaps between adjacent 
pericytes (Figure 6.2 and Figure 6.4, respectively). The only discrepancy between 
α-SMA-GFP or α-SMA-RFPcherry expression and α-SMA staining could be seen in 
cell nuclei, which are α-SMA negative but seemed to be GFP or RFPcherry positive 
(Figure 6.2 and Figure 6.4, respectively). One explanation for this difference might be 
that the reporter proteins expressed under the control of the α-SMA promoter are 
dispersed throughout the entire cytosol surrounding and covering the nucleus making 
it appear to be GFP or RFPcherry positive. α-SMA fibers on the other hand form a 
network throughout the cytosol, in which very few fibers seemed to be running across 
the nucleus. Apart from that, this characteristic of GFP and similar reporter proteins to 
translocate into the nucleus has been observed in numerous studies before. 
Based on these findings, α-SMA-GFP and α-SMA-RFPcherry mice provide an 
excellent tool for direct in vivo real time imaging of pericytes surrounding cremasteric 
post-capillary venules using confocal IVM. In addition, using the same marker 
permits direct comparison of data obtained by ex vivo immunofluorescence labelling 
of whole mounted cremaster muscles with real time analysis of post-capillary venular 
pericytes using direct 4D confocal IVM. 
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Figure 6.1: Phenotype of α-SMA-GFP mice. GFP expression could be detected in pericytes 
and vascular smooth muscle cells in the cremaster muscle. Representative 3D-reconstructed 
longitudinal confocal image sections are shown depicting different vessel types. Unstimulated 
α-SMA-GFP mice were injected i.s. with 2 μg anti-PECAM-1-Alexa647 antibody in 400 μl 
saline to label the endothelium (blue). After 2 h incubation, mice were sacrificed, cremaster 
muscles were dissected, fixed in 4 % PFA and subsequently used whole mounted for confocal 
microscopy. A, arteriole; C, capillary; CV, collecting venule; PCV, post-capillary venule. The 
arrow indicates a pericyte nucleus, which seems to contain GFP despite being α-SMA 
negative. Bars, 20 μm (top row) and 50 μm (middle and bottom row). 
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Figure 6.2: The discontinuous nature of the pericyte layer in post-capillary venules 
could also be seen in α-SMA-GFP mice in line with the α-SMA expression pattern 
visualized through immunostaining of tissues for α-SMA. A representative 3D-
reconstructed longitudinal confocal image section depicting a cremasteric post-capillary 
venule of an α-SMA-GFP mouse stained to visualise α-SMA is shown. The cremaster muscle 
was isolated from an unstimulated α-SMA-GFP mouse, fixed in 4 % PFA and used whole 
mounted for immunofluorescence labelling using the α-SMA-Cy3 antibody (clone 1A4), 
which was used throughout this study to visualize pericytes and vascular smooth muscle cells. 
Arrows indicate pericyte nuclei, which seem to contain GFP despite being α-SMA negative. 
Bar, 20 μm. 
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Figure 6.3: Phenotype of α-SMA-RFPcherry mice. RFPcherry expression could be 
detected in pericytes and vascular smooth muscle cells in the cremaster muscle. 
Representative 3D-reconstructed longitudinal confocal image sections are shown depicting 
different vessel types. Unstimulated α-SMA-GFP mice were injected i.s. with 2 μg anti-
PECAM-1-Alexa647 antibody in 400 μl saline to label the endothelium (blue). After 2 h 
incubation, mice were sacrificed, cremaster muscles were dissected, fixed in 4 % PFA and 
subsequently used whole mounted for confocal microscopy. A, arteriole; C, capillary; CV, 
collecting venule; PCV, post-capillary venule. The arrow indicates a pericyte nucleus, which 
seems to contain RFPcherry despite being α-SMA negative. Bars, 20 μm (top row) and 50 μm 
(middle and bottom row). 
  153 
 
Figure 6.4: The discontinuous nature of the pericyte layer in post-capillary venules 
could also be seen in α-SMA-RFPcherry mice in line with the α-SMA expression pattern 
visualized through immunostaining of tissues for α-SMA. A representative 3D-
reconstructed longitudinal confocal image section depicting a cremasteric post-capillary 
venule of an α-SMA-RFPcherry mouse stained to visualise α-SMA is shown. The cremaster 
muscle was isolated from an unstimulated α-SMA-RFPcherry mouse, fixed in 4 % PFA and 
used whole mounted for immunofluorescence labelling using an Alexa-488 conjugate of the 
α-SMA antibody (clone 1A4). Arrows indicate pericyte nuclei, which seem to contain 
RFPcherry despite being α-SMA negative. Bar, 20 μm. 
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6.2.2 Confocal Intravital Microscopy to observe TNF-α-induced 
pericyte shape change in real time in cremasteric post-
capillary venules of α-SMA-GFP mice 
Based on the findings of TNF-α- and IL-1β-induced pericyte shape change in vivo, 
using ex vivo immunofluorescence labelling and confocal microscopy of whole 
mounted cremaster muscles (Chapter 4), TNF-α-induced pericyte shape change was 
further investigated in more detail in vivo using real time 4D confocal IVM. 
α-SMA-GFP mice were used for these experiments, because GFP seemed to be 
brighter then RFPcherry and more stable in terms of laser-induced fluorescence 
photobleaching. 
For real time confocal IVM analysis of pericyte shape change upon TNF-α 
stimulation, α-SMA-GFP mice were anaesthetised and cremaster muscles were 
exteriorised and pinned out flat over the optical window of a heated microscope stage. 
Throughout the experiment, cremaster muscles were constantly superfused with 
Tyrode’s salt solution. Z-stack images of a post-capillary venule were captured every 
1 min. After 5 min of imaging, pericyte shape change was induced by adding TNF-α 
to the Tyrode’s solution at 30 ng/ml and images were taken every 1 min for a further 
2 h and 30 min. The dose of TNF-α employed for topical application was determined 
in preliminary studies and the in vivo test period was that known to elicit significant 
pericyte shape change as observed in time-course studies of pericyte shape change 
induced by local injection of TNF-α (described in Chapter 4). As control, cremasters 
were superfused with Tyrode’s salt solution alone. 
When applying Tyrode’s salt solution alone, pericytes showed no change in cell shape 
over time (Figure 6.5 left column, Movie 6.1), whereas topical application of TNF-α 
led to a change in cell shape in a time-dependent manner resulting in an enlargement 
of gaps between adjacent cells (Figure 6.5 right column, Movie 6.2). Interestingly, 
when comparing the confocal IVM observations with the time-course studies of 
TNF-α-induced pericyte shape change detailed in Chapter 4, similar dynamics were 
noted despite differences in the method by which TNF-α was administered. In the 
time-course studies gap enlargement could already be seen after 30 min which 
continued to peak at the 2 h time point. In the confocal IVM experiments pericyte 
shape change could also be noted already around 30 min after topical application of 
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TNF-α and slowly continued to peak at the 2 h time point. These experiments 
illustrate that TNF-α-induced enlargement of gaps between adjacent pericytes might 
occur in a continuous manner evolving over a time period of around 2 h. After 2 h of 
TNF-α stimulation, the enhanced gaps seemed to decrease in size again resulting in 
gap sizes similar to basal level at the final time point (2 h 30 min). 
To asses whether the dose and in vivo test period used for topical application of 
TNF-α induced an inflammatory response in the cremaster muscle, tissues were 
dissected after confocal IVM, fixed in 4 % PFA and used whole mounted for 
immunofluorescence labelling to visualise neutrophils (MRP-14, red). Subsequently, 
cremaster muscles were used whole mounted for confocal microscopy to image the 
neutrophil transmigration response around the post-capillary venule imaged during 
confocal IVM. Tyrode’s salt solution alone induced no transmigration of neutrophils 
into the tissue (Figure 6.6 left panel), whereas after topical application of TNF-α 
transmigrated neutrophils could be detected (Figure 6.6 right panel). 
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Figure 6.5: Direct 4D confocal IVM to investigate pericyte shape change in response to 
TNF-α in real time. α-SMA-GFP mice were anaesthetised and cremaster muscles were 
exteriorised and pinned out flat over the optical window of a heated microscope stage. 
Cremaster muscles were constantly superfused with Tyrode’s solution. The top panel shows 
two 3D-reconstructed confocal images of cremasteric post-capillary venules at the start of a 
confocal IVM experiment (left: Tyrode’s control experiment, right: Topical application of 
TNF-α). Bars, 20 μm. After 5 min of imaging, TNF-α was applied by adding it to the 
Tyrode’s solution at 30 ng/ml. Boxed regions are shown enlarged underneath, representing 
subsections of these venules at indicated time points of the confocal IVM experiment. Bars, 
20 μm. 
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Figure 6.6 Neutrophil transmigration upon topical application of TNF-α during 4D 
confocal IVM. After confocal IVM (2 h and 30 min of topical application of either Tyrode’s 
solution or TNF-α), cremaster muscles were dissected, fixed in 4 % PFA and used whole 
mounted for immunofluorescence labelling to visusalise neutrophils (MRP-14, red). The 
images show 3D-reconstructed longitudinal confocal image sections of the same post-
capillary venules shown in Figure 6.3 after MRP-14 staining (left: Tyrode’s control 
experiment, right: Topical application of TNF-α). Bars, 50 μm. 
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6.2.3 Generation of α-SMA-RFPcherryxLys-EGFP mice 
As detailed in section 6.2.1 α-SMA-RFPcherry mice provide an excellent tool for 
direct in vivo real time imaging of pericytes surrounding cremasteric post-capillary 
venules using confocal IVM. We then obtained mice, which have enhanced Green 
Fluorescent Protein (eGFP) knocked into the lysozyme gene, exhibiting GFP-labelled 
neutrophils and monocytes. By crossing these two mouse strains, we generated mice 
that could be used for 4D confocal IVM to study the transmigration of GFP labelled 
leukocytes through gaps between RFPcherry labelled pericytes in cremasteric post-
capillary venules in real time (Figure 6.7). The α-SMA-RFPcherry mice are 
transgenic reporter mice and need therefore to be paired with mice that are WT for the 
transgene to avoid excessive multiplication of the transgene in their genome, which 
could lead to insertional mutagenesis of endogenous genes (Palmiter and Brinster, 
1985). Hence, instead of using C57BL/6 WT mice Lys-EGFP mice were used, which 
are also on a C57BL/6 background. Litters were for the most part α-SMA-RFPcherry 
positive and were tested for α-SMA-RFPcherry expression as described in 2.1.2.2. To 
ensure that all litters from these pairings express GFP, homozygous Lys-EGFP mice 
were used for breeding (Figure 6.7). 
The endothelial cell layer was also visualised in α-SMA-RFPcherryxLys-EFGP mice 
using immunofluorescence in vivo staining for PECAM-1 to observe not only 
leukocyte transmigration through gaps in the pericyte sheath but also their 
transmigration through the endothelium and their behaviour whilst migrating in 
between endothelial and pericyte layer (Figure 6.8). For this purpose, mice were 
injected i.s. with 2 μg anti-PECAM-1-Alexa647 antibody in 400 μl saline. To elicit 
leukocyte recruitment 300 ng TNF-α were injected i.s. together with the anti-
PECAM-1 antibody. This dose was that known to elicit significant leukocyte 
transmigration as observed in time-course studies shown in Chapter 4. After 2 h 
incubation, mice were anaesthetised and cremaster muscles were exteriorised for 
direct 4D confocal IVM. This time point was chosen since previous findings from our 
group and time-course studies shown in Chapter 4 indicate that at 2 h after i.s. 
injection of TNF-α most leukocytes are starting to transmigrate through the 
endothelium (Figure 6.8). 
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Figure 6.7: Diagram of crossing α-SMA-RFPcherry mice with Lys-EGFP mice to 
generate α-SMA-RFPcherryxLys-EGFP mice, which exhibit RFPcherry positive 
pericytes and GFP positive leukocytes. These mice are an excellent tool to observe and 
study leukocyte-pericyte interactions in real time using confocal IVM. 
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Figure 6.8: The novel α-SMA-RFPcherryxLys-EGFP mouse colony generated during 
the present project is a powerful tool for direct in vivo real time imaging of leukocyte-
pericyte interactions in post-capillary venules. α-SMA-RFPcherryxLys-EFGP mice were 
injected i.s. with 2 μg anti-PECAM-1-Alexa647 antibody and 300 ng TNF-α in 400 μl saline 
to label the endothelium (blue) and elicit leukocyte recruitment, respectively. After 2 h 
incubation, mice were anaesthetised and cremaster muscles were exteriorised for direct 4D 
confocal IVM to observe leukocyte transmigration through the endothelium and the pericyte 
sheath in real time. The images show a representative 3D-reconstructed longitudinal confocal 
image section depicting a post-capillary venule of an α-SMA-RFPcherryxLys-EGFP mouse, 
stained to also visualise the endothelial layer, at the beginning of a confocal IVM experiment. 
Bar, 20 μm. 
  161 
6.2.4 Confocal Intravital Microscopy to investigate association of 
gap size changes with leukocyte transmigration in 
cremasteric post-capillary venules of α-SMA-RFPcherryxLys-
EGFP mice 
The previous section showed that PECAM-1 labelled α-SMA-RFPcherryxLys-EGFP 
mice provide a powerful tool for direct in vivo real time imaging of leukocyte 
transmigration through endothelium and pericyte sheath in cremasteric post-capillary 
venules. 
Using these mice, the involvement of TNF-α-induced pericyte shape change in 
leukocyte transmigration was investigated by confocal IVM. α-SMA-RFPcherryxLys-
EGFP mice were prepared as described in the previous section. 2 h after anti-
PECAM-1-Alexa647 and TNF-α injection, mice were anaesthetised and cremaster 
muscles were exteriorised and pinned out flat over the optical window of a heated 
microscope stage. Z-stack images of a post-capillary venule were captured every 
1 min for 2 h since most leukocytes completed transmigration into the surrounding 
tissue during this time period (Figure 6.9, Movie 6.3). Throughout the experiment, 
cremaster muscles were constantly superfused with Tyrode’s salt solution. 
At the start of the imaging period most leukocytes were observed rolling along the 
vessel wall. This was followed by firm adhesion to endothelial cells and subsequent 
transmigration across the endothelium so that 1 h into imaging, the majority of 
leukocytes were migrating in between the endothelium and the pericyte sheath 
(Figure 6.9). During the last hour of confocal IVM most leukocytes completed the 
transmigration process (Figure 6.9). All transmigration events observed occurred via 
the paracellular route through gaps between adjacent pericytes. To associate changes 
in the size of gaps between pericytes with leukocyte transmigration, Dr. Mathieu-
Benoit Voisin quantified the size of gaps used by leukocytes to breach the pericyte 
sheath. The mean gap size used for transmigration (17.1 ± 4.0 μm2) was strikingly 
higher than the mean gap size of unstimulated cremasteric post-capillary venules but 
comparable with the mean gap size measured after TNF-α stimulation (results shown 
in Chapter 4). Upon local TNF-a stimulation for 2 h in the cremaster muscle the 
frequency of gap sizes within 7 - 16 μm2 increased from 25 % to 41 % and 50 % of 
leukocytes used gaps in this range to cross the pericyte layer (frequency profiles are 
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based on the analysis of the results described in Chapter 4) (Figure 6.10). Another 
34 % of leukoctyes used even bigger gaps with sizes ranging from 22 μm2 to 42 μm2 
(Figure 6.10). Hence, transmigrating leukocytes were preferentially using pericyte 
gaps that had enlarged upon TNF-α stimulation to migrate into the surrounding tissue. 
These results suggest that TNF-α-induced pericyte shape change might facilitate 
leukocyte transmigration during inflammatory conditions. 
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Figure 6.9: Direct 4D confocal IVM to investigate leukocyte transmigration through the 
endothelium and the pericyte sheath. α-SMA-RFPcherryxLys-EGFP mice were prepared as 
described in Figure 6.8. 2 h after anti-PECAM-1-Alexa647 and TNF-α injection, mice were 
anaesthetised and cremaster muscles were exteriorised and pinned out flat over the optical 
window of a heated microscope stage. Throughout the experiment, cremaster muscles were 
constantly superfused with Tyrode’s solution. The images show 3D-reconstructed 
longitudinal confocal image sections of the same post-capillary venule at indicated time 
points of a confocal IVM experiment. Bar, 20 μm. 
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Figure 6.10: Range of sizes of gaps between adjacent pericytes preferentially used by 
leukocytes to cross the pericyte sheath. The graph shows the frequency of different sizes of 
gaps between adjacent pericytes in cremasteric post-capillary venules in percent (quantified as 
described in 2.6.3). Frequency profiles were generated by analysis of the results shown in 
Chapter 4 (Figure 4.5). Results are from n = 4 – 5 cremaster muscles and at least three 
venules were analysed in each. Gap sizes in the depicted range (1 – 51 μm2) represent 98 % 
and 96 % of all detected gaps in unstimulated (light grey bars) and TNF-α-stimulated (blue 
bars) cremasteric venules, respectively. Boxed regions highlight ranges of gap sizes 
preferentially used by leukocytes to transmigrate through the pericyte layer as observed in 
confocal IVM experiments using α-SMA-RFPcherryxLys-EGFP mice (shown in Figure 6.9). 
The numbers inside the boxes represent the frequency of leukocyte transmigration events in 
the respective range of gap sizes in percent. 3D reconstructed images from these experiments 
were analysed to determine the sizes of gaps used by transmigrating leukocytes per 
experiments (quantified as described in 2.6.3). These data were obtained using four mice 
(equivalent to four confocal IVM experiments). 
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6.3 Discussion 
To extend the findings described in Chapters 4 and 5, pericyte shape change and its 
involvement in leukocyte transmigration was observed and studied in vivo in real time 
using 4D confocal IVM. Since to date no pericyte surface marker for pericytes 
surrounding cremasteric post-capillary venules in the mouse is known that could be 
used for immunofluorescence in vivo labelling, the transgenic pericyte marker mouse 
strains α-SMA-GFP and α-SMA-RFPcherry were used. Phenotypic assessment of 
α-SMA-GFP and α-SMA-RFPcherry mice revealed that in cremasteric blood vessels 
GFP or RFPcherry expression corresponded directly with the expression pattern of 
α-SMA seen by immunofluorescence labelling to visualise α-SMA. Collectively, the 
finding indicate that these mice provide an excellent tool for direct in vivo real time 
imaging of cremasteric post-capillary venular pericytes. 
Pericyte shape change was imaged using α-SMA-GFP mice, showing for the first time 
in vivo that pericytes in post-capillary venules change their shape in response to 
stimulation with the inflammatory cytokine TNF-α resulting in an enlargement of 
gaps between adjacent cells. This confirms the results obtained in time-course studies 
of TNF-α-induced pericyte shape change detailed in Chapter 4 as similar reaction 
profiles were noted. The confocal IVM experiments further elucidated the TNF-α-
induced reaction showing that the enlargement of gaps between pericytes occurs in a 
continuous manner. The TNF-α stimulation protocol also induced neutrophil 
transmigration as shown by MRP-14 staining of tissues. 
To examine pericyte involvement in leukocyte transmigration in vivo 
α-SMA-RFPcherry mice were crossed with Lys-EGFP mice to generate 
α-SMA-RFPcherryxLys-EGFP mice. This novel mouse colony enabled for the first 
time visualisation and study of leukocyte transmigration (GFP labelled) through the 
pericyte sheath (RFPcherry labelled) surrounding cremasteric post-capillary venules 
in real time. All transmigration events observed occurred via the paracellular route 
through gaps between adjacent pericytes. Quantifications of the size of gaps used by 
transmigrating leukocytes revealed that leukocytes seem to preferentially use enlarged 
pericyte gaps to migrate into the surrounding tissue. The majority of neutrophils 
transmigrated just after the 2 h time point, when the gap size was at its maximum, 
highlighting the possibility that pericyte shape change might play a critical role in 
facilitating leukocyte transmigration during inflammatory conditions. Pericyte shape 
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change resulting in significant enlargement of gaps between adjacent cells might 
therefore support leukocyte transmigration. This may occur via a number of means 
such as enhancing the permissiveness of the pericyte sheath to migrating cells and 
contributing to the establishment of chemoattractant gradients. Chemoattractants and 
chemokines could also be presented on the surface of pericytes, facilitating the 
interaction of leukocytes with pericytes. In this context, in vitro studies have shown 
that pericytes express glucosaminoglycans (GAGs) on their cell surface (Stramm et 
al., 1987) which are known to bind chemoattractants and chemokines (Johnson et al., 
2005). Pericyte might also play a part in the enlargement of regions of low matrix 
protein deposition in the vascular basement membrane (termed low expression 
regions, LE regions or LERs) since pericytes express receptors for main basement 
membrane components including the integrins α1β1, α2β1 (collagen receptors), α3β1, 
α6β1, α7β1, α6β4 (laminin receptors), α4β1 and α5β1 (fibronectin receptors) (Silva et al., 
2008). Previous studies from our group show that LERs are directly in line with gaps 
in the pericyte layer and also increase significantly in size in response to 
inflammatory mediators such as TNF-α, IL-1β, CCL2 and LTB4 (Wang et al., 2006; 
Voisin et al., 2009; Voisin et al., 2010). These studies also highlight the fact that 
transmigrating leukocytes preferentially use permissive sites consisting of gaps 
combined with aligned LERs to migrate through venular walls. In addition, different 
leukocyte subtypes might use different mechanisms to breach the pericyte sheath and 
might therefore depend differently on pericyte responses. For example our group has 
previously reported that although both neutrophils and monocytes preferentially use 
LERs for penetrating the vascular basement membrane, these leukocyte subtypes use 
different and independent mechanisms (Voisin et al., 2009). Finally, pericyte shape 
change, which might be due to a contractile response, could also act to regulate 
leukocyte transmigration through venular contraction terminating the response. 
Overall, confocal IVM using α-SMA-RFPcherryxLys-EGFP mice presents a powerful 
tool for direct in vivo real time imaging of leukocyte-pericyte interactions and could 
be used for further investigations into the mechanisms that regulate and mediate 
leukocyte transmigration through the pericyte layer. Compared to time-course studies 
using ex vivo immunofluorescence labelling and confocal microscopy, pericyte 
responses to different inflammatory stimuli can be investigated in a more detailed 
manner since it is now possible to investigate changes in pericyte shape by observing 
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the same vessel over time and taking 3D confocal images every minute. As a result, 
this technique also reduces the time needed and the number of mice used to complete 
a full time-course study. Finally, this advanced 4D imaging technique together with 
IMARIS now enables imaging and analysis of leukocyte-pericyte interactions, which 
cannot be investigated by ex vivo confocal analysis. Interestingly, confocal IVM 
experiments combined with IMARIS quantifications currently conducted by Dr. 
Mathieu-Benoit Voisin show that after transmigration through the endothelium 
leukocytes crawl along pericyte processes when in between the endothelial and the 
pericyte layer. This process seems to involve the presence of ICAM-1. Additional, 
immunofluorescence in vivo labelling to visualise PECAM-1 allows observing and 
examining leukocyte transmigration through both cellular components of the venular 
wall. However, this method is limited to shorter time-course experiments since mice 
can only be kept alive for a certain time period (up to 4 h – 6 h). 
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7.1 Project overview 
The recruitment of leukocytes from the circulation to sites of inflammation is a 
crucial event during inflammatory responses. In the last decade the understanding of 
the mechanisms involved in leukocyte transmigration through the endothelium has 
improved substantially (Ley et al., 2007; Woodfin et al., 2010) and recently some 
progress has been made in understanding how leukocytes breach the underlying 
vascular basement membrane and migrate within the extravascular tissue (Wang et 
al., 2006; Voisin et al., 2009; Nourshargh et al., 2010; Voisin et al., 2010). However, 
to date the role of pericytes in leukocyte migration has not been investigated. 
Therefore, this study aimed to elucidate the potential role of pericytes in regulating 
leukocyte transmigration and to identify the corresponding mechanisms by which 
leukocytes penetrate the pericyte sheath. The findings of this work contribute to our 
understanding of the events that mediate leukocyte transmigration during 
inflammatory conditions. 
7.1.1 Identification and characterisation of pericytes in different 
types of blood vessels and in different vascular beds in the 
mouse 
Due to the lack of specific markers for pericytes, initial studies investigated the 
expression profile of various commonly used pericyte markers in the cremaster 
muscle using immunofluorescence staining and confocal microscopy. These 
experiments showed that α-SMA and NG2 are highly expressed by cremasteric 
pericytes. However, the expression of these markers differed among pericytes 
depending on the vessel type. Only α-SMA was found to be expressed by pericytes 
surrounding post-capillary venules. Hence, α-SMA was used for the rest of this study 
as a marker to visualise post-capillary venular pericytes in the murine cremaster 
muscle as well as in various other murine tissues. 
In common with pericyte marker expression, differences were also evident in 
pericyte shape when comparing different vessel types in the cremaster muscle. 
Capillary pericytes showed an elongated cell body consisting of two major processes 
from which numerous small processes originated. Pericytes in post-capillary venules 
were irregular in shape and orientation and exhibited multiple major processes 
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forming a discontinuous layer with gaps between adjacent cells. This confirmed 
previous observations that had been made using electron microscopy (Shimada et al., 
1992) or immunofluorescence staining and confocal microscopy (Morikawa et al., 
2002; Wang et al., 2006). Pericytes on collecting venules exhibited many major 
processes, however, mainly arranged circumferentially. Interestingly, the transition 
between the different pericyte phenotypes - marker expression as well as morphology 
- occurred gradually. 
Pericyte morphology was also compared among post-capillary venules of different 
vascular beds, such as the cremaster muscle, the mesentery, the skin of the ear, the 
peritoneal wall and the diaphragm using immunofluorescence staining and confocal 
microscopy of whole mounted tissues. This study demonstrated, that in all vascular 
beds investigated the pericyte layer surrounding post-capillary venules is 
discontinuous with significant gaps between adjacent cells (Voisin et al., 2010). 
However, a significant diversity in pericyte shape and coverage was noted among 
these tissues, resulting in different mean size and density of gaps between pericytes. 
This highlights the existence of a wide range of vascular pericyte coverage, which 
has been reported previously to differ among organs (Diaz-Flores et al., 1991; 
Shepro and Morel, 1993; Egginton et al., 1996). This diversity could lead to 
differences in pericyte function and vascular permeability as well as contribute to 
tissue-specific mechanisms of leukocyte transmigration, which has been discussed in 
relation to the functional needs of different organs (Butcher and Picker, 1996; Petri et 
al., 2008). 
All the tissues investigated were also immunostained to visualise the vascular 
basement membrane component type IV collagen. In these vascular beds the 
collagen IV layer surrounding post-capillary venules was expressed in a 
heterogeneous manner and exhibited LERs which were directly aligned with gaps 
between adjacent pericytes. The same was true for laminin-511 and we obtained 
similar results for laminin-411 and nidogen in cremasteric post-capillary venules 
(Voisin et al., 2010). These findings suggest that pericytes are an important source 
for these basement membrane components and that their venular coverage 
determines the properties of the venular basement membrane (Figure 7.1). Several in 
vitro studies have shown that pericytes can generate key basement membrane 
constituents such as collagen IV, laminin and fibronectin (Cohen et al., 1980; 
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Mandarino et al., 1993; Stratman et al., 2009). Immunostaining for perlecan also 
revealed a heterogeneous expression. However, perlecan LERs were mainly located 
at venular regions covered by pericytes indicating that pericytes are not involved in 
the generation of this basement membrane component. Overall, both endothelial cells 
and pericytes have been linked to the generation of the venular basement membrane, 
however, differences may exist between the relative contributions of these two cell 
types to the different basement membrane components. 
 
Figure 7.1: Both endothelial cells and pericytes contribute to the generation of the 
venular basement membrane leading to a heterogeneous expression profile of most 
basement membrane components. The schematic diagram illustrates the formation of 
venular basement membrane components, which are synthesized by both cellular 
components of venules (endothelial cells and pericytes). Endothelial cells form a confluent 
layer, which results in the generation of a continuous layer of basement membrane (left). In 
contrast to that, the pericyte sheath is discontinuous leading to a heterogeneous expression 
profile of basement membrane components (right). Therefore, the morphology and 
expression profile of the two cell types govern the properties of the basement membrane, 
especially the formation of LERs (yellow circles). Taken from Voisin et al., 2010. 
7.1.2 TNF-α and IL-1β stimulation induced shape change in post-
capillary venular pericytes in vivo and in murine pericyte-
like C3H/10T1/2 cells in vitro 
Previous findings from our group have shown that transmigrating neutrophils 
preferentially use the permissive sites formed by pericyte gaps and aligned LERs 
illustrating a functional implication of pericytes in leukocyte trafficking, especially 
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concerning pericyte morphology and pericyte coverage (Wang et al., 2006; Voisin et 
al., 2009; Voisin et al., 2010). 
To elucidate the role of pericytes in inflammatory conditions, pericyte responses to 
different inflammatory mediators were investigated in cremasteric post-capillary 
venules. Topical application of the chemoattractant LTB4 or the chemokine CCL2 
onto the exteriorised cremaster muscle induced no change in pericyte morphology at 
the time points analysed. In contrast, I/R injury or intrascrotal injection of the 
inflammatory cytokines TNF-α or IL-1β elicited pericyte shape change resulting in a 
significant enhancement of gaps between adjacent cells (Figure 7.2). Intra dermal 
injection of TNF-α or IL-1β into the skin of the ear also induced a significant 
increase in the mean pericyte gap size, showing no evidence for a tissue-specific 
phenomenon. This part of the study showed for the first time pericyte responsiveness 
to inflammatory mediators in vivo indicating that pericyte shape change might play a 
role in leukocyte transmigration during inflammatory scenarios. 
TNF-α- and IL-1β-induced reactions were selected for more detailed investigations 
and the responses were characterised regarding the time-course of neutrophil 
transmigration and pericyte shape change in the cremaster muscle. Local injection of 
both TNF-α and IL-1β elicited neutrophil transmigration and a significant 
enhancement of gaps between adjacent pericytes in a time-dependent manner. 
Interestingly, with regards to TNF-α, both the on-set and termination of the induced 
pericyte shape change response was faster than that observed for IL-1β highlighting 
the existence of different mechanisms of action for these two pro-inflammatory 
stimuli. IL-1β induced pericyte shape change might involve de novo synthesis of 
secondary mediators such as inflammatory mediators or mediators of intracellular 
signalling involved in regulating shape change. In both the TNF-α- and the IL-1β-
induced reaction the density of gaps was not altered, suggesting that overall neither a 
loss nor a generation of new gaps occurred. Existing gaps just increased in size, 
which might be due to pericyte contractility in response to these inflammatory 
cytokines, since pericyte contractility upon TNF-α and IL-1β treatment has already 
been reported for rat lung pericytes in vitro (Kerkar et al., 2006) (Figure 7.3). In 
addition, TNF-α and IL-1β are known to activate small GTPases such as RhoA, Rac 
1 and cdc42, which are well known for their ability to regulate the actin cytoskeleton 
(Puls et al., 1999). To investigate the involvement of neutrophils in pericyte shape 
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change TNF-α- and IL-1β-induced reactions were studied in neutrophil depleted 
mice. Neutrophil depleted mice showed the same significant increase in mean gap 
size after TNF-α and IL-1β stimulation indicating that in both reactions pericyte gap 
enhancement did not involve neutrophilic mediators or the presence of neutrophils. 
 
Figure 7.2: Schematic illustration of TNF-α- and IL-1β-induced pericyte shape change 
resulting in an increase in the mean size of gaps between adjacent pericytes. Left: 
Components of post-capillary venular walls in unstimulated tissues: Endothelial cells (blue), 
pericytes (red, with gaps between adjacent cells) and the vascular basement membrane 
(yellow, including LERs). Right: Local injection of TNF-α or IL-1β induced changes in 
pericyte morphology leading to a significant increase in the average pericyte gap size. In 
addition, our group has also shown that LERs, which are directly in line with gaps in the 
pericyte layer, significantly increase in size (Wang et al., 2006; Voisin et al., 2009; Voisin et 
al., 2010). 
The in vivo findings of TNF-α- and IL-1β-induced pericyte shape change were 
complemented with in vitro analysis of pericyte responsiveness to these 
inflammatory cytokines using the murine pericyte-like cell line C3H/10T1/2. By 
performing in vitro experiments, pericytes could be investigated singled out from 
their environment to elucidate whether the responses observed in vivo were 
dependent on cross talks with other cell types (e.g. endothelial cells). Fluorescence 
time lapse microscopy experiments showed that both TNF-α and IL-1β stimulation 
led to a respective change in cell shape in a time-dependent manner resulting in a 
significant cell elongation quantified by measuring cell eccentricity. This supports 
the in vivo findings of pericyte shape change during inflammatory conditions and 
provides further evidence to suggest that post-capillary venular pericytes are able to 
change their shape in direct response to TNF-α and IL-1β (Figure 7.3). Interestingly, 
TNF-α-induced cell elongation occurred more rapidly than it did upon IL-1β 
stimulation highlighting again the existence of different mechanisms of action for 
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these two pro-inflammatory stimuli and supports the hypothesis that IL-1β induced 
pericyte shape change might involve de novo synthesis of secondary mediators. 
To elucidate whether TNF-α or IL-1β can act directly on pericytes the expression 
profiles of the respective receptors (TNFRI/II and IL-1RI) were investigated in vitro 
and in vivo. These receptors have been reported to be present on endothelial cells 
(Orlinick and Chao, 1998; Eissner et al., 2004; Hehlgans and Pfeffer, 2005; Boraschi 
and Tagliabue, 2006), but this study demonstrated for the first time IL-1RI, and 
TNFRI/II expression on the second cellular layer of cremasteric post-capillary 
venules, the pericyte sheath, in vivo and on C3H/10T1/2 cells in vitro. Therefore, 
TNF-α- and IL-1β-induced pericyte shape change leading to gap enhancement might 
well be a direct effect of these cytokines on pericytes (Figure 7.3). 
 
Figure 7.3: Schematic illustration of pericytes facilitating leukocyte transmigration via 
gap opening upon direct TNF-α and IL-1β stimulation. Components of post-capillary 
venular walls are illustrated under TNF-α or IL-1β stimulation: Endothelial cells (blue), 
pericytes (red, with enhanced gaps between adjacent cells) and the vascular basement 
membrane (yellow, including increased LERs). Both endothelial cells and pericytes 
expressed IL-1RI (light pink) and TNFRI and II (light blue). Therefore locally administered 
TNF-α (blue) or IL-1β (pink) can act directly on pericytes inducing the increase in mean gap 
size in the pericyte layer. Gap enhancement might be due to a contractile response of 
pericyte to TNF-α and IL-1β stimulation. Pericyte contraction and the formation of stress 
fibers are depicted inside the cells as black arrows and black lines, respectively. Enhanced 
gaps were used by transmigrating neutrophils (green) as gates to cross the pericyte sheath. 
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7.1.3 Role of pericyte shape change in leukocyte transmigration 
in vivo 
The above findings highlight the possibility that pericytes might play a regulatory 
role in facilitating leukocyte transmigration via active shape change during 
inflammatory conditions. Therefore, pericyte shape change and its involvement in 
leukocyte transmigration were further investigated in more detail in vivo using 4D 
real time confocal intravital microscopy. Since to date no pericyte surface marker for 
pericytes surrounding cremasteric post-capillary venules in the mouse is known that 
could be used for immunofluorescence in vivo labelling, the transgenic pericyte 
marker mouse strains α-SMA-GFP and α-SMA-RFPcherry were used. GFP and 
RFPcherry expression in cremasteric blood vessels corresponded directly with the 
expression pattern of α-SMA seen by immunofluorescence labelling. 
Using α-SMA-GFP mice, this study showed for the first time in vivo in real time that 
pericytes in post-capillary venules change their shape in response to stimulation with 
the inflammatory cytokine TNF-α resulting in an enlargement of gaps between 
adjacent cells. This confirms the time-course studies of TNF-α-induced pericyte 
shape change as similar reaction profiles were noted. Furthermore, this experiment 
showed that the enlargement of gaps between pericytes occurs in a continuous 
manner. 
To examine pericyte involvement in leukocyte transmigration in vivo, 
α-SMA-RFPcherry mice were crossed with Lys-EGFP mice to generate 
α-SMA-RFPcherryxLys-EGFP mice. This novel mouse colony enabled for the first 
time visualisation and study of leukocyte transmigration (GFP labelled) through the 
pericyte sheath (RFPcherry labelled) around cremasteric post-capillary venules in 
real time. All transmigration events observed occurred via the paracellular route 
through gaps between adjacent pericytes. Quantifications of the size of gaps used by 
transmigrating leukocytes revealed that leukocytes seem to preferentially use 
enlarged pericyte gaps to migrate into the surrounding tissue (Figure 7.3). Hence, 
pericyte shape change resulting in significant enlargement of gaps between adjacent 
cells seems to support leukocyte transmigration, but the underlying mechanisms 
remain to be investigated. Pericyte shape change, which might be due to a contractile 
response, might enhance the permissiveness of the pericyte sheath to migrating cells 
and could contribute to the establishment of chemoattractant gradients (Figure 7.4). 
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In addition, chemokines and chemoattractants could also be presented on the surface 
of pericytes, facilitating the interaction of leukocytes with pericytes (Figure 7.4). 
Pericyte contraction could also act to regulate leukocyte transmigration through 
venular contraction terminating the response. Finally, pericytes might also play a part 
in the enlargement of basement membrane LERs since pericytes express receptors 
for main basement membrane components including the integrins α1β1, α2β1 
(collagen receptors), α3β1, α6β1, α7β1, α6β4 (laminin receptors), α4β1 and α5β1 
(fibronectin receptors) (Silva et al., 2008). Experimental approaches to investigate 
these potential mechanisms in future and additional future directions are detailed in 
the following sections. 
 
Figure 7.4: Hypothetical scenario of additional means by which enlarged pericyte gaps 
could aide leukocyte transmigration. Apart from increased permissiveness to 
transmigrating neutrophils as shown in Figure 7.3 enhanced pericyte gaps could also be more 
accessible to chemokines and chemoattractants (orange) and hence contribute to the 
establishment of chemoattractant gradients (depicted as an accumulation of chemokines and 
chemoattractants in gaps between adjacent pericytes). In addition, chemokines and 
chemoattractants could also be presented on the surface of pericytes bound to 
glycosaminoglycans (GAGs, black), facilitating the interaction of leukocytes with pericytes. 
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7.2 Future directions 
7.2.1 Analysis into the mechanisms by which pericytes mediate 
leukocyte transmigration through enhanced gaps between 
adjacent cells 
This study demonstrated that in the murine cremaster muscle TNF-α or IL-1β induce 
enlargement of gaps between adjacent pericytes and that this response supports 
neutrophil transmigration through the pericyte sheath. Future experiments should 
investigate the underlying mechanisms of pericyte shape change and elucidate how 
pericytes mediate neutrophil guidance towards as well as through enlarged gaps. 
The reaction profiles of pericyte shape change observed for TNF-α and IL-1β 
differed in terms of reaction speed in vitro and in vivo highlighting the existence of 
different mechanisms of action for these two pro-inflammatory stimuli. On-set and 
termination of pericyte shape change was slower when induced by IL-1β stimulation 
indicating that IL-1β induced pericyte shape change might involve de novo synthesis 
of secondary mediators. Secondary mediators could be inflammatory mediators (e.g. 
chemokines) or mediators of intracellular signalling pathways important for cell 
shape change. Dependence of pericyte shape change on de novo protein synthesis 
could be determined by using inhibitors of transcription or protein biosynthesis such 
as actinomycin D or cycloheximide, respectively. Depending on the outcome, 
secondary mediators could be identified in the cremaster muscle using 
immunofluorescence labelling and confocal microscopy. In addition, initial in vitro 
experiments should be performed using the murine pericyte-like cell line 
C3H/10T1/2 or even primary murine pericytes (potential isolation procedure is 
detailed in section 7.2.2). Secreted proteins could be detected in cell culture 
supernatants and changes in the expression of intracellular proteins could be 
investigated upon cell lysis by using enzyme-linked immunosorbent assay (ELISA) 
or Western Blot. In addition, gene expression arrays could be used to screen 
numerous genes for changes in expression. 
As indicated in Figure 7.3, TNF-α- and IL-1β-induced pericyte shape change leading 
to gap enhancement might be due to pericyte contraction. Pericyte contractility upon 
TNF-α and IL-1β treatment has already been reported for rat lung pericytes in vitro 
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(Kerkar et al., 2006). Furthermore, TNF-α and IL-1β are known to activate small 
GTPases such as RhoA, Rac 1 and cdc42, which are known to regulate the actin 
cytoskeleton (Puls et al., 1999). In vitro studies using bovine retinal pericytes 
demonstrated that RhoA but not Rac 1 and cdc42 mediates pericyte contractility 
(Kolyada et al., 2003; Kutcher et al., 2007; Kutcher and Herman, 2009). To elucidate 
whether TNF-α- and IL-1β-induced pericyte shape change is RhoA dependent, in 
vivo shape change experiments including RhoA inhibitors could be performed. 
However, these inhibitors could cause enormous side effects in vivo, since inhibition 
of RhoA would occur in every cell type. These side effects could then have an 
influence on pericyte responses. Therefore, in vitro time lapse experiments of 
TNF-α- and IL-1β-induced pericyte shape change including RhoA inhibitors might 
be more suitable, especially if primary murine pericytes can be used. Recently, mice 
have been generated that express the actin probe Lifeact-GFP (Riedl et al., 2010). 
These mice could provide a powerful tool to investigate the formation of actin stress 
fibers upon TNF-α or IL-1β stimulation in vivo in real time using confocal IVM, 
provided that it is possible to distinguish pericytes from endothelial cells, since all 
cells express Lifeact-GFP in these mice. 
Especially important future experiments are investigations into the mechanisms by 
which neutrophils are attracted to enlarged pericyte gaps. Interestingly, confocal 
IVM experiments combined with IMARIS quantifications, conducted by Dr. 
Mathieu-Benoit Voisin, showed that after transendothelial migration neutrophils 
crawl along pericyte processes to reach preferred gaps to exit the pericyte layer 
toward the extravascular space. This process involved the presence of ICAM-1 since 
including an ICAM-1 blocking antibody abolished abluminal crawling of 
neutrophils. Immunofluorescence labelling of cremaster muscles showed that apart 
from endothelial cells pericyte on post-capillary venules also express ICAM-1, which 
is increased post TNF-α stimulation. These results suggest a close interaction of 
neutrophils with pericytes, which could be ICAM-1 mediated. In addition, the cell 
adhesion molecule VCAM-1 has been implicated in T cell adhesion to TNF-α-
stimulated pericytes in vitro and has been shown to be expressed by brain pericytes 
during multiple sclerosis (Verbeek et al., 1995), suggesting that this molecule could 
also contribute to neutrophil-pericyte interactions upon TNF-α stimulation in vivo. 
Therefore, the presence of cell adhesion molecules such as VCAM-1 and integrins 
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and their implication in neutrophil transmigration should be investigated via 
immunofluorescence staining and confocal IVM, respectively. 
Enlargement of gaps between adjacent pericytes could support neutrophil 
transmigration via the establishment of chemoattractant gradients since pericyte gaps 
could be more permissive to chemokines and chemoattractants. Therefore, 
immunofluorescence staining could be performed to elucidate the localisation of 
chemoattractant molecules to determine whether they accumulate in pericyte gaps. 
Chemokines and chemoattractants could also be presented on the surface of 
pericytes, facilitating the interaction of neutrophils with pericytes. In this context, in 
vitro studies have shown that pericytes express glucosaminoglycans (GAGs) on their 
cell surface (Stramm et al., 1987) which are known to bind chemoattractants and 
chemokines (Johnson et al., 2005). Hence, immunofluorescence staining to visualise 
chemokines and GAGs could be performed in vivo. 
Furthermore, pericytes could facilitate neutrophil transmigration via the generation 
and release of pro-inflammatory mediators or proteases during inflammatory 
reactions. Therefore, their ability to generate pro-inflammatory mediators or 
proteases should be investigated. This could be done in vitro upon TNF-α and IL-1β 
stimulation by either using flow cytometry analysis of permeabilised cells or 
ELISA/Western Blot analysis of cell culture supernatants and cell lysates. 
The present study together with other studies from our group showed LERs of most 
basement membrane components are directly aligned with gaps between adjacent 
pericytes and that they form permissive regions which are preferentially used by 
transmigrating neutrophils (Wang et al., 2006; Voisin et al., 2009; Voisin et al., 
2010). These findings also suggest that pericytes are an important source for most 
basement membrane components. Several in vitro studies have shown that pericytes 
can generate key basement membrane constituents such as collagen IV, laminin and 
fibronectin (Cohen et al., 1980; Mandarino et al., 1993; Stratman et al., 2009). 
However, to date neither in vitro nor in vivo studies have been performed that 
directly compare the ability of endothelial cells and pericytes to generate different 
components of the vascular basement membrane in terms of relative contributions. 
Hence, in vitro experiments could be performed to investigate the expression of 
basement membrane components either in vitro by Real time PCR (RT-PCR) or flow 
cytometry of permeabilised cells or in vivo via immunofluorescence staining and 
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confocal microscopy. In addition, the presence of basement membrane components 
in cell culture supernatants could be examined under basal as well as inflammatory 
conditions using ELISA or Western Blot. 
7.2.2 Isolation of primary murine pericytes 
In the present study, the pericyte-like C3H/10T1/2 cells were used for in vitro studies 
into pericyte properties, but C3H/10T1/2 cells are a cell line and cannot be 
considered to be “authentic” pericytes. To avoid using pericyte-like cells in future, 
the isolation of primary murine pericytes should be established. However, isolation 
of primary pericytes from murine tissues presents technical difficulties due to the 
lack of specific markers for pericytes. Most methods for isolation and cultivation of 
pericytes to date are based on the selective culture of cell populations derived from 
tissues that exhibit high numbers of pericytes. Therefore, tissues from larger animals 
are used as a source (mainly rat lung and bovine retina). To date only two studies 
exist describing the isolation of primary pericytes from murine tissue (Tidhar et al., 
2001; Brachvogel et al., 2007), but these studies isolate all perivascular cells 
including smooth muscle cells. Primary murine pericytes could be isolated from 
α-SMA-GFP mice or α-SMA-RFPcherry mice using NG2 staining and fluorescence-
activated cell sorting (FACS). Using this approach, different perivascular cell subsets 
could be selectively collected to investigate their properties in vitro, isolated from 
other cell types. In addition, co-culture experiments with murine endothelial cells 
could be established. These could be used to investigate whether endothelial cells 
support and hence possibly even enhance pericyte shape change upon TNF-α and 
IL-1β stimulation, since they also express the respective receptors and have been 
reported to exhibit close interaction with pericytes. For instance, communication and 
exchange of small molecules has been shown in vitro to occur between 
microvascular endothelial cells and pericytes via gap junction (Larson et al., 1987). 
Furthermore, pericyte-endothelial cell co-cultures could be compared to pericytes 
alone in terms of permissiveness to neutrophils under both basal and inflammatory 
conditions. 
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7.2.3 Investigation into pericyte responsiveness in other vascular 
beds in the mouse 
Investigations into pericyte responses could be extended to post-capillary venules in 
other vascular beds. Local injection of TNF-α and IL-1β induced pericyte shape 
change in both the cremaster muscle and the skin of the ear, which indicates that this 
might not be a tissue-specific phenomenon. However, this should be investigated in 
additional vascular beds. Using immunofluorescence staining and confocal 
microscopy, the effect of TNF-α or IL-1β stimulation on pericyte shape could also be 
investigated in tissues such as the mesentery. Furthermore, pericytes and their 
responses could also be characterized on post-capillary venules in tissues that are not 
thin and transparent enough to be used whole mounted for confocal microscopy such 
as brain, heart and kidney. Tissue sections that are thick enough to allow for imaging 
of whole vessels (100 - 200 µm thick) could be cut from these tissues using a 
vibratome. Subsequently, these sections could be used for fluorescence 
immunostaining and confocal analysis. 
Especially interesting are investigations into pericyte responses in the mesentery, 
since gaps between adjacent pericytes are already quite large under basal conditions 
(more than twice as large as in the cremaster). In this tissue, pericyte responses to 
inflammatory stimuli could even be investigated in vivo in real time using confocal 
intravital microscopy (IVM) and α-SMA-GFP or α-SMA-RFPcherry mice. In 
addition, pericyte gaps and potential gap enhancement could be associated with 
neutrophil transmigration in α-SMA-RFPcherryxLys-EGFP mice as done for the 
cremaster muscle. 
7.2.4 Pericyte responses to other pro-inflammatory stimuli and 
during chronic inflammatory conditions 
The effects of other inflammatory stimuli on pericyte shape change and gap 
enhancement should also be investigated in more detail regarding their reaction 
profile in vitro and in vivo. Apart from the effects of TNF-α and IL-1β, this study has 
looked at pericyte responses to stimulation with the chemokine CCL2 and the 
chemoattractant LTB4, both of which did not induce changes in pericyte shape. 
However, just a single time point was investigated. Therefore time-course studies or, 
depending on the reaction speed, even confocal IVM should be performed. Other 
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stimuli that do not induce neutrophil infiltration such as histamine or serotonin could 
also be investigated, since TNF-α-and IL-1β-induced pericyte shape change occurred 
in a neutrophil independent manner. Furthermore, pericyte responses could be 
studied in experimental mouse models of chronic inflammatory conditions such as 
inflammatory bowel disease or autoimmune diseases (e.g. multiple sclerosis, mouse 
model: Experimental autoimmune encephalomyelitis (EAE)), since all investigated 
reactions to date have been acute inflammatory responses. 
In addition, since this study could demonstrate that pericytes express receptors for 
TNF-α and IL-1β, the expression of receptors for other inflammatory stimuli that 
caused pericyte responses could be examined and the expression profile of all 
receptors could be investigated under basal and inflammatory conditions. 
7.2.5 Do different leukocyte subtypes use different mechanisms 
to migration through the pericyte sheath? 
Concerning transmigration through LERs in the venular basement membrane 
different leukocyte subtype use different mechanisms to breach this barrier (Voisin et 
al., 2009). Hence, monocyte might also behave differently in penetrating the pericyte 
layer when compared to neutrophils. Therefore, monocyte-pericyte interactions and 
monocyte transmigration through the pericyte sheath should be studied in future. For 
this purpose, neutrophil depleted mice together with immunofluorescence staining to 
visualise monocytes and pericytes could be used for confocal microscopy. 
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